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Abstract  
Microalgal biotechnology has attracted considerable interest owing to it is potential to 
provide renewable energy and its capacity to produce molecules such as pigments, fatty 
acids and other high value compounds, which can be used in the biomaterials, cosmetics 
and pharmaceutical industries. One class of compounds are the terpenoids: a diverse group 
of molecules derived from C5 isoprene units that are exploited for their aromatic and 
bioactive properties. Terpenoid production in microalgae offers an alternative to extraction 
from plant species or chemical synthesis. However, metabolic engineering technology for 
microalgae is still in its infancy and far from economic viability. Thus, the aim of this study 
was to develop engineering tools for the industrial algal species Nannochloropsis gaditana, 
with the goal of manipulating the main terpenoid pathway located in the chloroplast. In 
parallel, the effects of such manipulation was studied using the laboratory species 
Chlamydomonas reinhardtii, for which chloroplast genetic engineering is already 
established.  
N. gaditana is a robust marine species well suited to industrial scale cultivation. The 
availability of a draft genomic sequence, nuclear transformation methodology and a high 
lipid productivity have positioned N. gaditana as a promising oleaginous alga for metabolic 
engineering. However, to develop it as an industrially relevant platform, further molecular 
tools are needed; in particular a reliable chloroplast transformation method. Thus, the aim 
of the first project was to develop chloroplast transformation for the alga. This involved 
optimizing the cultivation conditions for N. gaditana, evaluating its sensitivity to herbicides 
and chloroplast specific compounds in order to identify suitable selectable markers, and to 
construct chloroplast transformation vectors. In addition, the temporary increase in cell 
size by inhibition of cytokinesis was investigated in order to facilitate the delivery of DNA 
into the small chloroplast.  
C. reinhardtii is the most developed algal model with well-established tools for genetic 
manipulation, and can be used to study the effect of chloroplast metabolic engineering in 
other species such as Nannochloropsis. Thus, the second project focused on the 
manipulation of the terpenoid biosynthetic pathway: specifically, the chloroplast-localized 
methylerythritol phosphate pathway by over-expressing the rate limiting enzyme; 1-deoxy-
D-xylulose-5-phosphate synthase (DXS). An additional dxs gene from the cyanobacterium 
Synechocystis 6803 was introduced into the chloroplast genome in the hope of improving 
the productivity of downstream terpenoid metabolites. A number of transgenic lines were 
obtained and the successful integration was confirmed by molecular analysis. The effects of 
up-regulating DXS enzyme activity on overall algal growth and terpenoid profile are studied.  
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1. Introduction  
1.1. Algae 
Algae are a highly diverse and polyphyletic group of organisms that are capable of 
performing photosynthesis, and range from small unicellular or filamentous organisms 
(microalgae) that are only a few micrometres in diameter to complex multicellular 
macroalgae that are tens of meters long such as the giant Laminiaria seaweeds  (Leliaert et 
al. 2012; Friedl et al. 2012). The cyanobacteria (also known as blue-green algae) are 
traditionally considered to be algae, although they have a prokaryotic structure and most 
sources reserve the term “algae” for photosynthetic eukaryotes (Friedl et al. 2012). Algae 
live in diverse ecological habitats, with most being found in aquatic environments include 
freshwater, seawater and brackish water, while some algae are adapted to terrestrial 
environments such as soil, rocks and snow (Friedl et al. 2012; Purton 2001). The majority 
of algae are free-living cells, however, some algae form symbiotic relationships with 
multicellular organisms that need to gain access to photosynthetically-fixed carbon. Such 
symbiotic associations are commonly found in Cnidaria (corals, sea anemones and jellyfish) 
and the phyla Porifera (sponges) (Bruck & Garbe 2012). The most relevant example is the 
symbiotic relationship of the dingoflagellates with marine invertebrate such as coral and 
sea anemones, commonly referred to as zooxanthellae. 
In the context of evolution, it is widely accepted that algae originate from primary, 
secondary and tertiary endosymbiosis that involves the integration of several genomes 
from the hosts and symbionts to function as a single cell (Keeling 2004). Algae are indeed 
simple organisms compared to the higher plants, since they lack roots, leaves and other 
differentiated structures; however, both higher plants and algae possess chloroplasts for 
photosynthesis by which CO2 is fixed to synthesise carbohydrates and other cellular 
compounds using solar energy. All algal chloroplasts contain chlorophyll a as a primary 
photosynthetic pigment, and additional accessory pigments that vary among different algal 
groups (Purton 2001). The presence or absence of these accessory pigments has 
traditionally been used as a parameter in the taxonomic classification of algae, for example 
into green, red and brown algae. Nevertheless, the system of algal classification has changed 
remarkably with the availability of modern technologies that facilitate the study of 
evolutionary relationships between algae, through analysis of their ultrastructural 
characteristics using electron microscopy, together with molecular phylogenetics of nuclear 
and organelle genomes (Adl et al. 2005).  
 
 
 
16 
The biodiversity of algae is remarkable (Figure 1.1), as it is estimated that there are 30,000 
– 40,000 distinct algal species that have been described to date, and other algal species as 
yet undiscovered that may exceed the number of known species (Friedl et al. 2012). Such 
diversity accounts for the extremely broad variety of natural products that potentially could 
be exploited for various applications as nutraceuticals, cosmetics, pigments and 
pharmaceuticals (Table 1.1). Studies also suggest the potential uses of algae  in wastewater 
treatment, bioremediation and in agriculture as biofertiliser (Gangl et al. 2015; Georgianna 
& Mayfield 2012).  
In recent years there has been a considerable interest in the use of algae as a production 
platform for high value recombinant proteins due to their fast growth rate in comparison to 
higher eukaryotes and their ability to grow autotrophically thereby making the cultivation 
process potentially simple and cost effective (Barrera & Mayfield 2013; Georgianna & 
Mayfield 2012). Furthermore, a number of algal species have been assigned GRAS 
(Generally Recognized As Safe) status, which means they are safe for human consumption 
and subsequently there is no need for stringent purification steps for recombinant proteins, 
or perhaps the algae could be used as edible delivery systems (Barrera & Mayfield 2013; 
Rasala et al. 2013). In order to exploit these algae as a production platform, progress is being 
made in the development of genetic transformation methodologies for various algal species 
from distinctive groups (Kirchmayr & Griesbeck 2012). In addition, we are witnessing the 
development of modern strategies in reverse genetics to allow strain improvements by 
targeting endogenous genes through  knockouts or knockdown, or knocking-in of foreign 
genes (Shin et al. 2016; Scaife et al. 2015). However, to establish algae as effective platforms 
for industrial applications, advanced genetic engineering tools are required for more algal 
species, particularly those with industrial potential to allow the genetic manipulation of 
endogenous genes and the introduction of foreign genes (Gimpel et al. 2015; Georgianna & 
Mayfield 2012), as currently these advanced genetic tools are, to some extent, limited to the 
model algae Chlamydomonas reinhardtii and Phaeodactylum tricornutum (Spicer & Purton 
2016; Scaife et al. 2015). 
In the light of ongoing interest in algae as a source of renewable energy and natural 
products, recent efforts have also focused on improving algal cultivation systems at 
commercial scale (Figure 1.2). At present, the developed cultivation systems mainly fall into 
two categories: i) open raceway systems and ii) closed photobioreactor systems. In general, 
the choice of cultivation system depends on the species and the final products, as each of 
these systems has advantages and disadvantages (Ugwu et al. 2008; Chisti 2008). As such, 
closed photobioreactor systems offer proper containment for genetically modified algae, 
with a greater degree of control over growth conditions, and also minimise the 
contamination that is normally associated with open raceway systems (Wang et al. 2013). 
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On the other hand, open raceways are cost effective and are commonly used for algal species 
with extreme growth requirements, as the case for the extreme halophile Dunaliella salina 
(Ugwu et al. 2008). 
 
Figure 1.1 Algae biodiversity  
Selected examples of genera and species of algae exhibiting remarkable morphological and ecological 
diversity. (a) Light micrograph of a colony of the freshwater green alga Volvox sp. (b) Light 
micrograph of Pinnularia, a freshwater diatom. (c) Light micrograph of red marine microalga 
Porphyridium purpureum. (d) The brackish green microalgae species with flagella; Tetraselmis 
tetrathele. (e) The freshwater green Haematococcus pluvialis at resting stage. (f) Macrocystis pyrifera 
(giant kelp). Images are not on scale. The images (a, b and f) are taken from a website and (c, d and 
e) from Friedl et al. (2012).  
 
 
 
 
 
 
 
 
 
 
 
 
 
a b c 
d  e f 
 
 
18 
Table 1.1 Examples of microalgae currently used in or potentially suitable for 
biotechnological applications.  
Abbreviations are PUFA: polyunsaturated fatty acid, EPA: eicosapentaenoic acid, DHA: 
docosahexaenoic acid. Table is adapted from Friedl et al. (2012). 
Algal species/ genus Habitats Compounds and Applications 
Chlamydomonas reinhardtii Freshwater Recombinant proteins 
Dunaliella Marine Carotenoids (β-carotene), glycerol 
Haematococcus pluvialis Freshwater Fatty acids, carotenoids (astaxanthin) 
Botryococcus braunii Freshwater Oil, carbohydrates 
Chlorella vulgaris Freshwater Fatty acids, carbohydrates 
Nannochloropsis 
  
 
Marine water 
and freshwater 
Most promising algal EPA producer PUFA (EPA, DHA), 
lipids; pigments, carotenoids; β-1,3-glucan; poultry 
feed; aquaculture: rotifer and bivalve feed 
Skeletonema costatum 
 
marine PUFA (EPA); antibacterial activity, β-1,3-glucan; 
cosmetics: anti-ageing and anti-cellulite effects, 
aquaculture: mollusc and oyster feed; waste water 
treatment: detoxification of cadmium and copper, 
biodegradation of phenolic compounds  
Porphyridium cruentum  Marine, 
brackish and 
freshwater  
PUFA (EPA), pigments (phycoerythrin); antiviral 
activity, sulfated polysaccharides, antioxidants; poultry 
feed  
Haslea ostrearia  Freshwater  PUFA (EPA), linoleic acid; marennine (colouring agent); 
isoprenoids, tetra-unsaturated sesterterpenoids 
(haslenes)  
Phaeodactylum tricornutum  Freshwater  PUFA (DHA, EPA), lipids; aquaculture: rotifer feed  
Euglena gracilis  Freshwater PUFA, lipids; β-1,3-glucan (Paramylon), α-tocopherol  
Crypthecodinium cohnii  Freshwater  High content of PUFAs (DHA); pigments as colouring 
agents; extracts used in promoting lactic acid and 
bifidus bacterial growth; pharmaceuticals; pet foods; 
aquaculture feed  
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Figure 1.2 Algal cultivation systems 
Examples of different cultivations systems for microalgae; (A) Tubular photobioreactor at 
AlgaePARC in Wageningen, Netherlands (B) Hanging bags at Supreme Biotechnologies Ltd, located 
in Nelson, New Zealand, (C) Cascade open raceway cultivation system at Algae for Future (A4F) in 
Lisbon, Portugal (D) Hanging bag supported with steel-mesh frame at Vitaplankton Ltd, located in 
North Wales, United Kingdom.   
 
 
 
 
 
 
 A  B 
 C  D 
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1.2. Nannochloropsis species 
1.2.1. Nannochloropsis biology 
Nannochloropsis species are unicellular coccoid microalgae with high photoautotrophic 
biomass accumulation and high lipid content (Radakovits et al. 2012). As shown in Figure 
1.3, they are simple non-flagellated cells with a diameter of  2–4 μm that belong to the class 
of Eustigmatophyceae within the Heterokontophyta (Sukenik 1999). Each cell has one or 
more chloroplasts that occupy a large portion of the cell volume and contains chlorophyll a 
but not chlorophyll b or c. Other accessory pigments in the chloroplast include violaxanthin, 
β-carotene and vaucheriaxanthin ester (van de Hoek et al. 1995). The chloroplast is derived 
from the secondary endosymbiosis of a red alga, so it is complex compared to that of 
chlorophyte algae as it is surrounded by four membranes (Janouskovec et al. 2010). The 
outermost plastid membrane is connected with the outer nuclear envelope membrane to 
form a structure called a nucleus–plastid continuum (Murakami & Hashimoto 2009). The 
cell wall of Nannochloropsis species is made of cellulose with sulphated fucans, however, 
there is variation in the cell wall thickness among Nannochloropsis species (Corteggiani 
Carpinelli et al. 2014; Arnold et al. 2014). Interestingly, the saline growth conditions 
influence the thickness of the cell wall within a species. This response could be useful for 
industrial applications, where the growth conditions of these species could be optimised to 
suit downstream processing (Beacham et al. 2014).  
The Nannochloropsis genus is traditionally classified as consisting of the species 
Nannochloropsis gaditana, Nannochloropsis salina, Nannochloropsis oculata, 
Nannochloropsis granulata, Nannochloropsis oceanica and Nannochloropsis limnetica 
(Murakami & Hashimoto 2009). However, recent studies have suggested either 
reclassification of some species within the Nannochloropsis genus or addition of a new 
species such as Nannochloropsis australis based on rbcL and 18S rDNA sequencing data 
(Fawley et al. 2015; Starkenburg et al. 2014). Species that are currently classified as 
Nannochloropsis live in marine environments with the exception of N. limnetica, which is 
typically found in fresh and brackish water (Jinkerson et al. 2013). Nannochloropsis species 
have been reported by Kilian et al. (2011) as having a haploid genome, which is potentially 
useful for the identification of dominant and recessive mutations since both mutations 
display a phenotype. Nonetheless, there are no reports on the sexual reproduction of 
Nannochloropsis species. The absence of a diploid state limits the possibility of using 
classical breeding programs to improve desirable traits, map mutations and eliminate 
undesired mutations. 
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 Several species in the genus Nannochloropsis are recognised as being oleaginous due to 
their ability to produce naturally large quantities of lipids up to 60% of dry weight under 
various stress conditions, although there is variation in the lipid productivity and fatty acid 
composition among Nannochloropsis species (Beacham et al. 2014; Ma et al. 2014). In 
general, the lipid content and fatty acid composition of Nannochloropsis species can be 
manipulated by cultivation under various growth conditions such as nitrogen stress 
(nitrogen- replete and nitrogen-deplete) and sub-saturating light levels. Under nitrogen-
deplete conditions, Nannochloropsis preferentially accumulates nonpolar storage lipids 
such as triacylglycerols (TAG), which are enriched with saturated and monounsaturated 
short fatty acids and it could be ideal as feedstock for biofuel production. On the other hand, 
both sub-saturating light levels and nitrogen-replete conditions promote the synthesis of 
photosynthetic and cellular membranes in the form of polyunsaturated fatty acids (PUFA), 
which are composed of relatively high levels of eicosapentaenoic acid (EPA, C20:5) (Sukenik 
1999; Radakovits et al., 2012). 
 
Figure 1.3 Microscopy image and schematic representation of Nannochloropsis 
ultrastructure. 
(A) Microscopy image of N. gaditana. The image is taken from the Culture Collection of Algae and 
Protozoa. (B) Schematic diagram of Nannochloropsis genus showing the main physiological features 
under nitrogen replete conditions. Abbreviations are C: chloroplast, CER: chloroplast endoplasmic 
reticulum; M: mitochondrion; N: nucleus; OB: oil body; V; vesicle. Adapted from Al-Hoqani et al. 
(2016). 
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1.2.2. Genetic manipulation tools for Nannochloropsis 
Nannochloropsis species have attracted considerable interest among algal researchers 
owing to their natural ability to accumulate large quantities of lipids, high biomass 
productivity and their successful cultivation at industrial scale. However, the full 
exploitation of these oleaginous species for biotechnological applications necessitates 
molecular tools to further our understanding and enable genetic engineering. The first 
Nannochloropsis species to be fully sequenced, including all three genomes, was N.  
gaditana, by Radakovits et al. (2012). Soon thereafter, the nuclear genome sequence for N. 
oceanica became available (Vieler et al. 2012). Furthermore, chloroplast and mitochondrion 
genome sequences are available from at least one strain of each Nannochloropsis species 
(Wei et al. 2013). The complete genome data of several Nannochloropsis species provides a 
starting point for developing molecular tools, in particular those tools required for genetic 
engineering of the nuclear genome, as will be discussed in this section. In addition, the 
available genomic data has enabled researchers to carry out analysis of the transcriptome 
(Zheng et al. 2013; Tian et al. 2013), proteome (Simionato et al. 2013) and lipidome (Li et 
al. 2014) to gain basic knowledge about biosynthetic pathways in Nannochloropsis.   
Chen et al. (2008) first developed nuclear transformation in Nannochloropsis, 
demonstrating the successful expression of functional growth hormones under the control 
of an inducible promoter using electroporation of protoplasts. Since then, several methods 
have been developed for the nuclear transformation of Nannochloropsis without cell wall 
removal such as Agrobacterium-mediated transformation (Cha et al. 2011), electroporation 
(Kilian et al. 2011) and biolistics (Kang et al. 2015a). A number of selectable markers have 
also been developed for the identification of nuclear-transformed cells. The most widely 
used selectable markers in Nannochloropsis are the Sh ble and aph7 genes, which confer 
resistance to the antibiotics zeocin and hygromycin B, respectively (Radakovits et al. 2012; 
Vieler et al. 2012). As a potential selectable marker for Nannochloropsis, a study reported 
the successful knockout of two native genes that are essential for the growth on nitrate as a 
source of nitrogen (Kilian et al. 2011). The nitrate and nitrite knockout cell lines lost the 
ability to grow on nitrate as the nitrogen source but not on medium containing ammonium. 
Therefore, complementation of knockout cell lines that are deficient in the expression of 
either these native genes with a cloned wild-type gene should allow selection on nitrate. A 
different type of selectable marker that has also been expressed in Nannochloropsis is the 
chromoprotein gene from Stichodacyla haddoni (shCP) that allows visual identification of the 
transformed cell in the background of non-transformed cells by a distinctive brown 
phenotype (Shih et al. 2015).  
 
 
23 
Several reporter genes such as the ß-glucuronidase gene (GUS) and adapted versions of  
green fluorescent protein (GFP) have been developed in Nannochloropsis to test promoter 
efficiency and transformation techniques (Cha et al. 2011; Moog et al. 2015). In addition to 
this, GFP has been used for in vivo localisation studies, demonstrating the possibility of using 
N-terminal targeting sequences to direct nuclear-encoded proteins of interest into different 
subcellular compartments of N. oceanica; namely, the nucleus, mitochondria, endoplasmic 
reticulum and chloroplast include the periplastidal compartment and stroma (Moog et al. 
2015). A gene encoding a genetically modified mCherry fluorescent protein “sfCherry 
fluorescent” has been developed recently as a reporter gene in Nannochloropsis to overcome 
the interference signals of endogenous pigments and provide greater brightness with 
photostability (Kang et al. 2015a). 
The development of complementary techniques for engineering the chloroplast genome is 
not possible at present due to the inability to introduce exogenous DNA into the chloroplast 
genome, and indeed there is no report of successful chloroplast transformation of 
Nannochloropsis. Therefore, further development of these highly productive oleaginous 
algae as a potential platform for biofuels and high value compounds has been hampered 
since the chloroplast houses key metabolic pathways, including biosynthesis of fatty acids, 
carbohydrates, tetrapyrroles and terpenoids.  
1.2.3. Biotechnological applications of Nannochloropsis 
The ability of Nannochloropsis to produce high levels of triacylglycerides and 
polyunsaturated fatty acids has triggered an interest in exploiting these cellular chemicals 
as a feedstock for biofuels production, an aquafeed in the aquaculture industry and dietary 
supplements (Al-Hoqani et al. 2016), as summarised in Figure 1.4. Therefore, a number of 
studies have investigated the mass cultivation of Nannochloropsis for economically 
sustainable production of the omega-3 fatty acid EPA as a dietary supplement and an 
aquafeed (Camacho-Rodríguez et al. 2014; Becker 2013; Gressel 2013). Some of these 
studies have focused on the nutritional value of Nannochloropsis under different growth 
conditions and the transfer of their nutrients through food chains (Fernandez-Reiriz & 
Labarta 1996; Camacho-Rodríguez et al. 2014), while others have attempted to reduce algal 
production costs by enriching rotifers with frozen or  preserved algae (Camacho-Rodríguez 
et al. 2015; Lubzens et al. 1995).  
The current primary focus of commercial cultivation of Nannochloropsis is as a base of the  
food chain in the aquaculture industry due to the algae’s high content of eicosapentaenoic 
acid (Ma et al. 2016; Sukenik 1999). For example, concentrates of live cells, or frozen or 
lyophilised Nannochloropsis have been used to enrich aquafeed for cultivation of shrimps, 
molluscs and marine fish, or alternatively for production of rotifers, which in turn are used 
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as a food source for fish hatcheries (Camacho-Rodríguez et al. 2014; Lubzens et al. 1995). 
Furthermore, Nannochloropsis has been used as a feed to enrich animal products with PUFA. 
Such application has been demonstrated by Lemahieu et al. (2013), where the addition of 
Nannochloropsis biomass to the feed of laying hens greatly improved the nutritional value 
of egg yolk. Nannochloropsis has also been used in aquaculture as an oral delivery system 
for pharmaceutical proteins to improve both the growth rate of fish and survival rate during 
infection by pathogens. The most relevant example, an engineered N. oculata to produce 
growth hormone, has greatly improved the growth of tilapia larvae upon feeding them with 
this transgenic line (Chen et al. 2008). Another study reported an improved survival rate of 
medaka fish infected with a bacterial pathogen as a result of feeding them with an 
engineered transgenic line that produced the anti-microbial peptide bovine lactoferricin (Li 
& Tsai 2009).  
Nannochloropsis is a potentially important source of dietary omega-3 fatty acids in the 
human diet as it is a useful component in preventing various human diseases (Pérez-Heras 
et al. 2016; Doughman et al. 2007). Several studies have therefore investigated the safety 
aspect of using long chain omega-3 fatty acids from Nannochloropsis as a source. These 
studies reported the safe use of dietary supplements in feeding experiments carried out 
with animals (Kagan et al. 2014; Kagan & Matulka 2015).  
There has been considerable interest in Nannochloropsis species for the production of 
biofuels (Ma et al. 2014; Doan & Obbard 2014; Umdu et al. 2009; Hu et al. 2015; Zhu et al. 
2014). However, there are a number of issues that need to be considered before the 
efficiencies needed for economic production can be achieved (Georgianna & Mayfield 2012). 
These include i) developing industrial strains with the ability to produce large quantities of 
triacylglycerols, ii) understanding the effect of lipid productivity on cell growth, iii) 
improving large-scale cultivation systems and iv) developing cost effective downstream 
processing techniques. There is also a need to develop more advanced methodologies for 
Nannochloropsis species including genetic engineering approaches for all three genomes.  
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Figure 1.4 Current and potential applications of Nannochloropsis, adapted from Al-Hoqani et 
al. (2016).  
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1.3. Chlamydomonas reinhardtii  
1.3.1. C. reinhardtii Biology 
C. reinhardtii is a unicellular green freshwater microalga with an average diameter of 10 µm 
and it has a doubling time of 5–8 hours (Harris 1989). It is a member of the green algae 
(Chlorophyta), the most closely related algal group to the land plants, and it is characterised 
by the presence of chlorophyll a and b, and the ability to accumulate starch as a storage 
compound (Friedl et al. 2012). C. reinhardtii has a single cup-shaped chloroplast that 
occupies approximately two thirds of the cell volume and it contains 50–80 copies of the 
chloroplast genome (Harris 1989). Other distinguished features of C. reinhardtii include a 
pair of anterior flagella, eye spot and a pyrenoid, as shown in Figure 1.5. The C. reinhardtii 
cell is enclosed within a thick cell wall consisting of seven principal layers made of 
hydroxyproline-rich glycoproteins. Several cell wall mutants have been isolated with 
defects in cell wall biogenesis and these mutants have been widely used as recipient strains 
for transformation with exogenous DNA, as the process is more efficient with cell wall-less 
cells (Harris 2001). 
C. reinhardtii represents an excellent model organism for basic and applied scientific 
research, as it is genetically well characterised with genomic resources and molecular tools 
(Scaife et al. 2015). It has a range of exceptional features. C. reinhardtii features two animal-
like flagella and has a chloroplast that resembles those found in land plants. In addition to 
its autotrophic nature, C. reinhardtii can grow heterotrophically in the dark if supplied with 
acetate, or even in the case of a disrupted photosynthetic machinery (Harris 2001). These 
features have made C. reinhardtii the system of choice to study photosynthesis (Rochaix 
2011), circadian rhythms (Suzuki & Johnson 2001), phototaxis (Foster et al. 1984) and 
flagella assembly (Ringo 1967). 
C. reinhardtii cells are normally haploid, though they can propagate mitotically as a stable 
diploid (Harris 1989), as illustrated in Figure 1.6. The haploid cells exist as two genetically 
distinctive mating types; plus (mt+) and minus (mt-) and these cells tend to reproduce 
asexually by binary fission under favourable conditions. On the other hand, environmental 
stress conditions, such as nitrogen deprivation, triggers sexual reproduction, where the 
vegetative cells differentiate into sexually competent gametes as minus or plus mating type. 
Opposite mating types initiate the fusing by intertwining flagella and then the cell wall is 
removed upon the secretion of the metalloprotease autolysin (Buchanan et al. 1989; 
Kinoshita et al. 1992).  Following fusion of the cells, the diploid zygote forms a dormant 
structure termed a zygospore that is capable of withstanding adverse environmental 
conditions. Under favourable growth conditions, the zygospore germinates and divides by 
meiosis to form four haploid daughter cells. The daughter cells inherit the mitochondria 
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from the mating type minus and the chloroplast from the mating type plus. Nuclear genes 
follow a Mendelian inheritance pattern (Harris 2001).  
The existence of haploid and diploid states in C. reinhardtii has greatly contributed to 
genetic studies. The haploid state of C. reinhardtii has been useful for identification and 
isolation of mutant strains, since both dominant and recessive mutations display a specific 
phenotype, whereas, the diploid state is ultimately important for classical breeding 
programs, to obtain a combined desirable trait, eliminate any undesirable mutations, and 
map mutations.  
 
 
Figure 1.5  A schematic representation and microscopy image of C. reinhardtii. 
(A) Illustrative structure of C. reinhardtii cell, adapted from Dent et al. (2001). Abbreviations are N 
nucleus, Nu nucleolus, C chloroplast, T Thylakoid membranes, P pyrenoid, ES eye-spot, F flagellum, 
V vacuole, T thylakoid membranes, S starch grains, and St stroma. (B) Light micrograph of C. 
reinhardtii cells, adapted from Protist Information Server.  
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Figure 1.6 The sexual reproduction cycle of C. reinhardtii. 
Sexual reproduction starts by gametogenesis when the haploid progeny of either plus or minus 
mating type becomes haploid gametes and pairs with their opposite mating type. This is followed by 
fusion of the two cells and formation of a vegetative zygote. The vegetative zygote then forms a 
zygospore that germinates under favourable growth conditions. The zygospore gives rise to four 
haploid daughter cells – two mating type plus and two mating type minus. A small percentage of 
vegetative zygotes fail to initiate zygote maturation and so divide mitotically as stable diploid cells. 
The diagram is taken from Harris (2009). 
1.3.2. Genetic manipulation tools for Chlamydomonas reinhardtii 
Although C. reinhardtii has been used as a model organism to further our understanding in 
various research fields, there has also been considerable interest in biotechnological 
exploitation of this microalga. Extensive research has been carried out to develop molecular 
tools to allow the genetic engineering of C. reinhardtii for various purposes, which 
potentially could be also applied to other microalgae. These efforts have led to the 
development of numerous molecular resources for C. reinhardtii, and include the complete 
sequence of all three genomes (nuclear, chloroplast and mitochondrial), cDNA libraries, 
expression sequence tags (ESTs) databases, transcriptomic and proteomics information 
(Scaife et al. 2015). The wealth of genetic information has greatly contributed to the 
establishment of robust methods to transform the nucleus, chloroplast and mitochondria, 
representing a breakthrough in the genetic engineering of C. reinhardtii. DNA delivery 
methods include biolistics (Boynton et al. 1988; Randolph-Anderson et al. 1993), agitation 
with silicon carbide whiskers (Dunahay 1993), electroporation (Shimogawara et al. 1998) 
and Agrobacterium-mediated transformation (Kumar et al. 2004). One of the most 
commonly used methods of transformation relies on agitation of a cell wall-deficient strain 
with glass beads (Kindle et al. 1989; Kindle et al. 1991).  
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A number of selectable markers have been developed that rely on the expression of a 
heterologous gene that confers antibiotic resistance or the complementation of mutants 
that are deficient in the expression of essential genes (Table 1.2). The latter approach has 
become a preferred selection system for chloroplast transformation in this alga, where 
transformants can be selected by rescuing non-photosynthetic mutants with a cloned wild-
type gene e.g. psbH and atpB (Young & Purton 2016; Wannathong et al. 2016). On the other 
hand, antibiotic selection is most commonly used for nuclear transformation and include 
markers such as the Sh ble gene that confers resistance to zeocin (Rasala et al. 2012; Neupert 
et al. 2009; Stevens et al. 1996). For the purposes of assessing transgene expression levels 
and identifying the subcellular location of proteins, several reporter genes have been 
developed such those encoding β-glucuronidase (GUS), green fluorescent protein (GFP), 
luciferase (lux) and red mCherry (Gangl et al. 2015; Scaife et al. 2015; Rasala et al. 2013), as 
well as codon-optimised versions of both GFP and lux for the chloroplast (Mayfield & Schultz 
2004; Franklin et al. 2002). With recent advancements in genome editing technologies, 
several methods have been applied successfully to improve gene targeting of the nuclear 
genome in C. reinhardtii, and therefore allow the creation of a knockout collection (Scaife et 
al. 2015). The most recent method, called CRISPR-Cas9, has been used successfully in C. 
reinhardtii to create gene knockouts, thereby generating strains with improved 
photosynthetic productivity (Shin et al. 2016). There are other genome editing methods that 
have also been used successfully for targeted mutagenesis in C. reinhardtii, including 
transcription activator-like effector nucleases (TALENs) and zinc-finger nucleases (ZFNs) 
(H. Gao et al. 2014; Sizova et al. 2013).  
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Table 1.2 Selectable markers for C. reinhardtii genetic transformation. 
Modified from Day & Goldschmidt-Clermont (2011). 
Marker  Selection  Compartment  References 
Photosynthesis  
atpB Photoautotrophy Chloroplast (Boynton et al. 1988) 
tscA, psbA Photoautotrophy Chloroplast  (Kindle et al. 1991) 
psaA/B Photoautotrophy Chloroplast  (Redding et al. 1998) 
petB Photoautotrophy Chloroplast (Cheng et al. 2005) 
Antibiotic resistance  
Ble  Zeocin  Nucleus (Stevens et al. 1996) 
Aph7 Hygromycin B Nucleus (Berthold et al. 2002) 
aphVIII Paromycin 
Kanamycin 
Neomycin 
Nucleus (Sizova et al. 1996) 
rrnL Erythromycin Chloroplast (Newman et al. 1990) 
aphA-6 Kanamycin, amikacin Chloroplast (Bateman & Purton 2000) 
rrnS Spectinomycin, 
streptomycin  
Chloroplast (Kindle et al. 1991; Newman et al. 
1990; Roffeyt et al. 1991) 
aadA Spectinomycin, 
streptomycin 
Nucleus/ 
chloroplast  
(Goldschmidt-Clermont 1991) 
Herbicide resistance 
psbA DCMU, metribuzin Chloroplast  (Newman et al. 1992; Przibilla et al. 
1991) 
ALS Sulphonylurea Nucleus (Kovar et al. 2002) 
Metabolism     
ARG9 Arg auxotrophy  Chloroplast (Remacle et al. 2009) 
codA 5-fluorocytosine Chloroplast  (Young & Purton 2016) 
1.3.3. Biotechnological applications of Chlamydomonas reinhardtii 
The exploitation of C. reinhardtii as a source of renewable energy has been the main focus 
of intense biofuel production efforts due to the fast growth rate, ease of cultivation, genetic 
tractability and ability to utilise sunlight, inorganic nutrients and CO2 for the production of 
biological products (Ibáñez-Salazar et al. 2014; Georgianna & Mayfield 2012). The 
production of algal biofuels from microalgae normally exploits their ability to accumulate 
storage lipids, such as triacylglycerols. The storage lipid represents the main feedstock for 
the biofuel production, in which it can be extracted and then can be converted into biodiesel 
through the transesterification process (Amin 2009). Additionally, triacylglycerols can be 
converted into either gasoline or jet fuel through distillation or cracking (Luo et al. 2010). 
Efforts to genetically engineer C. reinhardtii to improve biofuel phenotypes have been 
successful (Work et al. 2010; Li et al. 2010). For example, starchless mutants defective in 
ADP-glucose pyrophosphorylase rerouted photosynthetic carbon flux towards TAG 
synthesis and so resulted in a 10-fold increase of TAG accumulation under stress (Li et al. 
2010). However, C. reinhardtii is not an inherently exceptional producer of biomass or 
lipids, and therefore extensive genetic modifications are required to achieve the efficiencies 
that are needed for biofuel applications. Biofuel research has now mostly shifted the focus 
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to alternative microalgae that are naturally high producers of biomass or lipids, such as 
Nannochloropsis species, and use C. reinhardtii as a genetic model for those productive algal 
species (Rupprecht 2009). Furthermore, the focus is moving towards utilisation of C. 
reinhardtii as a production platform for other industrially relevant compounds such as 
therapeutic proteins and high value terpenoids. A number of high value recombinant 
proteins have been produced in the microalga, such as the production of a human single-
chain antibody in the chloroplast (Mayfield et al. 2003). A full human monoclonal antibody 
was also expressed in the C. reinhardtii chloroplast, and was demonstrated to have antigen-
binding activity similar to the same antibody expressed in mammalian cells (Tran et al. 
2009). Selected examples of therapeutic proteins that have been successfully expressed in 
C. reinhardtii are summarised in Table 1.3. Most recently, Lauersen et al. (2016)  reported 
efficient production of a high value sesquiterpenoid patchoulol from C. reinhardtii through 
metabolic engineering of the terpenoid biosynthetic pathway. Several attempts have been 
made to improve the carotenoid content and/or profile in C. reinhardtii (Cordero et al. 2011; 
León et al. 2007; Tan et al. 2007). A successful example of improving carotenoids in C. 
reinhardtii, the overexpression of a phytoene synthase gene from Dunaliella salina, resulted 
in increased levels of endogenous carotenoids such as lutein and β-carotene (Couso et al. 
2011). The use of C. reinhardtii in wastewater treatment has also been the focus of research 
over the past decade. A number of studies have suggested the potential use of either 
immobilised C. reinhardtii cells in alginate beads or non-living cells as a bio-sorbent to 
recover heavy metals for safe disposal (Arica et al. 2005; Bayramoǧlu et al. 2006). 
Table 1.3 Some examples of therapeutic proteins/dsRNA expressed in the C. reinhardtii,  
modified from Stoffels (2014).   
Gene 
Expressed 
Function Location Applications Reference 
HSV8-lsc Human antibody against 
glycoprotein from herpes simplex 
virus 
Chloroplast Therapeutic (Mayfield et al. 
2003) 
CTB- VP1 Protein VP1 from foot and mouth 
disease virus fused to CTB 
Chloroplast Vaccine (Sun et al. 2003) 
CSFV-E2 Swine fever virus structural 
protein E2 
Chloroplast Vaccine (He et al. 2007) 
VP28 White spot syndrome virus 
protein 28 
Chloroplast Vaccine (Surzycki et al. 
2009) 
CTB-D2 D2 fibronectin-binding domain of 
Staphylococcus aureus fused to 
CTB 
Chloroplast Oral vaccine (Dreesen et al. 
2010) 
dsRNA-YHV* RNA dependent RNA polymerase 
of shrimp yellow head virus  
Nucleus Oral vaccine (Somchai et al. 
2016) 
 *RNA interference approach. 
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1.4. Terpenoids 
Terpenoids are a diverse class of naturally occurring compounds consisting of more than 
50,000 structurally different chemicals, which are found in all living organisms (Pateraki et 
al. 2015). Many terpenoids are of plant origin, and most of them are functionally important 
in various aspects of cell metabolism, including photosynthesis, membrane permeability 
and fluidity, respiration, and regulation of growth and development (Bohlmann & Keeling 
2008). Another class of plant terpenoids – often referred to as secondary metabolites – is 
more specialised and limited to certain plant families or genera with functions in defence 
against plant pathogens, abiotic stress conditions or the attraction of pollinators (Vranová 
et al. 2012; Marasco & Schmidt-Dannert 2008). An example of such secondary metabolites 
can be seen in trees of the pine family that accumulate large quantities of viscous oleoresin 
constituted mainly of monoterpenoids and diterpene acids as defence mechanisms against 
herbivores and pathogens (Zulak & Bohlmann 2010; Keeling & Bohlmann 2006). Other 
examples are the volatile floral and fruit scents that are normally emitted by flowering 
plants to attract pollinators (Gershenzon & Dudareva 2007). Due to their functional 
diversity, these secondary metabolic terpenoids are of great industrial interest, largely in 
areas such as pharmaceuticals, agricultural chemicals, flavours and fragrance additives 
(Bohlmann & Keeling 2008). For example, the plant derived terpenoid, paclitaxel, is used 
currently as a potent anticancer drug (Li et al. 2015), while the isolated essential oil from 
wild mint, menthol, is widely used as a flavour and fragrance additive (Caputi & Aprea 
2011). Additionally, recent studies indicate that terpenoids also possess properties 
favourable in fuels, with potential to serve as advanced biofuel precursors (Peralta-Yahya 
et al. 2011; Harvey et al. 2010). The structural and functional diversity of plant derived 
terpenoids is illustrated in Figure 1.7.  
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Figure 1.7 Structural diversity of industrially relevant terpenoids in wide range of 
applications. 
1.4.1. Terpenoid biosynthetic pathways in photosynthetic eukaryotes 
Despite the enormous structural diversity, all terpenoids are derived from the five carbon 
precursor isopentenyl diphosphate (IPP), which is assembled repetitively to produce 
different classes of terpenoid molecules, such as hemiterpene (C5), monoterpene (C10), 
sesquiterpene (C15), diterpene (C20), triterpene (C30) and tetraterpene (C40). The 
biosynthetic pathway of these terpenoid molecules can be divided into four main steps 
(Figure 1.8), as classified by Chung et al. (2016): i) the synthesis of the isoprene C5 units 
(i.e. IPP) ii) the sequential addition of isoprene units to generate linear prenyl diphosphate 
of varying chain lengths (C5, C10, C15, … etc), which can serve as direct precursors for the 
synthesis of various types of terpenoid molecules. iii) The formation of various terpene 
skeletal types through cyclisation reactions by a class of enzyme called terpene synthases 
and iv) further enzymatic modification of the terpene skeletons by downstream enzymes 
such as the addition of functional groups by cytochrome P450.  
    Paclitaxel (anti–cancer drug)     Menthol (aroma additive) 
     β-carotene (nutritional supplement and food colorant)  
 Cis-abienol 
   (fragrance precursor) 
Bisabolene 
(biofuel precursor) 
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Figure 1.8 Overview of terpenoid biosynthetic pathways in photosynthetic eukaryotes. 
The biosynthesis is initiated by the formation of isoprene unit (IPP) by the methylerythritol 
phosphate (MEP) and mevalonate (MVA) pathways if the organism has both pathways otherwise 
from either MEP or MVA.  Head to tail condensation of DMAPP (dimethylallyl diphosphate) with one 
or more IPP units leads to the formation of the following direct precursors; geranyl diphosphate 
(GPP), farnesyl diphosphate (FPP), and geranylgeranyl diphosphate (GGPP). The number of added 
IPP units in the reactions is indicated as 1 IPP, 2 IPP and 3 IPP. Depending on the terpene synthase, 
these precursors lead to various monoterpene, sesquiterpenes and diterpenes, which are further 
modified by downstream enzymes into various terpenoid end products. TPS represents terpene 
synthase. The diagram was modified from Li et al. (2015). 
In photosynthetic eukaryotes, the five carbon precursor IPP is synthesised by two 
alternative pathways; the methylerythritol phosphate (MEP) and mevalonate (MVA) 
pathways that are localised in different cellular compartments (Cordoba et al. 2009), as 
depicted in Figure 1.9. The presence of the particular pathway or even both pathways 
depends on the organism. For example, higher plants and diatoms possess both the MVA 
and MEP pathways whereas green algae have only the plastidic MEP pathway (Matsushima 
et al. 2012; Lohr et al. 2012; Cvejić & Rohmer 2000). More examples for the distribution of 
the MVA and the MEP pathways in various photosynthetic species are summarised in Table 
1.4. The classical mevalonate pathway starts with the condensation of three units of acetyl-
CoA in the cytosol to produce 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA), which is 
reduced by HMG-CoA reductase (HMGR) to mevalonate at the ER surface (Vranová et al. 
2012). The reaction then proceeds through two successive phosphorylation steps of 
mevalonate and is followed by a decarboxylation step that leads to the formation of the 
isopentenyl pyrophosphate (IPP). The formation of its isomer DMAPP is catalysed by 
isopentenyl diphosphate isomerase (IDI). The isoprene C5 units derived from this pathway 
provide precursors for the formation of cytosolic and mitochondrial terpenoids such as 
sesquiterpenes and triterpenes (Bohlmann & Keeling 2008). 
 
MEP pathway 
(plastid) 
 
         
MVA pathway 
     (cytosol) 
  TPS 
  TPS 
  TPS 
 
Geraniol 
Limonene 
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On the other hand, plastidic terpenoids are derived from the MEP pathway located in the 
chloroplast of photosynthetic eukaryotes and it is used for the formation of monoterpenes, 
diterpenes and tetraterpenes (Vranová et al. 2012; Bohlmann & Keeling 2008). The MEP 
pathway starts from the condensation of pyruvate and glyceraldehyde 3-phosphate (GA-
3P) to form 1-deoxy-D-xylulose-5-phosphate (DXP), catalysed by 1-deoxy-D-xylulose-5-
phosphate synthase (DXS). The next step involves the intramolecular rearrangement and 
reduction of DXP to produce MEP, which is catalysed by DXR. The resulting MEP is 
converted into 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (ME-2,4cPP) through three 
enzymatic steps and then followed by a reduction catalysed by 1-hydroxy-2-methyl-2-
butenyl 4-diphosphate synthase (HDS) to produce 1-hydroxy-2-methyl-2-butenyl 4-
diphosphate (HMBPP). In the last step in the MEP pathway, the reaction is catalysed by the 
isopentenyl diphosphate: dimethylallyl diphosphate synthase (IDS) to produce both IPP and 
DMAPP as final products (Roberts 2007). In spite the fact that both IPP and DMAPP are 
made, the IDI enzyme is also found in the MEP pathway presumably to maintain a balanced 
supply of IPP and DMAPP (Lohr et al. 2012).  
 
Figure 1.9 Biosynthesis of isopentenyl diphosphate in photosynthetic eukaryotes with the 
cytosolic MVA pathway and the plastidic MEP pathway. 
The MVA pathway begins with condensation of acetyl-coenzyme A (CoA) units to generate the 
universal precursor isopentenyl diphosphate (IPP) and its allylic isomer dimethylallyl diphosphate 
(DMAPP), whereas the MEP pathway begins with the condensation of pyruvate and D-glyceraldehyde 
3- phosphate, see the text for further explanations. Transporter (TP) is responsible to transport the 
isomeric C-5 precursors and prenyl diphosphate across membranes. Dashed arrows indicate a 
number of steps are involved (not shown). Abbreviations: DXS, 1-deoxy-D-xylulose-5-phosphate 
synthase; DXR, 1-deoxy-D-xylulose-5-phosphate reductoisomerase; HDS, hydroxy-2-methyl-2-(E) 
butenyl 4-diphosphate synthase; IDS, isopentenyl diphosphate: dimethylallyl diphosphate synthase; 
IDI, isopentenyl diphosphate isomerase. The diagram is taken from Roberts (2007). 
  TP 
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Table 1.4 The distribution of MVA and MEP pathways in some photosynthetic species. 
This table was modified from Lohr et al. (2012). 
Photosynthetic species Pathway Reference 
 MEP MVA  
Synechocystis sp. PCC 6714 + –  (Disch et al. 1998) 
Chlamydomonas reinhardtii + –  (Lohr 2009) 
Chlorella fusca + – (Disch et al. 1998)  
Euglena gracilis + + (Disch et al. 1998) 
Phaeodactylum tricornutum + + (Cvejić & Rohmer 2000) 
Nannochloropsis gaditana + – (Radakovits et al. 2012) 
Cyanidium caldarium + + (Disch et al. 1998) 
Cyanidioschyzon merolae + – Genome Project& 
Nitzschia ovalis + + (Cvejić & Rohmer 2000) 
Tetraselmis striata + – (Schwender et al. 2001) 
Arabidopsis thaliana¥ + + (Lichtenthaler et al. 1997) 
& Genome project (http://merolae.biol.s.u-tokyo.ac.jp/). 
¥ All land plants that have been investigated to date have both pathways 
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1.4.2. Applications of terpenoids 
Many terpenoids accumulate in small quantities in plant tissue, but direct extraction from 
the plant is not sufficient for commercial production. The biotechnological applications of 
these terpenoids in various industrial fields has led to an increased interest in 
understanding the many terpenoid biosynthetic pathways, with a view to enabling 
sustainable production of terpenoids based on renewable resources (Schrader & Bohlmann 
2015; Bohlmann & Keeling 2008). Only by understanding the underlying biosynthetic 
pathways required to produce terpenoids, can genetic engineering be plausible and 
potentially facilitate genetic manipulation to produce terpenoids on a commercially viable 
scale. Pathway manipulation can be undertaken either in their natural host, or in other 
biological platforms (Li et al. 2015). These attempts are briefly discussed in this section by 
highlighting the progress being made for selected examples of terpenoids with 
biotechnological applications. Finally, the current and emerging options for the commercial 
production of those selected terpenoids will be reviewed.  
1.4.2.1 Ambroxide-related diterpenoids  
Several naturally occurring diterpenoids of plant origin have been used as starting materials 
for the synthesis of fragrance molecules with ambergris characters, such as Ambrox®. This 
semi-synthesis process was originally developed to substitute the use of a biliary secretion 
of the sperm whales known as ambergris in perfume formulations (Zerbe & Bohlmann 
2015). The diterpene alcohol, cis-abienol, is an example of a major aromatic oleoresin 
component from balsam fir (Abies balsamea) that serves as a starting material for the 
industrial synthesis of Ambrox® (Zerbe et al. 2012). Another example is the diterpene diol, 
mainly obtained from clary sage plants (Salvia sclarea) and it is also used as a precursor for 
Ambrox® or related ambroxide fragrance synthesis (Zerbe & Bohlmann 2015). There is 
other additional plant derived diterpenoids that could potentially serve as a precursor for 
the commercial production of Ambrox®, such as labdanolic acid, abietic acid and manool, 
as illustrated in Figure 1.10. The use of plant-derived terpenoids as starting materials for 
the fragrance industry, as is the case for many naturally-derived products, is hindered by 
low yields, high extraction costs and further expensive chemical synthesis requirements 
(Cordoba et al. 2009).  
Given the high value of these diterpenoids, there has been a focus on the identification of 
the relevant biosynthetic genes and corresponding enzymes which may be genetically 
engineered to improve production of high value terpenoids (Zerbe et al. 2012; W. Gao et al. 
2014; Bruckner et al. 2014). The identification and functional annotation of diterpene 
synthases that are involved in sclareol biosynthesis resulted in successful production of 
sclareol in engineered yeast, achieving approximate titres of 400 mg/L (Ignea et al. 2015). 
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In addition, genetically engineered E. coli producing high titres of sclareol up to 1.5 g/L 
(Schalk et al. 2012) demonstrates a sustainable and cost effective platform. These successful 
engineered microbial sclareol production systems have been facilitated by the fact that the 
biosynthesis of sclareol does not require oxidation steps catalysed by P450 enzymes. 
Transcriptome analysis of balsam fir identified a bifunctional diterpene synthase that 
produces cis-abienol, a terpene of value to the fragrance industry. Given the slow growing 
and low yielding nature of balsam fir, there exists an opportunity for metabolic engineering 
in more a feasible expression system for the commercial production of cis-abienol (Zerbe et 
al. 2012).  
 
Figure 1.10 The semi-synthetic route for the production of Ambrox®. 
Several plant species produce diterpenoids that serve as a starting material for the synthesis of 
Ambrox® of high value in fragrance industry, adapted from Zerbe & Bohlmann (2015). 
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1.4.2.2 Nootkatone  
The sesquiterpenoid (+)-nootkatone is a high value aromatic compound that was first 
isolated from the heartwood of Alaska yellow cedar (Chamaecyparis nootkatensis) and later 
discovered to exist in trace amounts in grapefruit (Citrus paradisi), mandarin (Citrus 
reticulata) and pummelo (Citrus grandis) (Leonhardt & Berger 2015). It is characterised by 
the grapefruit odour, a slightly bitter taste and an extremely low odour threshold of 
approximately 1 µg/L water. These characteristics led to the exploitation of (+)-nootkatone 
as a flavour and fragrance compound for the food and cosmetic industries (Leonhardt & 
Berger 2015; Caputi & Aprea 2011). The sesquiterpenoid (+)-nootkatone also possesses 
insecticidal properties as reported by Miyazawa et al. (2000), where an extract of (+)-
nootkatone from Alpinia oxyphylla demonstrated insecticidal activity against Drosophila 
melanogaster. Another study reported the use of (+)-nootkatone as a strong repellent and 
toxicant to termites (Coptotermes formosanus), thereby opening the possibility of using this 
sesquiterpenoid to target other insects such as tick and flea species (Flor-Weiler et al. 2011; 
Zhu et al. 2001). Interestingly, (+)-nootkatone and its derivatives have also been reported 
to exhibit therapeutic activities, such as antiplatelet aggregation effects (Seo et al. 2011) and 
anti-proliferative activity against some cancer cell lines (Gliszczynska et al. 2011).  
However, direct extraction of (+)-nootkatone from its natural sources is not sufficient to 
meet the industrial demand, mainly due to i) the fact that few species can produce (+)-
nootkatone, ii) slow biomass accumulation, iii) poor recovery after extraction and iv) 
overall low concentrations of (+)-nootkatone (Leonhardt & Berger 2015; Fraatz et al. 2009). 
The current synthetic route for (+)-nootkatone production relies upon the oxidation of the 
abundantly available sesquiterpene (+)-valencene, a constituent of orange and mandarin oil 
(Figure 1.11). This oxidation process normally uses oxidizing agents known to be unsafe 
such as the carcinogen, chromatic acid (Salvador & Clark 2002; Wilson & Shaw 1978). As a 
result, there is an increasing interest in alternative approaches such as de novo (+)-
nootkatone synthesis, or the bioconversion of (+)-valencene to (+)-nootkatone 
(Wriessnegger et al. 2014; Gliszczynska et al. 2011; Furusawa et al. 2005).  
Many studies have reported the possibility of bioconverting (+)-valencene to (+)-
nootkatone using whole cell extracts of bacteria, fungi, microalgae and plants 
(Wriessnegger et al. 2014; Fraatz et al. 2009; Furusawa et al. 2005). The knowledge gained 
from the bioconversion of (+)-valencene has been utilised for the identification of the 
enzymes responsible for the production of this compound, and in turn has facilitated its 
production in different expression systems via metabolic engineering. As such, the use of 
lyophilisates of the edible mushroom Pleurotus sapidus for the bioconversion of (+)-
valencene produced more than 250 mg/L of (+)-nootkatone. The oxygenase responsible for 
such catalytic activity from P. sapidus has been identified, and the gene successfully 
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expressed in E. coli (Zelena et al. 2012; Fraatz et al. 2009). Another study screened a large 
number of cytochrome P450 enzymes from bacteria for their oxidizing activity, and a 
cytochrome (CYP109B1) from Bacillius subtilis was reported to be the most suitable 
enzyme. This enzyme might be used for the production of (+)-nootkatone, (Girhard et al. 
2009). Most recently, Wriessnegger et al. (2014) reported the development of a sustainable 
route for the production of (+)-nootkatone in vivo by metabolically engineered P. pastoris, 
achieving approximate titres of 208 mg/L of cell culture. This was achieved by a 
combinatorial approach, involving the co-expression of genes for valencene synthase from 
Callitropsis nootkatensis, premnaspirodiene oxygenase from Hyoscyamus muticus and 
cytochrome P450 reductase from Arabidopsis thaliana. The successful production of (+)-
nootkatone in P. pastoris is a promising step to make (+)-nootkatone production practical 
and environmentally friendly, but there is a need for the development of more cost-effective 
bioprocess technologies.  
 
Figure 1.11 The proposed biosynthetic process for (+)-nootkatone from farnesyl 
diphosphate (C15), modified from Leonhardt & Berger (2015).   
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1.4.2.3 Carotenoids 
Carotenoids constitute a large group of naturally occurring terpenoid pigments with 
antioxidant properties that are mainly synthesised by plants, algae and photosynthetic 
bacteria (Sandmann 2015; Fraser & Bramley 2004). Carotenoids are widely responsible for 
the yellow, orange and red pigments seen in fruits, vegetables, flowers and algae. A number 
of carotenoids are of high value to humans as food colorants, animal feed and nutraceuticals 
(Gong & Bassi 2016; Sandmann 2015). These high value carotenoids are shown in Figure 
1.12. The best established role of carotenoids in human health is in pro-vitamin activity, 
where dietary carotenoids, in particular β-carotene, are a precursor for vitamin A which is 
required for the visual pigment rhodopsin (Sandmann 2015; Fraser & Bramley 2004). Since 
humans cannot synthesise carotenoids, a deficiency of pro-vitamin A in their diet will 
ultimately lead to a deficiency in vitamin A, which in turn may cause blindness and even 
death in severe cases (Black et al. 2016). In addition to β-carotene, other carotenoids are 
also important for human vision, including zeaxanthin and lutein. A deficiency of these 
carotenoids may result night blindness, exophthalmos and keratinization of the conjunctiva 
(SanGiovanni & Neuringer 2012; Bone et al. 2003; Britton 1995). Due to the anti-oxidative 
properties of carotenoids, several carotenoids are also reported to benefit human health in 
some chronic diseases (Gong & Bassi 2016), as summarised in Table 1.5.  
 
Figure 1.12 Simplified diagram for the structures and biosynthesis of industrially relevant 
carotenoids. 
The immediate precursor for tetraterpenes including carotenoids is formed by the condensation of 
two geranylgeranyl pyrophosphate (GGPP), and followed by several enzymatic reactions to form 
various carotenoids. The colour of the corresponding carotenoid is shown as a coloured circle. The 
dotted arrow indicates the chemical conversion. This diagram was modified from Sandmann (2015).  
 
 
2X GGPP 
(C20) 
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Table 1.5 Reported human health benefits of carotenoids, adapted from Gong & Bassi 
(2016). 
Carotenoids Health benefits Reference  
Astaxanthin Strong anti-oxidant property  
Anti-inflammatory effects 
Anti-cancer  
Cardiovascular health 
(Fasano et al. 2014) 
(Pashkow et al. 2008) 
(Chew et al. 1999) 
Lutein Prevents cataract and age-related macular 
degeneration  
Anti-oxidant property  
Anti-cancer  
Prevents cardiovascular diseases 
(Manayi et al. 2016) 
(Granado et al. 2003) 
(Bone et al. 2003) 
(Cha et al. 2008) 
(Vijayapadma et al. 2014) 
(Alves-Rodrigues & Shao 2004) 
β-carotene Prevent night blindness  
Anti-oxidant property 
Prevents liver fibrosis 
(Dufossé et al. 2005) 
(Virtamo et al. 2014) 
(Shaish et al. 2006) 
Lycopene Anti-cancer  
Prevents cardiovascular diseases  
Radiation protection  
Anti-oxidant property 
(Viuda-Martos et al. 2014) 
(Srinivasan et al. 2009) 
(Devasagayam et al. 2004) 
As a result of the identified health benefits of carotenoids, there has been a focus upon 
improving the levels of human consumption of carotenoids. One successful method has been 
by the genetic manipulation of carotenoid biosynthetic pathways in staple crops. The most 
common example is “Golden rice”, where the co-expression of genes for phytoene synthase 
and carotene desaturase in rice endosperm resulted in transgenic rice with a high level of 
β-carotene (Paine et al. 2005). The staple crop potato, which typically accumulates lutein 
and violaxanthin, was also targeted for genetic engineering to accumulate zeaxanthin as 
another important dietary pro-vitamin (Omer et al. 2002). 
In addition to fortification of staple crops, carotenoids have been used as food additives in 
the aquaculture and poultry industries. Crustaceans and pink-fleshed fish such as salmon 
and trout contain astaxanthin as a result of addition of astaxanthin in the diet (Cardozo et 
al. 2007). Similarly the addition of carotenoids in poultry feed enhances the nutritional 
value of eggs as well as the pigmentation of the egg yolk (Sandmann 2015; Tyczkowski & 
Hamilton 1986). Because of the colour of carotenoids, from yellow to red, these compounds 
have been exploited as natural colorants in the food industry and in cosmetics. For instance, 
the use of water soluble norbixin (annatto) provides the yellow pigmentation in dairy 
products, while lycopene or canthaxanthin provides red pigmentation in food and 
beverages (Sandmann 2015).  
Carotenoids are synthesised chemically to meet increasing demand for these compounds in 
various applications (Ernst 2002). However, the chemical synthesis process is limited to 
producing only a few carotenoids; namely β-carotene, astaxanthin, canthaxanthin, lycopene 
and zeaxanthin. Some natural carotenoids are also commercially available, and are derived 
from plants and algae such as lutein from the flowers of marigolds, lycopene from tomato 
fruit, β-carotene from carrot roots, and astaxanthin from Haematococcus pluvialis 
 
 
43 
(Sandmann 2015). Currently, there is an interest in the production of carotenoids by genetic 
manipulation of microorganisms. These offer a promising alternative for sustainable 
production of natural carotenoids (Gimpel et al. 2015; Das et al. 2007). In efforts to make 
this possible, many studies attempted the synthesis of carotenoids in metabolically 
engineered E. coli, reporting concentrations of 6.2 mg/g dry weight β-carotene, 1.4 mg/g 
dry weight astaxanthin and around 30 mg/g dry weight lycopene (Chen et al. 2013; Lemuth 
et al. 2011). In addition, engineering non-carotenogenic fungi for the production of 
carotenoids (for instance, the genetic manipulation of P. pastoris) resulted in successful 
production of lycopene and β-carotene (Araya-Garay et al. 2012). The yeast 
Xanthophyllomyces dendrorhous has also been targeted for genetic engineering in order to 
improve astaxanthin productivity, as it already has the ability to produce astaxanthin 
naturally. Combining classical mutagenesis with genetic engineering has resulted in a strain 
with an improved productivity of astaxanthin, achieving in total approximately 9 mg/g dry 
weight (Gassel et al. 2014).  
1.5. Metabolic engineering of terpenoid biosynthetic pathways in algae 
In spite of the major success of plant cell suspension culture in the production of numerous 
terpenoids in particular high-value pharmaceutical terpenoids such as anti-cancer Taxol® 
and anti-malarial artemisinin, this approach suffers from low yield and variability of 
accumulated terpenoids, which in turn complicate the regular supply of these high value 
compounds at large scale (Ikram et al. 2015; Roberts 2007). Recent genetic engineering 
efforts therefore have been directed towards finding alternative production platforms for 
terpenoids other than plants, as genetic manipulations of whole plants often requires in-
depth understanding of the metabolic system and regulatory complexity to enable the 
successful manipulation of the biosynthetic pathway without disturbing other essential 
processes within the plant (Ikram et al. 2015; Saxena et al. 2014). Terpenoids are indeed 
important in higher plants for their growth, development and survival (Bohlmann & Keeling 
2008). Many studies have demonstrated that genetic manipulations of terpenoid 
biosynthetic pathways in higher plants is possible, however, these attempts are normally 
associated with challenges including growth retardation and low yield of the desired 
terpenoid (Saxena et al. 2014; Farhi et al. 2011).  Microalgae may offer an alternative 
platform for terpenoid production due to their inherently desirable characteristics, in which 
they combine the high growth rate and ease cultivation of microorganisms with an ability 
to perform the post-transcriptional and post-translation modifications of plants (Scaife et 
al. 2015; Gangl et al. 2015). In addition, microalgae have the natural capacity to produce the 
precursor molecules for bioactive compounds such as terpenoids and fatty acids 
(Georgianna & Mayfield 2012). As a matter of fact, several algal species have a remarkable 
capability to accumulate industrially relevant terpenoids under unfavourable condition, as 
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the case for β-carotene in Dunaliella salina and astaxanthin in Haematococcus pluvialis (Lohr 
et al. 2012; Eonseon et al. 2006; Ramos et al. 2011). In addition, microalgae have other 
advantages over higher plants including their rapid growth, the speed of genetic 
manipulation in term of generating transgenic lines, their potential low cost for large scale 
production and most importantly their ease of containment in closed photobioreactors 
(Mayfield et al. 2007).  
The genetic manipulation of microalgae as a production platform for terpenoid compounds 
is fundamentally very similar to that of higher plants, where the metabolic engineering of 
the pathways can be achieved by inserting transgenes into the nuclear or chloroplast 
genomes (Gimpel et al. 2015; Kempinski et al. 2015). Nuclear transformation offers the 
advantage of post-translational modifications and the possibility of targeting the 
heterologous protein into different subcellular compartments (Purton 2007; Franklin & 
Mayfield 2004), and indeed most of involved enzymes in terpenoid metabolism in the 
chloroplast are nuclear encoded (Gimpel et al. 2015). However, the process of transgene 
integration into the nuclear genome of most algae is essentially random leading to many 
difficulties associated with positional effects. These include a significant variation in the 
expression levels of the nuclear transgene and suppression of transgene expression, which 
is often known as a gene silencing (Franklin & Mayfield 2004). As a consequence, protein 
accumulation is typically lower compared to transgene expression in the chloroplast where 
these problems do not arise.  Chloroplast transformation proceeds through homologous 
recombination allowing the precise integration of a transgene into any loci within the 
chloroplast genome, and therefore, avoids unpredictable integration and the disruption of 
essential endogenous genes (Purton 2007; Franklin & Mayfield 2004). In addition, the 
polypoid nature of the chloroplast genome results in a high copy number of the transgene, 
thereby aiding high level expression. Chloroplast transformation also offers the possibility 
to express multiple transgenes as an operon (Purton 2007).  
Current research has investigated the possibility of exploiting microalgae as cell factories 
for the production of terpenoids through metabolic engineering by increasing the 
productivities of the desired terpenoids, improving terpenoids profiles and producing 
designer terpenoid molecules (Gimpel et al. 2015; Lohr et al. 2012). Since most terpenoid 
metabolism in microalgae occur in the chloroplast, metabolic engineering has been 
achieved by nuclear and chloroplast transformation. At present, the primary focus of algal 
terpenoid metabolism is the metabolic engineering of carotenoid biosynthetic pathways in 
the model microalga, C. reinhardtii (Gimpel et al. 2015). Various approaches have been 
employed to engineer carotenoid pathways in C. reinhardtii by either targeting different 
endogenous enzymes or introducing new enzymes (Figure 1.13). One such approach relies 
on the overexpression of genes for rate-limiting endogenous enzymes to increase the 
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accumulation of the desired product. For example, separate studies successfully 
demonstrated that the expression of an additional copy of the phytoene synthase from 
either D. salina or Chlorella zofingiensis resulted in a significant increase in carotenoid 
content of the transgenic C. reinhardtii (Cordero et al. 2011; Couso et al. 2011),  see Figure 
1.14. Similarly, the expression of an additional copy of a mutant version of the gene for the 
endogenous phytoene desaturase in C. reinhardtii resulted in a significant increase in 
carotenoid content (Liu et al. 2013). Another approach was attempted in C. reinhardtii using 
anti-sense RNA to down regulate the endogenous phytoene synthase, however, such 
manipulation did not result in dramatic changes in the carotenoid profile (Vila et al. 2008). 
Fukusaki et al. (2003) reported an indirect approach to improving the productivity of 
carotenoids content in C. reinhardtii through increasing the available precursor pool of 
GGPP by the expression of an additional copy of the GGPP synthase gene from a thermophilic 
archaeon. However, the additional activity of GGPP synthase in C. reinhardtii did not result 
in measurable changes in the terpenoid profile. As for the introduction of novel enzymes to 
direct the metabolic flux towards the production of industrially relevant carotenoids, an 
engineered C. reinhardtii expressing a β-carotene ketolase cDNA from H. pluvialis resulted 
in the synthesise of  an unexpected novel ketocarotenoid (León et al. 2007).  
The genetic manipulation of terpenoids in C. reinhardtii is not limited to the carotenoid 
pathways and there is growing interest in introducing new pathways to harness microalgae 
in general as cell factories for the production of novel terpenoids. Most recently, Lauersen 
et al. (2016) reported the successful production of the non-native sesquiterpenoid 
patchoulol from FPP in engineered C. reinhardtii with a patchoulol synthase from the plant 
Pogostemon cablin, achieving productivities up to 922 ± 242 µg/g dry weight in six days. 
Another study attempted to introduce a bifunctional diterpene synthase from balsam fir 
into the C. reinhardtii chloroplast, where this enzyme catalyses the formation of industrially 
relevant cis-abienol 4 from GGPP (Zedler et al. 2014). This study could not detect cis-abienol 
4 in spite of the successful heterologous expression of the diterpene synthase gene.  
In addition to metabolic engineering attempts using C. reinhardtii, there is ongoing efforts 
to improve the productivity of other biotechnologically relevant microalgae, such as H. 
pluvialis which is the leading commercial producer of natural astaxanthin. A study reported 
successful stable transformation of H. pluvialis using a mutant phytoene desaturase gene that 
confer resistance to norflurazon (Steinbrenner & Sandmann 2006). The additional copy of 
the mutant gene improved the accumulation levels of astaxanthin in the transformant lines 
up to 26% compared to the wild type after 48 hours of being stressed with high light. 
Another study reported a similar approach in Chlorella zofingiensis where the transformant 
lines showed an improved accumulation levels of total carotenoids and astaxanthin up to 
approximately 32 % and 54%, respectively (Liu et al. 2014).  
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Figure 1.13 Schematic representation of various possible approaches to metabolic engineering of terpenoid biosynthetic pathways in algae. 
Genetic engineering of the nuclear genome is carried out by transformation plasmids (1, 2 and 3). The addition of the signal peptide (SP) allows targeting of the proteins into 
different cellular compartments including the chloroplast, mitochondria and endoplasmic reticulum (ER), as indicated by red arrows. The genetic engineering of the 
chloroplast genome directly is possible by plasmid 4, which could carry genes either for an engineered enzyme (EE) or transcription factors (TF). Plasmid 5 contains multiple 
transgenes that could be expressed as an operon in the chloroplast genome. The genetic engineering of terpenoid pathways using transcription factors and multiple 
transgenes approaches have been reported in the genetic engineering of plants but not in algae. Terminator is abbreviated by T. Asterisk (*) indicates the existence of the 
MVA pathway depending on the algal species, although this is not found in C. reinhardtii.   
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Figure 1.14 Biosynthetic pathway for astaxanthin in green microalgae. 
Targeted enzymes for genetic engineering in microalgae are indicated by asterisks. The 
abbreviations are: PSY, phytoene synthase; PDS, phytoene desaturase; ZDS, ζ-carotene desaturase; 
LYC-B, lycopene β-cyclase; BKT, β -carotene ketolase; CrtR-b, β-carotene hydroxylase. Adapted from 
Gimpel et al. (2015). 
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1.6. Aims of the presented work  
With recent interest in the use of terpenoids in a wide range of industrial and 
pharmaceutical applications, many efforts have focused on the commercial production of 
these high value compounds in novel biological systems using metabolic engineering 
technologies. As a photosynthetic platform, microalgae may considered as an attractive 
alternative to their counterpart plants for terpenoid production due to their minimal 
growth requirements, their fast growth rate, their containment and potential low cost for 
large scale production. However, metabolic engineering technologies for microalgae are 
still in their infancy, and there is a need to develop engineering tools for those novel algal 
species with industrial potential such as Nannochloropsis. At the same time, new strategies 
for engineer terpenoids need to be tested in established laboratory species such as 
Chlamydomonas reinhardtii. The aims of the research described in this thesis are therefore:  
1. The development of a reliable chloroplast transformation method for N. gaditana so 
that the genetic engineering of the plastidic terpenoid pathway would be possible. 
This work includes: 
 Testing different transformation methods that are commonly employed in the 
chloroplast transformation of other microalgae (Chapter 3). 
 Exploring new transformation strategies that address some of the uncertainties 
of chloroplast transformation, focusing on the development of an endogenous 
selectable marker and the temporary increase in cell size to facilitate the 
delivery of DNA into the small chloroplast (Chapter 4). 
2. The genetic manipulation of the terpenoid biosynthetic pathway in the C. reinhardtii 
to investigate the effect of overexpressing a gene for the rate limiting DXS enzyme 
on downstream terpenoid levels, and so gain a better understanding of terpenoid 
biosynthetic pathways in C. reinhardtii for further genetic engineering studies 
(Chapter 5). 
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1.7. An overview of the presented work and hypothesis  
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 Metabolic engineering of the algal chloroplast for terpenoid production 
 The metabolic engineering of the chloroplast genome in N. gaditana is not possible at present due to the inability to introduce 
exogenous DNA into the chloroplast genome. Therefore, the aim of this research is to develop a reliable chloroplast 
transformation method for N. gaditana 
 
 
Classical approach to develop chloroplast 
transformation method (Chapter 3) 
 
 
Evaluation of antibiotic sensitivity to identify the 
potential selection method  
 
Construct transformation plasmid, which contains a 
selectable marker gene to confer antibiotic resistance 
phenotype 
 Develop transformation methodology by testing two 
delivery methods – biolistics and electroporation. 
 
The attempts were not successful highlighting the 
challenges in transforming the chloroplast genome of N. 
gaditana, which are i) the small size of the cell (and 
therefore the plastid) and ii) the complexity of the 
plastid membranes 
 
 
An improved approach to develop chloroplast 
transformation method (Chapter 4) 
 
 
Evaluation of sensitivity to chloroplast-specific 
compounds 
 
 
 
Construct transformation plasmid, which contains a 
psbA variant allele as an endogenous selectable 
marker to confer the tolerance to herbicide atrazine 
(photosystem II inhibitor) 
 
 
Synchronise N. gaditana at the mitotic stage as a 
means to increase the cells size prior to biolistics 
transformation. 
 
Test chloroplast transformation using biolistics at 
high velocities with these enlarged to allow the 
delivery of exogenous DNA across multiple 
chloroplast membranes without killing the cells. 
 
The genetic engineering technologies for microalgae are still in their infancy, 
so the focus of this research is to gain a better understanding of the 
methylerythritol phosphate pathway that leads to terpenoid biosynthesis in 
the chloroplast of C. reinhardtii by investigating the effect of overexpressing 
dxs on plastidic downstream terpenoids (Chapter 5) 
 
Construct transformation plasmids to introduce an additional copy of the 
dxs gene into the chloroplast genome. 
a) Plasmid contains an intact dxs gene 
b) Plasmid contains a mutant dxs gene  
 Chloroplast transformation of C. reinhardtii to generate marker-less C. 
reinhardtii lines expressing dxs in the chloroplast    
  Analysis of transgene integration into the chloroplast genome and homoplasmy  
 Analysis of the DXS protein accumulation in the C. reinhardtii chloroplast  
 
 Studying the effect of overexpressing dxs in C. reinhardtii growth  
 Analysis of terpenoid profile of the genetically engineered C. reinhardtii  
 Novel microalga with industrial potential (Nannochloropsis gaditana)  Model microalga with well-established tools for genetic manipulation 
(Chlamydomonas reinhardtii) 
Hypothesis: the genetic manipulation of the plastidic terpenoid biosynthetic pathway in the model microalga C. reinhardtii will further our understanding about terpenoid metabolism and rate-limiting steps, 
which is important for successful terpenoid metabolic engineering. Engineering strategies developed could also be transferred into other microalgae with industrial potential such as N. gaditana upon the 
development of plastome engineering tools including a reliable chloroplast transformation method.  
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CHAPTER 2 
Materials and Methods 
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2. Materials and Methods 
2.1. Strain and growth conditions 
2.1.1. Escherichia coli  
2.1.1.1 Escherichia coli strain 
Escherichia coli DH5α (F-, (φ80lacZΔM15), Δ(lacZYAargF) U169, deoR, recA1, endA1, 
hsdR17(rk-, mk+), supE44, thi-1, gyrA96, relA, λ) was used as a recipient strain for molecular 
cloning.  The E. coli strain was supplied by Clontech (Saint-Germain-en-Laye, France).  
2.1.1.2 E. coli maintenance and growth  
E. coli strains were grown on Luria-Bertani (LB) medium, containing 10 g/L bacto-tryptone 
(Difco), 5 g/L bacto-yeast extract (Difco) and 10 g/L NaCl supplemented with appropriate 
antibiotics when necessary. Liquid cultures were grown overnight at 37°C in a shaking 
incubator at 200 rpm. For growth on solid medium, the strain was plated on 1.5% (w/v) LB 
agar and incubated at 37 °C for 24 hours (Fisher Scientific Incubator). For long-term storage, 
frozen stocks were prepared by mixing 100 μl of overnight E. coli culture and 100 μl 50% 
(v/v) glycerol, and were stored at –80 °C. 
2.1.2. Nannochloropsis gaditana 
2.1.2.1 Strain and growth conditions 
Nannochloropsis gaditana CCMP526 was kindly provided by Dr. Matthew Posewitz and was 
cultivated photoautotrophically in defined artificial seawater medium (ASW). The ASW was 
prepared as follows: 15 g/L NaCl, 6.6 g/L MgSO4·7H2O, 5.6 g/L MgCl2·6H2O, 0.5 
g/LCaCl2·2H2O, 1.45 g/L KNO3, 0.12 g/L KH2PO4, 0.04 g/L NaHCO3, 0.01 g/L FeCl3·6H2O, 
0.035 g/L Na2-EDTA, 0.25 ml/L 3.64 mM MnCl2·4H2O, and 0.5 ml/L trace metal mix (20 
mg/L CoCl2·6H2O, 12 mg/L Na2MoO4·2H2O, 44 mg/L ZnSO4·7H2O, 20 mg/L CuSO4·5H2O, 7.8 
g/L Na2-EDTA). The pH of the trace metal mix was adjusted to 7.5 and the final pH of the 
ASW was adjusted to 7.3. The cultures were grown in liquid ASW under continuous light 
intensity of 30–80 μE with constant shaking at 120 rpm and at 25 °C (Innova 4340 incubator 
shaker, Germany). Agar plates were prepared by adding 2% (w/v) DifcoTM agar (Becton, 
Dickinson company, USA). A loopful of culture was streaked on ASW 2% (w/v) agar plates 
and maintained at light intensity of approximately 20–50 μE at 25 °C. 
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2.1.3. Chlamydomonas reinhardtii 
2.1.3.1 Chlamydomonas reinhardtii strains  
The C. reinhardtii strains used are show in Table 2.1 and maintained in either an 
illuminated incubator or a culture room in the Purton laboratory.   
 
Table 2.1 Summary of the C. reinhardtii strains used in this study 
Strain Description  Source 
/Reference  
Purpose  
TN72 Cell wall deficient and non-
photosynthetic psbH mutant  
(Wannathong 
et al. 2016) 
Recipient strain for chloroplast 
transformation of C. reinhardtii 
H1 TN72 transformed with empty 
chloroplast transformation vector 
(pSRSapI), restoring psbH function. 
(Young & 
Purton 2014) 
Control strain for growth analysis, 
Western blot analysis, enzyme 
activity assays and HPLC analysis 
L1 TN72 transformed with pRY134a. 
The strain has an additional copy of 
the dxs gene. 
Dr Rosie 
Young  
Transgenic lines that were created 
to study the effect of overexpressing 
the dxs gene in downstream 
terpenoids metabolites in the C. 
reinhardtii 
L3-L5 TN72 transformed with pRY134a. 
The strains have an additional copy 
of the dxs gene. 
This study  
dl1-dl2  TN72 transformed with 
pRY134aΔdxs. The strains have an 
additional, but mutated, copy of dxs 
This study  
2.1.3.2 Chlamydomonas reinhardtii growth conditions and maintenance 
C. reinhardtii strains were cultivated heterotrophically on tris-acetate phosphate (TAP) 
medium. The TAP was prepared by mixing three main stock solutions as follows: 4 x 
Beijerinck salts stock solution (0.3M NH4Cl, 14mM CaCl2.2H2O and 16mM MgSO4.7H2O), 1M 
(K)PO4 stock solution (1M K2HPO4 titrated to pH 7.0 with 1M KH2PO4) and trace metal mix 
stock solution (180 Mm H3BO3, 77mM ZnSO4.7H2O, 26mM MnCl2.4H2O, 18 mM FeSO4.7H2O, 
7mM CoCl2.6H2O, 6mM CuSO4.5H2O, 0.1M Na2EDTA, 0.9mM (NH4)6Mo7O2.4H2O).  
All C. reinhardtii strains, except photosynthetic mutant strain (TN72), were grown in a 
shaking incubator, under continuous illumination of intensity approximately 80–100 μE, at 
25 °C (New Brunswick™ Innova, Germany). The strains were maintained on 2% (w/v) agar 
TAP in an illuminated incubator at 80–100 μE at 25 °C. The photosynthetic mutant strain 
(TN72) was grown shaking under dim light conditions of approximately 5–10 μE at 25 °C 
and maintained in a culture room at the same conditions. The C. reinhardtii strains were 
sub-cultured every six to eight weeks as suggested by Harris, (1988). 
Sueoka’s high salt minimal (HSM) medium plates were used to select for C. reinhardtii 
transformants. The preparation of HSM is similar to TAP except that the 1 M (K)PO4 stock 
is replaced by 2 x PO4 stock solution (80mM K2HPO4 and 50mM KH2PO4, adjusted to pH 6.9 
with KOH) and no acetic acid is added. 
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2.2. Quantification of cell density  
The cell density of microalgae was counted by eye under a light microscope (x40 objective) 
at x400 magnification using a haemocytometer (Axio Scope. A1, Zeiss). In order to count the 
C. reinhardtii cells, they were first treated with 10μl tincture of iodine (19.7 mM iodine in 
95 % (v/v) ethanol) per 1 ml sample to immobilize the cells and facilitate counting. The 
addition of iodine solution was not necessary to count N. gaditana cells, due to the absence 
of flagella. The number of cells per ml of culture was calculated as follow: average cell count 
x dilution factor x 104. The optical density of cells was measured at 750 nm with a 1 cm path 
length using a spectrophotometer (Unicam UV/Vis Spectrometer UV2). 
2.3. Growth analysis 
A commercial lab scale photobioreactor known as an Algem® (Algenuity, UK) was used 
either to investigate the effect of different parameters on the growth rate of N. gaditana or 
to compare the growth rate among different strains of C. reinhardtii. To study the effect of 
growth conditions on N. gaditana, the Algem® was set up to expose the culture (approx. 
500 ml) in two chambers simultaneously to different conditions by altering a physical 
parameter such as the light regime, light intensity, light wavelength or temperature. In 
contrast, to compare the growth rates between different C. reinhardtii strains, the 
comparison was carried out by growing the strains under identical conditions; a constant 
temperature of 25 °C, a constant light intensity of 200 µE and constant mixing at 120 rpm. 
The cell growth for both species of microalgae was monitored by measuring the optical 
density at 740 nm and the readings were saved automatically every 10 minutes. The 
recorded data were later retrieved for graph plotting and data analysis using the 
instrument’s built-in software when necessary or using Microsoft Excel. 
2.4. Sensitivity test 
Sensitivity of N. gaditana to various compounds, as tabulated in the appendices 
(Appendix.1), was evaluated initially by spotting a small volume (5 µl) of culture onto 
nutrient agar plates (so-called “spot tests”). The spot test is based on measuring algal 
growth in the presence of the tested compound, in comparison to the growth of a control. 
The cells were re-suspended in ASW medium and then diluted in ten-fold dilutions (0, 10-1, 
10-2, 10-3 and 10-4). The suspension of diluted cells was pipetted onto 2% (w/v) ASW agar 
supplemented with one of the following concentrations: 0, 50, 100, and 200 µg/ml of the 
tested compound. For those compounds which inhibited the growth, a high density of cell 
suspension (> 5x104 cells/plate) was plated on 2% (w/v) agar ASW plates supplemented 
with the corresponding compound to assure the consistent inhibition of growth at high 
density as well. The plates were maintained at a light intensity of 20–50 μE at 25 °C.  
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A further test to confirm the effect of a particular compound was carried as follows: the N. 
gaditana was cultured in liquid ASW medium to log phase (OD750 0.6–0.8) and then the 
culture was aliquot into a 12 well microplate; 3 ml in each well. The tested compound was 
added to each well to give a range of concentrations from 10 µg/ml to 300 µg/ml. However, 
the tested compound was omitted from three wells as a positive control for each row. The 
culture was maintained in a shaking incubator at a light intensity of 20–50 μE at 25 °C. Four 
weeks later, the sensitivity of N. gaditana to various concentration of compound of interest 
in liquid state was evaluated by spotting 5 µl of culture onto 1.5% (w/v) ASW agar plates. 
The plates were maintained at light intensity of 20–50 μE at 25 °C. 
2.5. DNA manipulations 
2.5.1. Plasmids 
A number of plasmids was used in this study and the details of these plasmids is listed in 
Table 2.2.  
Table 2.2 Summary of used plasmids in this study. 
Vector Source Function / purpose  
pJet1.2 Thermo Scientific A cloning vector for DNA manipulation and genetic engineering.  
pSRSapI Purton’s 
collection 
(Dr Rosie Young) 
A cloning vector to introduce genes into the C. reinhardtii 
chloroplast under the control of the psaA exon 1 promoter/5’UTR 
and the rbcL 3’UTR.  
pRY134a Purton’s 
collection 
(Dr Rosie Young) 
A cloning vector to introduce the intact dxs gene into the C. 
reinhardtii chloroplast. 
pRY134a∆dxs Modified in this 
project 
A cloning vector to introduce an additional copy of the dxs gene, 
but mutated, into the C. reinhardtii chloroplast genome.  
pARG1.3 Purton’s 
collection 
A source of the chloramphenicol acetyl transferase gene (cat) 
pUH.NCc2 Made in this 
project 
A cloning vector for introducing the cat gene into the N. gaditana 
chloroplast under the control of the psaA promoter/ 5’UTR and the 
psbA 3’UTR. . 
pUH.psbA264A Made in this 
project 
A cloning vector to mutate the wild type psbA gene with an 
atrazine tolerant psbA allele.  
2.5.2. Isolation of genomic DNA from microalgae 
Extraction of genomic DNA either from N. gaditana or C. reinhardtii strains was performed 
by taking a loopful of cells and re-suspending them in 20 μl of double distilled water 
(ddH2O). Then 20 μl of absolute ethanol was added to the mixture and incubated at room 
temperature for 1 minute. About 200 μl of 5% (w/v) Chelex-100 resin (Bio-Red) suspension 
was added and the mixture was briefly mixed using a vortex. The mixture was heated in a 
heating block (Thermomixer, Eppendorf) at 99 °C for 5 minutes. After heating, the mixture 
was centrifuged (Heraeus Biofuge Pico) at 13,000 rpm for 2 minutes, followed by transfer 
of the supernatant into a fresh Eppendorf tube. The genomic DNA samples were stored in 
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the freezer for later use in PCR. A 2 μl aliquot of extracted genomic DNA was used in a 50 μl 
PCR reaction. 
2.5.3. Isolation of plasmids from Escherichia coli  
Small scale plasmid isolation was conducted by initially inoculating 5 ml LB medium, 
supplemented with the appropriate antibiotic, and incubating overnight at 37 °C with 
constant shaking at 200 rpm (Innova 4300 incubator shaker, New Brunswick Scientific). 
The overnight grown cells were harvested by centrifugation at 5,000 x g for 15 minutes at 
4 °C. The plasmids were isolated from the cells using a Gene JET plasmid mini-prep kit 
following the manufacturer's instructions. A large volume of LB (approximately 30 ml) 
supplemented with appropriate antibiotic was inoculated for larger scale isolation. The 
large scale isolation was conducted using the Qiagen plasmid Midi kit following the 
manufacturer’s instructions. The concentration of isolated plasmid was quantified using a 
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). 
2.5.4. Polymerase chain reaction 
The amplification of target DNA sequences was performed in a 25 µl PCR reaction that 
contained: 1x Phusion® HF or GC buffer (NEB), 1 unit of Phusion® High-Fidelity DNA 
Polymerase (NEB), 10mM of each deoxyribonucleotide triphosphate (dNTPs), 5µM of each 
forward and reverse oligonucleotide primers (MWG), ~2.5 ng/µl DNA template and ddH2O 
to make the final volume 25 μl. The PCR reactions were performed in a thermal cycler 
(either Eppendorf mastercycler® personal (Hamburg, Germany) or Techne TC-3000X 
Thermal Cycler, (California, USA). The cycle conditions employed varied based on the size 
and GC content of DNA fragment to be amplified. The PCR products were analyzed on a 1% 
(w/v) agarose gel in TAE buffer (40 mM Tris, 20 mM acetic acid and 1mM sodium EDTA) 
containing 1 µg/ml ethidium bromide. The PCR products were visualized on a UV 
transilluminator and results captured on black/white thermal paper (UVP Gel 
Documentation System). The sizes of fragments were estimated by reference to a Gene 
Ruler DNA ladder Mix (Thermo Scientific). The primers used were synthesized by Eurofins 
MWG operon and the primer details for each reaction are listed in the appendices 
(Appendix.2). 
2.5.5. Gibson assembly  
A Gibson assembly method, as described by Gibson et al. (2009) was used to assemble 
multiple overlapping DNA fragments in a single reaction by the action of different enzymes. 
The reaction was performed in a total volume of 20 µl and consists of 5 x isothermal buffer 
(5% PEG-8000, 500 mM Tris-HCl pH 7.5, 50 mM MgCl2, 50 mM DTT, 1 mM each of the four 
dNTPs and 5 mM NAD), 5 µl of equimolar quantities of each of the DNA fragments and a 
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three enzyme cocktail (0.64 μl of 10 U/μl T5 exonuclease, 2 μl of 40 U/μl Taq DNA ligase 
and 0.5 μl of 2U/μl Phusion DNA polymerase). The reaction was carried out at 50 °C for 60 
minutes. The reaction product was stored in a freezer at –20 °C to be used later.   
2.5.6. Restriction endonuclease digestion 
DNA samples were digested with 10 units of restriction endonuclease per 1 g of DNA in 
the recommended buffer according to the manufacturer’s instructions. For a double 
digestion, the online NEB double digest finder program (www.neb.com) was used to 
determine the suitable buffer for both enzymes. All restriction endonucleases were 
supplied from New England Biolabs. 
2.5.7. PCR purification and gel extraction 
PCR products were purified using Gene Jet PCR purification kit (Thermo Scientific) as per 
the manufacturer’s instructions. For gel extraction, the DNA fragment was visualized on a 
UV transilluminator and excised from the agarose gel using a razor blade. Then, the DNA 
fragment was purified using the Gene JET gel extraction kit (Thermo Scientific) as per the 
manufacturer’s instructions. 
2.5.8. DNA ligation  
The ligation reaction for DNA samples was carried out in a total volume of 10 l, containing 
1 unit of T4 DNA ligase per 1 g of DNA and 1x DNA ligase buffer (NEB). The DNA ratio of 
insert:vector was 1:3, respectively. The reaction was incubated for 1-2 hours at room 
temperature and then the ligated plasmids were transformed into competent E. coli cells by 
heat shock transformation (Sambrook & Russell 2001). Cells were grown on 1.5% (w/v) LB 
agar medium supplemented with the appropriate antibiotic. Colonies containing the correct 
plasmid and insert were identified either by colony PCR or restriction digests of the purified 
plasmid.  
2.5.9. DNA sequencing 
DNA was sequenced by Source Bioscience Services. DNA samples were supplied either in 
plasmid form or as a purified PCR product at a concentration of 100 ng/l and 1 ng/l per 
100 bp, respectively. The primers were supplied for sequencing at a concentration of 3.2 
M. The results of the sequencing were analysed using MacVector with assembler (version 
12.6.0).  
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2.6. UV mutagenesis to isolate atrazine tolerant mutants 
Cells of N. gaditana were grown in 100 ml ASW medium to mid-log phase with a cell density 
of approximately 1 x 106 cells/ml and then approximately 60 ml of culture was irradiated 
by UV light at 254 nm wavelength at a distance of 15 cm from a 6W ultraviolet light bulb 
using an in-house built ultraviolet box. During UV irradiation, the cells were stirred 
constantly in a large petri dish approximately 14 cm in diameter using a sterilised paper 
clip as a stirrer. To produce a kill curve for N. gaditana, 50 l samples were taken over 10 
minutes at 1 minute intervals. The cells were left to recover in the dark for 1 hour to limit 
photo-reactivation of cells. Afterwards, each aliquot was diluted 1 in 100 with fresh ASW 
medium and plated on 2% (w/v) ASW agar. The plates were scored for colonies after 3–4 
weeks and viable cells were calculated. A kill curve was plotted of viable cells against time 
of exposure in order to estimate the time (t10) of exposure needed to produce a 10% survival 
of cells. 
Once a 10% survival rate was estimated for N. gaditana, the procedure was repeated using 
this time, t10, to screen for chloroplast mutant colonies. However, to induce chloroplast 
mutations, the cells were treated with a 5-fluorodeoxyuridine (FdUrd) prior to UV 
mutagenesis in order to reduce the chloroplast genome abundance (Wurtz et al. 1979; 
Anthony et al. 2014). In order to do this, N. gaditana cells were grown in 200 ml in ASW 
medium to mid-log phase with a cell density of approximately 1 x 106 cells/ml. Sterilised 
glucose was added to the culture to give a final concentration of 20 mM. Thereafter the 
culture was split equally into three sterilised flasks, with each flask contains approximately 
50 ml culture. The FdUrd was added at two different concentrations; 0.5 mM and 1 mM. The 
third flask contained no FdUrd and was used as a control. All cultures were maintained in 
the dark under constant agitation for 20 days until they reach stationary phase. The Fdurd-
treated cells were washed twice with ASW medium and re-suspended to a cell density of 2 
x 108 cell/ml. An aliquot of cells (500 l) was removed from each culture for PCR analysis. 
The rest of the re-suspended cultures were subjected UV mutagenesis for time t10. The cells 
were left to recover in the dark for 1 hour and after that, a 500 l aliquot of cells was spread 
onto 20 prepared 2% agar (w/v) ASW plates, supplemented with various concentrations of 
atrazine (50 g/ml, 80 g/ml and 100 g/ml). The mutant colonies were observed after  
6–8 weeks under atrazine pressure and these colonies were chosen for further analysis.  
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2.7. Genetic transformation 
2.7.1. Escherichia coli  
2.7.1.1 Preparation of E. coli competent cells 
E. coli (DH5α) cells were streaked from a glycerol stock on to a fresh 2% LB agar (w/v) plate 
and incubated overnight at 37 °C. A single colony was used to inoculate the starter culture 
and the culture was incubated overnight at 37 °C with constant shaking at 200 rpm. 1 ml of 
starter culture was used to inoculate 100 ml fresh LB medium and grown under the same 
conditions for 2.5 hours, at which point the OD600 was measured to be approximately 0.6 
(Unicam UV/Vis Spectrometer UV2). The 100 ml culture was then cooled on ice for 15 
minutes followed by pelleting the cells in pre-cooled sterilin tubes at 4000 x g for 5 minutes. 
The pellets were re-suspended in 40 ml of ice-cold 50 mM CaCl2, then incubated on ice for 
30 minutes and centrifuged again at 4000 x g for 5 minutes. The pellets were re-suspended 
in 1.5 ml of fresh ice-cold 50mM CaCl2 up to a final volume of 8 ml. The re-suspended 
solution was mixed with 3.5 ml of 50 % (v/v) glycerol. The competent cells were dispensed 
as 200μl aliquots, frozen in liquid nitrogen and stored –80 °C until required. 
2.7.1.2 Transformation of E. coli  
The prepared competent cells were transformed using the heat shock method. The aliquots 
of competent cells (100 μl) were thawed on ice, and then either 10 μl of ligation mixture or 
1 μl of plasmid miniprep, diluted in water by a factor of 10, was added. Another tube of 
competent cells (100 μl) was included without the addition of DNA as a negative control. 
The samples were incubated on ice for 30 minutes and then heat shocked at 42 °C for 1 
minute. The samples were returned immediately to ice and 1 ml of LB medium was added 
to each tube, followed by incubation for 1 hour at 37 °C. The aliquots were spread on 1.5 
(w/v) LB agar plates supplemented with the appropriate antibiotic. The plates were 
incubated overnight at 37 °C.  
2.7.2. Transformation of the Chlamydomonas reinhardtii chloroplast 
The chloroplast transformation method used was adapted from the original glass bead 
method described by Kindle et al. (1991), with some modifications. The recipient cell wall 
deficient and photosynthesis deficient strain (TN72) was grown in 500 ml TAP to mid-log 
phase (with a cell density of 1–2 x 106 cells/ml) under dim light approximately 5–10 μE. 
The cells were harvested by centrifugation at 5,000 rpm for 5 minutes at 16 °C (Sorvall 
Evolution RC, Thermo Scientific) and then re-suspended in fresh TAP to a concentration of 
2 x 108 cells/ml. Aliquots of the cell suspension were pipetted into test tubes containing ~ 
0.3 g of glass beads (Glass beads, acid washed, 425-600 μm, Sigma). 10 μg of DNA was added 
into each tube containing 300 μl of cell suspension and then agitated for 15 seconds at 
maximum speed using a Vortex genie-2. Then 3 ml of molten 0.5% (w/v) HSM agar at 42 °C 
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was added to each tube and immediately the mixture was poured onto 2% HSM (w/v) agar 
plates. The plates were incubated under a light intensity of approximately 50 μE at 25 °C for 
6–8 weeks, with the selection based on restoration of photosynthesis and the ability to grow 
autotrophically on 2% (w/v) HSM agar plate. The putative transformant colonies were 
picked and re-streaked three times on 2% HSM agar (w/v) plates before being screened for 
homoplasmicity by PCR.  
2.7.3. Nannochloropsis gaditana 
2.7.3.1 Transformation of N. gaditana using electroporation  
Cells of N. gaditana were grown in 500 ml of ASW medium supplemented with 50 μg/ml 
kanamycin and 100 μg/ml ampicillin to late log phase with a cell density of ~1–2 x 107 
cells/ml. The cells were harvested by centrifugation at 3, 500 x g at 22 °C for 15 minutes and 
then cells were washed three times with 375 mM sorbitol.  After the final wash, the cells 
were re-suspended in 5 ml to give the final concentration of approximately 1 x 109 cells/ml, 
following which the cells were dispensed into fresh 1.5 ml tubes as 400 μl aliquots. The 400 
μl aliquot of cells was mixed with 5–10 μg of linearized DNA and kept on ice prior to 
electroporation. The electroporation was performed with a constant time Electroporator 
(2510 Electroporater, Eppendorf) or (Gene Pluser XcellTM Electroporation system, Bio-Rad) 
in 2-mm cuvettes. The suspension of cells and DNA was transferred into a cuvette and 
subjected to an electrical field strength at set conditions. After electroporation, the cells 
were allowed to recover in 10 ml of ASW medium for 24 hours at 25 °C with shaking under 
dim light (approximately 5–10 μE). The cell concentration was adjusted to give ~ 1 x 108 
cells per plate, and then plated on 2% (w/v) ASW agar plates containing the appropriate 
selection agent. Successful transformants were scored after 4 weeks and re-streaked onto 
fresh plates one week later. 
2.7.3.2 Biolistic Transformation of N. gaditana  
The biolistic transformation of N. gaditana was performed using the BioRad PDS-1000/He 
Biolistic® Particle Delivery System. For the cell preparation, the cells were grown in 400 ml 
of ASW medium supplemented with 50 μg/ml kanamycin and 100 μg/ml ampicillin to late 
log phase with a cell density of 1–2 x 107 cells/ml. The cells were then diluted with one-
sixth of its original volume and subsequently nocodaozle (Sigma-Aldrich) added to give the 
desired final concentration. The cells were allowed to grow in the presence of nocodaozle 
for 24 hours with light intensity at 50 μE at 25 °C with constant shaking at 120 rpm. After 
that, the cells were harvested at 3,500 x g for 15 minutes at 22 °C and the pellet was re-
suspended in fresh ASW medium containing the desired concentration of nocodazole to a 
concentration of 5 x 108 cells/ml. The cells were spread evenly on 2% (w/v) agar ASW in 
which the cell concentration was adjusted to 1–5 x107 cells per plate. The plated cells were 
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allowed to dry briefly in a laminar flow hood, and then were bombarded with DNA-coated 
microparticles within 2 hours.  
For DNA preparation, the plasmids were linearised and then coated onto gold particles with 
a diameter of 0.55 μm using the DNAdelTM gold particles kit (Seashell Technology, San 
Diego) as per the manufacturer’s instructions. The coated microparticles were washed with 
70% (v/v) ethanol and re-suspended in absolute ethanol to give a final concentration of 0.5 
mg gold particle coated with 5–10 μg DNA per shot. This suspension solution was briefly 
sonicated in a water bath and then applied to the center of sterilized macro-carriers (Bio-
Rad laboratories Ltd, Hertfordshire, UK). Before loading the macro-carriers for 
bombardment, they were allowed to air dry in a laminar flow for few minutes.  
The bombardment of prepared algal plates was performed by following the instructions for 
the PDS-100/He device, using 1350 psi rupture disk (Bio-Rad laboratories Ltd, 
Hertfordshire, UK). After bombardment, the cells were allowed to recover by incubating the 
plates under dim light at 25 °C for 24 hours. Afterwards, the cells were re-suspended in fresh 
ASW medium using a spreader and were then harvested by centrifugation at 3,500 x g for 
15 minutes at 22 °C. Twice the pellet was washed by centrifugation at 3,500 x g for 15 
minutes followed by pellet re-suspension in 10 ml of sterile ASW medium. Following the 
washing steps, the cells were left to recover in 10 ml ASW medium for 1 hour at 25 °C with 
shaking at low light intensity (5–10 μE). The cells were harvested by centrifugation at 3,500 
x g for 15 minutes at 22 °C and re-suspended in 2 ml of sterile ASW medium. About 500 μl 
of re-suspended cells were spread on 2% (w/v) ASW agar supplemented with the 
appropriate selection agents. The plates were incubated at 25 °C under constant 
illumination at approximately 80–100 μE. The putative transformed colonies were 
observed after 4–6 weeks and re-streaked on fresh selective medium for further analysis.  
2.8. Protein analysis 
2.8.1. Preparation of crude total protein extract from C. reinhardtii 
Cultures of C. reinhardtii cells were grown to log phase (OD750 0.8–1.5) in a shaking 
incubator and the optical density of cultures at 750 nm was measured using a 
spectrophotometer. The cells were prepared by centrifuging 20 ml of culture at 5,800 x g 
for 5 minutes and then re-suspending the pellet in a volume of solution A containing 0.8 M 
Tris.HCl pH 8.3, 0.2 M sorbitol, 1 % (v/v) β-mercaptoethanol. The added volume of solution 
A in each sample depends on OD750 readings to ensure that all samples are more or less at 
the same concentration. Afterwards, 50 μl aliquots of the algal suspension was stored at  
–80 °C to be used later for western blot analysis.  
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2.8.2. Preparation of protein extract from E. coli 
E. coli cells were grown overnight at 37 °C with constant shaking at 180 rpm. The overnight 
cultures were harvested by centrifugation for 10 minutes at 5,500 rpm at 4 °C. The protein 
was then extracted from cells using BugBuster® protein extraction reagent (Novagen) 
following the manufacturer’s instructions. The resulting supernatant was transferred into 
a fresh 1.5 ml tube and stored as 0.5 ml aliquots at –80 °C to be used later in western blot 
analysis and fluorometric assay.  
2.8.3. SDS-polyacrylamide gel electrophoresis 
The proteins were resolved on a 15% SDS-PAGE gel. The 1.0 mm thick gel was set up using 
a Bio-Rad mini-PROTEAN tetra system and the gels (resolving and stacking) were made 
following Laemmli’s gel recipe (Sambrook & Russell 2001). The resolving gel was prepared 
by adding the chemicals in the following order: 2.8 ml 40 % (w/v) acrylamide: 
bisacrylamide at 37:1, 1.87 ml 1.5 M Tris-HCl (pH 8.8), 75 μl 10 % (w/v) SDS, 2.65 ml ddH2O, 
75 μl 10 % (w/v) ammonium persulphate and 3 μl TEMED. 4 ml of this solution was added 
to the pre-set plates, leaving a few centimeters at the top for the stacking gel and then 
overlain with ethanol. The gel polymerization was allowed to set at room temperature for 
at least 30 minutes.  After polymerization, the ethanol overlay was removed and the surface 
of the gel was washed several times with distilled water.  
The stacking gel was then prepared by adding the chemicals in the following order; 375 μl 
40 % (w/v) acrylamide: bisacrylamide at 37:1, 375 μl 1M Tris-HCl (pH 6.8), 30 μl 10 % 
(w/v) SDS, 2.15 ml distilled H2O, 30 μl ammonium persulphate and 3 μl TEMED. 
Approximately 1 ml of this solution was used to fill the plates with stacking gel right to the 
top. The appropriate comb was inserted carefully into the stacking gel and left for at least 
for 30 minutes at room temperature for the gel to set.  
After setting up the gel, the 50 μl protein extract aliquots previously stored at –80 °C were 
prepared for loading by adding 5 µl of 10% (w/v) SDS followed by heating on the heatblock 
for 1 minute at 99 °C. The samples were centrifuged for 2 minutes at 13,000 rpm and a 25 
μl volume of supernatant was used in the loading. The molecular weight of proteins was 
estimated by reference to a PageRuler™ prestained ladder (Fermentas, York, UK). The 
proteins were run in cold electrophoresis buffer containing 0.25 M Tris, 1.92 M glycine, 1 % 
(w/v) SDS pH 8.3 for 90 minutes at 150 V until the green chlorophyll was close to the bottom 
of the gel.  
2.8.4. Western blot analysis 
The semi-dry electrophoresis method detailed by Sambrook and Russell , (2001) was used 
to transfer proteins separated by SDS-PAGE to Hybond-ECL nitrocellulose membranes (GE 
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Healthcare). To set up the gels for transfer, 6 sheets of equivalent sized 3MM Whatman 
paper and a sheet of nitrocellulose membrane were soaked in Towbin buffer (25 mM Tris, 
192 mM glycine and 20 % (v/v) methanol) at room temperature for 10 min. Three sheets 
of soaked 3MM paper were placed on the semi-dry blotter followed by the nitrocellulose 
membrane, the gel and then the remaining three sheets of 3MM paper. Excess buffer and air 
bubbles in the assembled stack were removed by rolling with a plastic pipette. 
The transfer of proteins was conducted using the Bio-Rad Trans-Blot SD semi-dry 
electrophoretic transfer system at a constant voltage of 20 V (Fisons FEC 570 powerpac) 
for 2 hours. Following transfer, the membrane was blocked overnight in 20 ml of 5 % (w/v) 
skimmed milk powder in TBS-T (20 mM Tris base, pH adjusted to 7.4 with 5M HCl, 137mM 
NaCl, 0.1 % (v/v) Tween-20) at 4 °C shaking at 50 rpm (Mini-orbital Shaker, Stuart). The 
membrane was rinsed briefly with TBS-T, followed by two rounds of 15 minute washes in 
TBS-T while shaking at 50 rpm. Diluted rabbit anti-HA antibody (1:2000) was used as the 
primary antibody and the membrane was treated with primary antibody for 1 hour at room 
temperature with shaking at 60 rpm. The membrane was rinsed several times briefly and 
the membrane was then washed four times in TBS-T for 10 minutes.  
For the ECL detection method, a horseradish peroxidase-conjugated anti-rabbit IgG 
antibody (GE Healthcare) was used as the secondary antibody. The membrane was 
incubated in 0.5% (w/v) skimmed milk in TBS-T with the secondary antibody (1:5000 
dilution) for 1 hour at room temperature with shaking at 60 rpm and then the membrane 
was washed as for the primary antibody. The proteins were detected by the ECL method 
using a luminescence substrate detection kit according to the manufacturer's instructions 
(SuperSignal West Pico Chemiluminescent substrate, supplied by Pierce). The membrane 
was sealed between polythene sheets using a heat sealer and taped in a developing cassette. 
In the dark room, a sheet of Hyperfilm ECL (GE Healthcare) was exposed to the membrane 
and then developed using an automatic film processor (Xograph Compact X4 film 
developer). The signal strength was adjusted by changing the exposure duration until the 
protein of interest was visualized at the desirable level.  
As for the Odyssey detection method, a goat anti-rabbit IgG Dylight 800 (Thermo Scientific) 
was used as secondary antibody. The membrane was therefore incubated in 0.5% (w/v) 
skimmed milk in TBS-T with the secondary antibody (1:2000) for an hour at room 
temperature with shaking at 60 rpm and then the membrane was washed as for the primary 
antibody. An additional washing step with TBS was included to remove the excess Tween. 
Afterwards the protein was detected using the Odyssey® Infrared Imaging system (Li-COR 
Bioscience, USA).  
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2.9. Protein activity assay 
2.9.1. Preparation of crude extracts for the DXS enzyme activity assay 
The C. reinhardtii transformant lines were grown to exponential phase (OD750 1.0–2.0) and 
then the cells were harvested by centrifugation at 5,000 rpm for 10 minutes. The cell pellet 
for each strain was washed with water and then re-suspended in extraction buffer (40mM 
Tris-HCl, 5mM 2-mercaptoethanol, 2.5 mM MgCl2, pH 7.5) containing protease inhibitor 
Roche cOmplete, EDTA-free (Roche, Switzerland). Afterwards, the cells were lysed by a 
freeze and thaw method. Cells were frozen in liquid nitrogen and thawed in a water bath at 
35 °C. The freeze and thaw cycle was repeated three times and then the lysed cells were 
centrifuged at 5,500 x g for 30 minutes. The supernatant was the recovered, which is 
referred as the crude enzyme extract. In some cases, the crude enzyme extract was further 
centrifuged at 100,000 x g for an hour in Sorvall Discovery 90SE ultracentrifuge (Hitachi, 
USA) to get rid of more cellular debris and non-soluble proteins. The crude enzyme extract 
was transferred into a new tube and stored as 1 ml aliquots at –80 °C to be used later in a 
fluorometric assay.  
2.9.2. Fluorometric assay for the DXS enzyme  
The reaction mixture for the DXS enzyme activity assay consisted of 40 mM Tris–HCl, 2.5 
mM MgCl2, 5 mM 2-mercaptoethanol, 1mM thiamine diphosphate, 10mM sodium pyruvate, 
and 20 mM DL-glyceraldehyde 3-phosphate, and the crude enzyme extract to make the final 
volume of 100 μl. The reaction mixture was incubated at 30 °C for 60 minutes. The reaction 
was stopped by heating the mixture at 80 °C for 5 minutes, and then centrifuged at 13,000 
x g for 5 minutes. The supernatant wa s transferred into a new tube and diluted with 
distilled water to 1 ml. The diluted supernatant was mixed with an equal volume of 10 mM 
DABA in 5 M phosphoric acid, and then heated in a boiling water bath for 15 minutes. The 
supernatant containing the enzymatic product ‘DXP’ was analyzed at an excitation 
wavelength of 396 nm using a fluorometer (LS 55 Luminescence, PerkinElmer). 
2.10. Freeze-drying the algal materials 
C. reinhardtii strains were grown in 250 ml of TAP medium to late log phase (OD750 1.0–2.0). 
The cells were harvested by centrifugations at 5,000 rpm for 15 minutes at 16 oC (Sorvall 
Evolution RC, Thermo Scientific). The cell pellets were washed with distilled water followed 
by the transfer of the re-suspended cells in water into 50 ml falcon tubes wrapped with foil. 
The cells were harvested and frozen in liquid nitrogen. Once the cells were frozen, the freeze 
dryer (Modulyo Freeze Dryer, Edwards) was set up for the use according to the 
manufacturer’s instructions. The frozen samples were placed into the freeze dryer 
chamber, where the lid of falcon tubes was kept loose to allow moisture to escape during 
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the process. The air was evacuated from the chamber, allowing the cells to dry for 
approximately 48 hours at –50 °C, Pressure < 1 Pa. The cells were removed from the freeze 
drier chamber according the manufacturer’s instructions, and the lid was tightened 
properly. The freeze-dried algal materials were kept at room temperature for a few days 
and then they were sent for HPLC analysis in the laboratory of Professor Paul Fraser, Royal 
Holloway, London.  
2.11. Cell cycle synchronisation using nocodazole 
A culture of N. gaditana was grown in 200 ml ASW medium supplemented with 100 μg/ml 
ampicillin and 50 μg/ml kanamycin to log phase (OD750 1.0–1.2) at light intensity of 
approximately 50–80 μE with constant shaking at 120 rpm. The culture was diluted with 
ASW medium to one-sixth of its original volume and then DMSO was added to give a final 
concentration of 1% (v/v). The culture was then divided equally among four culture flasks 
and nocodazole was added at three different concentrations; 20 ng/ml, 3 μg/ml, 15 μg/ml. 
One of the cultures did not contain nocodaolze and was used as an asynchronous control 
culture. Afterwards the cultures were grown for 72 hours under continuous illumination 
(approximately 50 μE) with constant shaking at 120 rpm at 25 °C. Throughout 72 hours, the 
cultures were monitored every 12 hours by measuring the optical density (OD750) as well 
as microscopically observing the cells (Axio Scope. A1, Zeiss). 
2.12. Flow cytometry analysis 
The cells grown in the presence of nocodazole at different concentrations and durations, 
along with the asynchronous control culture were harvested by centrifugation for 15 
minutes at 3,500 x g. The cell pellets were washed twice with Phosphate Buffered Saline 
(PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4). After the second wash, 
the pellets were re-suspend in PBS buffer and equalized to an OD750 of 0.5. A 500 μl aliquot 
of suspension from each culture was transferred into a fresh Eppendorf tube and then the 
cells were fixed by adding 1 ml of 70% (v/v) of ice cold ethanol slowly while sonicating the 
cells in the water bath. Afterwards, the fixed cells were incubated on ice for 30 minutes, 
harvested by centrifugation at 13,000 rpm for 5 minutes and washed twice with PBS buffer. 
After the last wash, the pellet was re-suspended in 0.5 ml PBS buffer and then the cells were 
treated with 100 μg/ml RNase. The cells treated with ribonuclease were incubated at room 
temperature for 30 minutes and then all Eppendorf tubes were wrapped with foil as a 
preparatory step before adding DNA stain. The cells were then stained with propidium 
iodide (5 mg/ml) and stored at 4°C. Prior to analysis, the cells were passed through a syringe 
and vortexed briefly. The cells were then analysed using an AccuriTM C6 flow cytometer 
and AccuriTM C6 software- Cflow Plus (BD Biosciences, San Jose, CA, USA) according to the 
manufacturer’s instructions. 
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CHAPTER 3 
Classical approach of developing a chloroplast 
transformation methodology in N. gaditana  
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3. Classical approach of developing a chloroplast transformation 
methodology in N. gaditana 
3.1. Introduction 
Microalgae are a highly diverse group of photosynthetic organisms that have attracted 
attention as a potential platform for biofuels, nutraceuticals, therapeutics and industrial 
chemicals. In particular the chloroplast within these microalgae, in addition to being the site 
of photosynthesis, is also the site for synthesis of industrially relevant compounds such as 
pigments, fatty acids, and starch. Stable transformation of the algal chloroplast was first 
reported in 1988 using the model Chlamydomonas reinhardtii (Boynton et al. 1988). Since 
then, significant progress has been made in the development of molecular tools and efforts 
to transfer developed technologies to other industrially relevant species including higher 
plants. There has been also success in expressing high value recombinant proteins in the 
Chlamydomonas chloroplast such as protein vaccines and therapeutic antibodies (Barrera 
& Mayfield 2013; Purton et al. 2013). 
Nonetheless, there are other algae species yet to be exploited, especially those algal strains 
with high growth density and suited for large-scale cultivation, such as Nannochloropsis. 
The biotechnological exploitation of these microalgae requires the development of 
molecular tools and technologies (Al-Hoqani et al. 2016). There is also a need to develop a 
reliable chloroplast transformation method for these industrially relevant species, so that 
the genetic engineering of chloroplast metabolism would be possible. Since transformation 
of the chloroplast for these microalgae is a first step in their biotechnological exploitation, 
the focus of the research in this thesis is primarily on developing a chloroplast 
transformation method for Nannochloropsis gaditana. 
3.1.1. Chloroplast  
The chloroplast organelle is the site of photosynthesis within algal and plant cells. Plastids 
such as chloroplasts also house important biosynthetic pathways such as the synthesis of 
carbohydrates, fatty acids, carotenoids, tetrapyrroles and terpenoids. The chloroplast has 
its own genetic material as a result of a cyanobacterial endosymbiosis event that occurred 
over a billion years ago. The chloroplast has retained many features that reflect its 
prokaryotic origin including a polyploid circular genome termed the “plastome”, and  
prokaryotic-like transcriptional and translational machinery such as a prokaryotic-type 
RNA polymerase and 70S ribosomes. The plastome is relatively small in size; it contains 
approximately 100–250 genes and these genes are often organized in polycistronic units 
across the genome. The majority of these genes code for either subunits of the 
photosynthetic apparatus or components required for the transcription-translational 
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machinery (Green 2011; Purton 2007). The level of chloroplast gene expression is generally 
high in actively growing cells, indicating the primary role of these genes in encoding the 
core components of photosynthetic apparatus: for example, psbA which encodes the D1 
core subunit of photosystem II. Although the chloroplast has its own genome, chloroplast 
gene expression is regulated by various nuclear-encoded factors that act on chloroplast 
mRNA. These factors are involved in post-transcriptional steps such as RNA processing, 
RNA stability and translation (Stern et al. 1997).  
The chloroplast genome represents an attractive target for genetic engineering for a 
number of reasons: First, the small size (100–200 kb) and low genetic complexity of the 
genome, with less than 100 protein-coding genes; Second, the high level of gene expression 
particularly genes for core components of the photosynthetic apparatus; Third, the precise 
integration of foreign DNA to any loci within chloroplast genome by homologous 
recombination; Fourth, the absence of gene silencing effects and the possibility to express 
multiple transgenes as an operon. In addition, the algal chloroplast is a major site of 
metabolism and product storage (Wang et al. 2009; Wani et al. 2010).  
Interestingly, chloroplast transformation in all studied species to date proceeds through 
double homologous recombination events between chloroplast sequences on the plasmid 
and corresponding genomic sequences (Figure 3.1). The stable integration of exogenous 
DNA into the chloroplast genome needs sufficient homologous sequences to the targeted 
site of insertion, normally around ~ 1 kb of homologous sequence flanking either side of the 
exogenous DNA to allow recombination events. Therefore, the exogenous DNA can be 
targeted precisely to any region in the chloroplast genome provided it is a ‘silent site’ for 
transgene integration so that it does not interrupt any essential function (Purton 2007).  
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Figure 3.1 Schematic representation of chloroplast transformation. 
A typical chloroplast transformation plasmid, consisting of the transgene under the control of an 
endogenous promoter and regulatory elements, and a selectable marker gene under the control of 
different endogenous promoter and regulator elements, together with flanking regions (left arm and 
right arm). The homologous recombination occurs between homologous sequences shared between 
the plasmid and the plastome, resulting in the integration of the cloned gene/s into the plastome. X–
X represents the double homologous recombination events, whereas SS reperesents the silent site 
for the transgene integration into the plastome.  
3.1.2. The algal chloroplast and genetic transformation 
The chloroplast of unicellular microalgae has been the focus of recent genetic engineering 
efforts as most microalgae contain a single chloroplast per cell. This makes the genetic 
manipulation of the chloroplast genome much easier compared to the plant leaf for 
instance, which can have up to a hundred plastids per cell (Day & Goldschmidt-Clermont 
2011). The algal chloroplast also has the ability to accumulate significant amounts of starch, 
lipid or pigments under stress conditions, which can be utilized for the production of 
industrially relevant products (Radakovits et al. 2010). In addition, some algal species are 
characterized by high growth rates, low cultivation cost and diverse metabolic capabilities 
(Purton et al. 2013). Given all these advantages, the genetic engineering of algal chloroplasts 
can offer an ideal platform for large-scale production of biofuel molecules and high value 
compounds with nutritional, cosmetic and pharmaceutical applications.   
The first stable transformation of the chloroplast genome of a unicellular alga was reported 
by Boynton et al. (1988) using the biolistic method. This was achieved by rescuing a 
photosynthetic mutant of C. reinhardtii carrying a deletion in the chloroplast gene, atpB 
back to photoautotrophic growth with the cloned wild-type gene. Another DNA delivery 
method that has been used successfully to transform the chloroplast of C. reinhardtii 
involves agitation of a cell wall deficient strain with glass beads (Kindle et al. 1991). Soon 
thereafter, the first recombinant protein produced in chloroplasts was reported by 
Goldschmidt-Clermont (1991), where a bacterial gene was expressed successfully in the C. 
reinhardtii chloroplast. Since then, the molecular tools for genetic manipulation for this alga 
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have been further improved and refined. These improvements include developing new 
selectable marker/reporter genes, recipient strains and better understanding for the key 
elements for the successful chloroplast transformation (Wannathong et al. 2016; Young & 
Purton 2016; Scaife et al. 2015). As illustrated in Figure 3.2, the availability of molecular 
tools and resources for genetic manipulation for this green alga in general has increased 
dramatically over the past 30 years providing significant insights into the chloroplast gene 
function and expression. With such resources and tools, C. reinhardtii has become a model 
system for chloroplast genetics and molecular biology. Several techniques first developed 
for chloroplast genome engineering in this species have since been applied in other algal 
species and higher plants, in particular tobacco (Bock 2014). 
The C. reinhardtii chloroplast has been exploited as a heterologous protein expression 
system for the production of high value recombinant proteins such as therapeutic 
antibodies and protein vaccines (Rasala & Mayfield 2010). In fact, a number of high value 
recombinant proteins have been produced in microalgae, such as the production of a human 
single-chain antibody in the chloroplast of C. reinhardtii (Mayfield et al. 2003). A full human 
monoclonal antibody was also expressed in the Chlamydomonas chloroplast, and was 
demonstrated to have antigen binding activity similar to the same antibody expressed in 
mammalian cells (Tran et al. 2009). 
 
Figure 3.2 Timeline of molecular advances in the development of tools and techniques for 
engineering C. reinhardtii. 
Development of chloroplast and nuclear transformation (Boynton et al. 1988; Blowers et al. 1989; 
Kindle et al. 1989), mitochondrial transformation (Randolph-Anderson et al. 1993), C. reinhardtii as 
a model photosynthetic organism (Harris 2001), proteomics for system analysis (Hippler et al. 
2001), first therapeutic recombinant protein to be expressed in the chloroplast (Mayfield et al. 2003), 
sequencing the nuclear genome (Merchant et al. 2010), development of genome editing techniques 
(Jiang et al. 2014; Sizova et al. 2013; Gao et al. 2014; Shin et al. 2016), establishment of a knock-out 
collection (Zhang et al. 2014). Figure modified from Scaife et al. (2015) 
                          1988: Chloroplast transformation 
                          1989: Nuclear transformation 
1980s 
                           1993: Mitochondrial transformation 1990s 
                            2001: Proposed model organism 
                            2003: Therapeutic protein 
2000s 
                         2013-16: Genome editing techniques 
                         2014: knock out collection 
2010s 
 
 
70 
Currently, C. reinhardtii is the most developed algal species for biotechnology with well-
established transformation methods and molecular tools.  However, when it comes to its 
biosynthetic capacity for production at a commercial level, it is still far from reaching 
economic viability. There are successful attempts to improve biofuel phenotypes of C. 
reinhardtii using genetic engineering (Li et al. 2010; Work et al. 2010), but this alga is not 
naturally an exceptional producer of either lipid or biomass and so extensive genetic 
modification will be required before it is suitable for industrial applications. For the 
biotechnological exploitation of the algal chloroplast, the chosen species should be a 
naturally exceptional producer of biomass and well-suited for large-scale cultivation. A 
number of Nannochloropsis species have attracted interest due to their high rates of 
biomass accumulation, their high lipid productivity and their successful cultivation at 
industrial scale by several companies. Such companies include Aurora Algae, Seambiotic, 
Solix Biofuels, Hairong Electric Company and Proviro.  One species of particular interest is 
N. gaditana, which has a high photoautotrophic biomass rate, and can grow to high densities 
(> 10 g dry weight/litre) and high lipid content (Radakovits et al. 2012). The availability of 
the complete genome sequence for N. gaditana has facilitated the development of a nuclear 
transformation methodology and subsequently the development of more tools for nuclear 
genetic engineering (Al-Hoqani et al. 2016). These tools include electroporation and other 
methods to deliver DNA into the nuclear genome of Nannochloropsis (Kilian et al. 2011; Cha 
et al. 2011), and the development of various selectable marker and reporter genes to allow 
the selection of nuclear transformants and assessment of expression levels, respectively. In 
addition, forward and reverse genetic studies using Nannochloropsis species in general have 
provided some insights into nuclear gene function and expression, especially for those 
genes involved in lipid biosynthesis (Al-Hoqani et al. 2016).  
However, the full exploitation of N. gaditana as a biotechnology platform for biofuel 
production or synthesis of high-value metabolites requires the development of molecular 
tools and techniques for engineering the chloroplast genome. Chloroplast transformation 
has yet to be described for Nannochloropsis, and indeed the genetic manipulation of the 
chloroplast is still limited to very few algal species (see Table 3.1), as it has proved 
challenging due to a number of reasons. Firstly, the exogenous DNA needs to be delivered 
across a cell wall and multiple membranes – as many as five depending on the species that 
is being transformed. Secondly, the exogenous DNA needs to integrate into the chloroplast 
genome and be expressed successfully using the organelles’s expression machinery. 
Thirdly, the chloroplast contains multiple copies of the plastome and so a strong selection 
strategy is required to recover a stable transgenic cell with all plastome copies carrying the 
modification (Purton 2001). So, there is a need to develop chloroplast transformation 
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method that is applicable to more algal strains, especially for those adapted to cultivation 
for large-scale production. 
Table 3.1 Reports of chloroplast transformation in microalgae.  
Algal species Transformation 
method 
Selectable 
marker 
Selection References 
Chlamydomonas 
reinhardtii 
 
Particle gun atpB Photoautotrophy Boynton et al. 1988 
Glass beads tscA, psbA Photoautotrophy Kindle et al. 1991 
Euglena gracilis 
 
Particle gun aadA Streptomycin, 
spectinomycin 
Doetsch et al. 2001  
Porphyridium sp. Particle gun AHAS 
(W492S) 
Sulfometuron 
methyl  
Lapidot et al. 2002 
Haematococcus pluvialis Particle gun aadA Spectinomycin Gutiérrez et al. 2012 
Dunaliella tertiolecta Particle gun ereB Erythromycin Georgianna et al. 
2013  
Platymonas 
subcordiformis 
Particle gun bar Basta Cui et al. 2014 
Phaeodactylum 
tricornutum 
Electroporation cat Chloramphenicol Xie et al. 2014 
Cyanidioschyzon 
merolae 
PEG-mediated 
transfection, 
particle gun 
cat Chloramphenicol Zienkiewicz et al. 
2016 
3.1.3. Aim and objectives 
The overall aim of this chapter is to develop a reliable chloroplast transformation method 
for oleaginous and industrially relevant algae, in particular N. gaditana.  
Specifically, the aims of the work in this chapter are: 
1. Optimisation of cultivation conditions for N. gaditana by testing different growth 
conditions. 
2. Evaluation of the antibiotic sensitivity of N. gaditana in order to identify suitable 
selection strategies for chloroplast transformation. 
3. Construction of a chloroplast transformation plasmid for the introduction of novel 
genes into the chloroplast genome.  
4. Optimizing a nuclear transformation protocol as a control for testing different DNA 
delivery methods for N. gaditana. 
5. Testing different delivery methods including electroporation and biolistics to 
transform the chloroplast of N. gaditana. 
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3.2. Results 
3.2.1. Preliminary studies on Nannochloropsis gaditana cultivation 
Several groups have cultivated various species of Nannochloropsis successfully and it seems 
each species has different requirements for optimum growth (Rocha et al. 2003; Radakovits 
et al. 2012; Kilian et al. 2011). Although the growth conditions of N. gaditana CCMP526, the 
strain under be studied in this research, have been already been optimized as reported by 
Radakovits et al. (2012), this needs to be re-examined to suit our lab facilities and lab scale 
cultivation. Therefore, a number of important parameters were tested throughout the 
optimization using a commercial lab scale photobioreactor known as an Algem®. These 
parameters are temperature, light conditions, additional source of carbon and addition of 
vitamins. First, different temperatures were assessed for the optimum growth of N. 
gaditana.  The result of cell cultivation at different temperatures (Figure 3.3) shows that the 
fastest log-phase growth for N. gaditana in artificial seawater (ASW) is observed at 25 °C.  
Figure 3.3 Growth of N. gaditana at different temperatures using an Algem® 
photobioreactor. 
(A)The growth curves of N. gaditana cultures at different temperature for two weeks. These cultures 
were inoculated from same starter culture. The cells illuminated continuously with 200 μE. (B) The 
calculated growth rate and doubling time of N. gaditana at different temperatures. The the growth 
rate of N. gaditana was calculated by identifying two points at log phase and using these points into 
the following equation: specific growth rate (μ)= (ln X2− lnX1)/ (t2− t1), where X1 and X2 is the optical 
density of cells at time (t1) and time 2 (t2), respectively. The calculated growth rate was used then 
into the following equation to calculate the doubling time, where doubling time = ln 2/μ.  
 
  
 Temp. 25 °C Temp. 22 °C  Temp. 20 °C Temp. 18 °C 
Growth rate (day-1) 0.69 0.53  0.50 0.16 
Doubling time (hours) 24 31  34 105 
 
(A) 
(B) 
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As for the light conditions, the Algem® was set up to expose the cultures in four chambers 
simultaneously to different light intensities and regimes: namely: constant light 50 µE; 100 
µE and 200 μE, and a sine wave (sw) cycle from 100–200 μE. The sw cycle in the algem® is 
programmed such that it allows a gradual increase of light intensity from 100 to 200 μE, 
followed by a gradual decrease from 200 to 100 μE. The period of the sw is 12 h. The results 
(Figure 3.4) show that there is an obvious growth difference among the cultures exposed to 
constant light intensities. The 200 μE constant light showed an improved growth rate in 
comparison to constant illumination of 50 μE and 100 μE. However, the sw condition clearly 
gives a higher growth rate in comparison to constant illumination of 200 μE. Subsequently, 
the cells were able to accumulate more biomass when harvested on day 14, measured as 
1.1 g and 2 g wet weight per liter for the grown culture under constant light illumination of 
200 μE and sw illumination of 100-200 μE, respectively. 
 
Figure 3.4 Cultivation of N. gaditana under different light conditions. 
The light conditions are constant illumination of 50, 100 and 200 μE, and sine wave light regime from 
100–200 μE. The temperature was set up at 25 °C in the growth chambers. The raw data was 
retrieved from Algem®. 
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The effect of adding different carbon sources to N. gaditana also was tested by adding either 
an organic source of carbon or supplying the culture with 5% CO2. The mixotrophic 
conditions using various organic carbon sources (i.e. glucose, galactose and sucrose) did not 
result in any improvement in the rate of growth of N. gaditana as shown in Figure 3.5.   This 
result highlights the absence of a hexose symporter in this species that enables glucose 
uptake from the growth medium (Doebbe et al. 2007), as confirmed by the available genome 
data (Radakovits et al. 2012), where the hexose symporter gene (HUP1) is absent in the N. 
gaditana genome1. Although the genome data indicates the presence of a putative galactose-
proton symporter gene with accession number Naga_100010g2, the growth evidence 
suggests that N. gaditana does not take up galactose from medium, which is unlikely to be 
found in the marine environment.  
The addition of 5% CO2 at 50 cm3 per min to the medium showed a deleterious impact on 
N. gaditana growth as shown in Figure 3.6 (right panel). Such a result could be due to either 
the high flow rate leading to a shear stress effect in the 500 ml cultures, or a marked drop 
in pH as a result of carbon dioxide uptake, resulting in the inhibition of growth. 
 
Figure 3.5 Effect of different sources of organic compounds on N. gaditana growth 
The effect of various organic carbon sources on cell growth. The cells illuminated continuously with 
200 μE at 25 °C. The temperature was set up at 25 °C in the growth chambers.  
 
 
                                                             
1 http://www.nannochloropsis.org/ 
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Figure 3.6 The effect of 5% CO2 on the cultivation of N. gaditana in the Algem® 
photobioreactor. 
In left panel; the growth curves of two cultures i) a control culture was grown in ASW without CO2. 
ii) a tested culture was bubbled with 5% CO2 at 50 cm3 per min. In right panel, a visual comparison 
of the effect of CO2 after 10 days of cultivation. +5% CO2 and –5% CO2 indicate the cultures were 
grown in presence and absence of CO2 supply, respectively. The cultures were illuminated 
continuously with 200 μE at 25 °C in ASW. 
As reviewed by Croft et al. (2006) a number of algal species require an exogenous supply of 
one or more B vitamins for their metabolism: namely, vitamin B1 (thiamine), vitamin B12 
(cobalamin) and vitamin B7 (biotin). Therefore, the effect of those vitamins has been tested 
in N. gaditana growth. However, the addition of exogenous vitamins did not improve the 
growth of N. gaditana (data not shown). This result is further supported by a BLAST search 
of the Nannochloropsis gaditana genome which identified the METE gene (Nga 00266) that 
encodes the B12-independent methionine synthase. The presence of this gene has been 
shown to correlate with a lack of dependence for exogenous B12 (Helliwell et al. 2011). In 
addition, the under representation of genes involved in vitamin acquisition as reported by 
Radakovits et al. (2012) indicates that N. gaditana growth does not require exogenous 
sources of B vitamins.  
After testing different growth conditions, the best achieved specific growth rate of N. 
gaditana in ASW using the Algem® is under sine wave illumination of 100–200 μE at 25 °C 
and ranged from 0.8 to 0.69 per day (i.e. a doubling time of 21–24 hours, respectively). The 
preliminary growth studies using Algem® facilitated the identification of the key parametrs 
in N. gaditana growth include temperature and light conditions. However, the best light 
conditions to cultivate N. gaiditana using the Algem® ws not possible to be applied in the 
subsequent experiments manily due to i) the absence of the since wave condition in the 
standard growth chamber and ii) the growth of cultures in small volumes (≤ 20 ml) can be 
inhibited by high light intensity (See section 2.3 for the volumes used in the Algem®). 
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3.2.2 Evaluation of antibiotic sensitivity 
In order to identify a suitable selectable marker for chloroplast transformation, the 
antibiotic sensitivity of N. gaditana was evaluated by growth tests on solid medium (i.e. 
“spot tests”). This technique involved spotting a few microlitres of culture onto nutrient 
agar plates and then assessing the growth in the presence of various antibiotics compared 
to a control plate without antibiotic. The spot test results, as summarized in Table 3.2, 
indicate N. gaditana is resistance to different antibiotics even at high concentrations as 200 
μg/ml. In particular, N. gaditana shows resistance to kanamycin, streptomycin and 
spectinomycin at tested concentrations from 10 to 200 μg/ml. Sensitivity of N. gaditana to 
erythromycin and paromomycin was observed at 100 μg/ml and higher. Although these five 
antibiotics cannot therefore be used as a selection method for chloroplast transformant 
lines, they could be useful for eliminating bacterial or other contaminants in N. gaditana 
cultures. N. gaditana is most sensitive by far to chloramphenicol in which cell growth was 
strongly inhibited from 50 μg/ml as shown in Figure 3.7. Chloramphenicol therefore was 
initially chosen as a potential selection method for chloroplast transformants. The 
inhibitory effect of chloramphenicol was further studied by more tests to determine the 
appropriate concentrations to inhibit the growth of N. gaditana at high cell density 
throughout a period of time. Sensitivity of N. gaditana to chloramphenicol was tested by 
spreading a culture at mid-log phase on ASW plates containing 50, 100 and 200 μg/ml of 
chloramphenicol and the results, as shown in Figure 3.8, demonstrate a very low frequency 
of any spontaneous resistance to chloramphenicol with no colonies observed on any of the 
plates. The minimum concentration of chloramphenicol required to inhibit the N. gaditana 
growth was 50 μg/ml, which is consistent with results reported on-line by PhotoSynLab2. 
However, a number of Nannochloropsis strains were found to be resistant to 100 μg/ml of 
chloramphenicol (Vieler et al. 2012).  
Table 3.2 The effect of a number of selected antibiotics on N. gaditana based on spot tests.  
The concentrations of tested antibiotics are 10, 50, 100 and 200μg/ml. “+” indicates the natural 
resistance to the respective concentration from low to high. Resistance gene refers to a microbial 
gene conferring resistance to the corresponding antibiotic. 
Antibiotic Resistance gene Natural resistance (10, 50, 100 and 200 
μg/ml) 
Kanamycin aphA-6 ++++ 
Streptomycin aadA ++++ 
Spectinomycin aadA ++++ 
Erythromycin ereB ++ 
Paromomycin aphVIII ++ 
Chloramphenicol catA1 + 
 
                                                             
2 http://unitedscientists.org/labs/norway/NTNU/PhotoSynLab/ 
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Figure 3.7 The spot test for growth response of N. gaditana to different concentrations of 
kanamycin and chloramphenicol.  
Spot tests demonstrated the sensitivity of N. gaditana to chloramphenicol in which cell growth was 
strongly inhibited from 50 μg/ml. Aliquots of N. gaditana were spotted on 2% ASW containing 
increasing concentrations of kanamycin (left panel) or chloramphenicol (right panel), with serial 
tenfold dilutions left to right. Plates were incubated under 30 μE illumination for three weeks.   
 
 
 
 
Figure 3.8 Growth response of N. gaditana with high cell density to different concentrations 
of chloramphenicol.  
Equal volumes of culture at mid-log phase were spread onto ASW medium (control) and on ASW 
containing 50, 100 and 200 μg/ml of chloramphenicol. The plates were left to grow for three weeks 
under 30 μE light at 25 °C. The control plate has shown the growth of N. gaditana, whereas the cells 
on ASW plates containing chloramphenicol were not able to grow.  
A further test to confirm the effect of chloramphenicol was carried out in liquid ASW to 
ensure the evaluation of antibiotic sensitivity was conducted in both agar-solidified ASW 
and liquid ASW. This test involved growing N. gaditana to mid-log phase and then the 
culture was aliquoted into a 12 well microplate; 3 ml in each well. The chloramphenicol was 
added to each well to give a range of concentrations from 10 µg/ml to 300 µg/ml. However, 
the chloramphenicol was omitted from three wells as a positive control for each row. Four 
weeks later, the sensitivity of N. gaditana to increasing concentrations of chloramphenicol 
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in liquid state was evaluated by spotting 5 µl of each culture onto a 1.5% ASW plate. The 
results (see Figure 3.9) show the similar inhibition effect to as indicated earlier by both the 
spot and spread tests. However, the effect of chloramphenicol in liquid state was more 
potent compared to the agar-solidified ASW, with the cell growth inhibited at 
concentrations as low as 10 µg/ml. In general, the evaluation of sensitivity of N. gaditana 
against a wide range of antibiotics using different test methods confirms that the N. 
gaditana CCMP526 used in this study is most sensitive to chloramphenicol. Therefore, the 
chloramphenicol acetyl transferase gene (cat) represented the most promising selectable 
marker for chloroplast transformation of N. gaditana. This marker has been used 
successfully for chloroplast transformation of tobacco (Li et al. 2011), although attempts to 
express the marker in the green alga C. reinhardtii were not successful (Wannathong 2012).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Growth response of N. gaditana to chloramphenicol in liquid ASW at different 
concentrations.  
An aliquot of 3 ml of a culture at mid-log phase was pipetted into each well of a 12 well microplate 
(left panel). The cultures in three wells were used as controls, and thus no chloramphenicol was 
added. Whereas, the rest were treated with different concentration of chloramphenicol from 10 to 
300 μg/ml final concentration. Spotted cells on 2% ASW after being cultivated in ASW or in ASW 
supplemented with different concentration of chloramphenicol for three weeks (right panel). 
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3.2.3. Construction of a chloroplast transformation vector 
3.2.3.1 Design and construction of a chloroplast transformation vector 
The first stage in developing chloroplast transformation technology is to demonstrate that 
we can introduce foreign DNA, in the form of a selectable marker gene, into the chloroplast 
genome such that it is expressed and confers an antibiotic resistance phenotype. 
Chloroplast transformation in plants and algae occurs exclusively via a double homologous 
recombination event involving endogenous sequences flanking the foreign DNA (the left- 
and right homologous recombination regions, LHRR and RHRR), so the choice of these 
elements determines the site of integration of the foreign DNA as shown in Figure 3.10. 
Since it is desirable that this DNA integrates into a neutral locus in which the expression of 
endogenous genes is not affected, then the N. gaditana chloroplast genome was searched 
for a suitable insertion site (see Appendix.3 for potential insertion sites in the chloroplast 
genome of N. gaditana). The best site was identified as that shown in Figure 3.10, a region 
between two tRNA genes that are transcribed in opposite directions. Primers were 
therefore designed to amplify this region from total genomic DNA to obtain the LHRR and 
RHRR elements. As shown in figure 3.11A (3), a PCR product of the expected size (2164 bp) 
was obtained and this was cloned into the standard plasmid vector, pJet. In order to drive 
expression of the selectable marker gene, it is necessary to fuse it to an endogenous 
promoter/5’ untranslated region (UTR) and a 3’ UTR. The next stage of making the 
chloroplast transformation plasmid is therefore to amplify a suitable promoter/5’UTR.  It 
was decided to use the element from the highly expressed psaA gene and this was amplified 
using suitable primers to give a 276 bp product with appropriate overlaps for Gibson 
assembly (Figure 3.11A (1)). Finally, the 3’UTR of another gene, psbA was amplified to give 
a 318 bp product, with overlaps (Figure 3.11A (1)). As chloramphenicol was suggested to 
be a potential selection method, the cat gene conferring resistance to chloramphenicol was 
amplified directly from plasmid pARG1.3 generating a cat PCR product of the expected size 
of 701 bp, with overlaps figure 3.11A (1). After successfully amplifying the key elements 
that were required for make the expression cassette –P/5’UTR. cat. 3’UTR–  for constructing 
the transformation vector, the next step was assembling these overlapping fragments using 
Gibson assembly (Gibson et al. 2009). The product of the Gibson assembly reaction was 
used as a template for a second round of PCR to add AflII restriction sites resulting in a 1157 
bp fragment, as shown in Figure 3.11A (2). The cat cassette was then digested with AflII and 
ligated into the linearized LHRR and RHRR element cloned into pJet to form the desired 
construct. The correct construct (pUH.NCc2) was confirmed by digestion and DNA 
sequencing. The physical map of pUH.NCc2 is shown in Figure 3.11B.  
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Figure 3.10 Schematic representation of chloroplast transformation by homologous 
recombination in N. gaditana. 
 A typical chloroplast expression vector containing the essential elements for introducing a foreign 
gene into the chloroplast genome. The foreign gene in the form of a selectable marker is placed under 
the control of endogenous regulatory sequences (promoter/5’UTR and 3’UTR). For the precise 
integration into the chloroplast genome by double homologous recombination event, the cassette is 
flanked by endogenous sequences called the left and right homologous recombination regions (LHRR 
and RHRR). The intergenic region between trnW and trnL may act as a neutral site for cassette 
integration since trnW and trnL are transcribed in opposite directions. The transcriptional direction 
of the genes is depicted by their location on the strand and arrows. The chloroplast genes are colour 
coded by function; green for photosystem II (psbK and psbZ), red for photosystem I (psaB), yellow 
for cytochrome b6/f (petG), blue for tRNA (trnW, trnL and trnT) and orange for transcription/ 
translational (rpl11, rpl1, rpl12 and rpl14).  Abbreviations are T: trnT, L: trnL and W: trnW 
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Figure 3.11 A schematic representation of the steps involved in making the chloroplast 
transformation vector pUH.NCc2.  
(A) Schematic diagram of the steps involved in making the chloroplast transformation vector 
pUH.NCc2. Three parts consisting of i) the promoter and 5’UTR of psaA, ii) the cat gene, and iii) the 
3’UTR of psbA were amplified successfully at expected size resulting in three DNA fragments sharing 
terminal sequence overlaps. These three parts were assembled using a Gibson assembly method. The 
restriction sites were added to the assembled parts (cassette1) by PCR, resulting in a 1157 bp 
product. In parallel, the cloned LHRR:RHRR region in the pJet vector was linearized by digestion and 
the expected size was obtained ~ 5176 bp. The linear vector backbone was ligated to the cassette, 
forming a construct of 6318 bp; pUH.NCc2. (B) The pUH.NCc2 vector containing the cat gene under 
the control of the psaA promoter/5’UTR and the psbA 3’UTR. This cat expression cassette is bordered 
by sequence between psbK and trnL gene as left homologous recombination region (LHRR) and 
sequence around the trnW gene as right homologous recombination region (RHRR). The pJet vector 
region of the plasmid is depicted as a dashed line.  
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3.2.3.2 Studying the expression of cat gene under the control 5’ untranslated of N. 
gaditana chloroplast in Escherichia coli.  
There are a number of chloroplast genes in microalgae that have maintained bacterial 
features of regulatory elements such as the –35 and/ or –10 promoter elements and 70S 
ribosome-binding site. This can be exemplified by the promoter and 5’ untranslated region 
(P/5’UTR) of the highly expressed psaA exon 1 gene in the C. reinhardtii chloroplast. The 
P/5’UTR of psaA has been used extensively to drive robust expression of foreign genes in 
the C. reinhardtii chloroplast and has also been found to function effectively in E. coli 
(Wannathong et al. 2016). Indeed, a strategy of codon reassignment has been developed to 
overcome the problem of cloning genes that are toxic to E. coli when producing the plasmid 
vector  (Young & Purton 2016).  
In order to investigate possible E. coli ribosome binding in the 5’ UTR of the Nannochloropsis 
psaA (referred as psaAn) used in the chloroplast transformation vector, the nucleotide 
sequences around the translational initiation site of psaA were analysed. This involved 
alignment of the 35 nucleotide regions immediately upstream from the start codon of cat, 
psaAc and psaAn then comparing these mRNA sequences to a consensus Shine-Dalgarno (SD) 
sequence from E. coli (Figure 3.12A). The cat sequence represents the P/5’UTR region found 
on pARG1.3 that drives the expression of this bacterial gene. The psaAc sequence represents 
the P/5’UTR of the psaA gene from the C. reinhardtii chloroplast genome. 
As illustrated in Figure 3.12A, the initial analysis of these regions reveals the presence of SD 
core sequences in the mRNA sequences of cat and psaAc, but not psaAn. The absence of the 
core sequences of SD in the mRNA sequences of psaAn suggests that translation initiation 
for the cat gene in E. coli is not possible using this chloroplast element and therefore, the 
CAT protein will not be produced in E. coli. To support the initial suggestion, a set of E. coli 
cultures carrying different plasmids (i.e. pARG1.3, pSRSapI and pUH.NCc2) were spotted 
onto solid medium containing increasing amounts of chloramphenicol to test for growth 
(Figure 3.12B). It is noteworthy that pSRSapI does not contain cat gene while pUH.NCc2 
lacks of a core SD sequences, hence the growth of these transformants are not expected 
under chloramphenicol selection. As expected, the growth test shows the growth of a 
positive control, pARG1.3 transformant, while pSRSapI was not able to grow under such 
selection. For pUH.NCc2 there is some limited growth observed only at the lowest 
chloramphenicol and highest plating (10-1 dilution), demonstrating that translation of cat 
is occurring very inefficiently. The absence of SD core sequence on the mRNA sequences of 
N. gaditana psaA, together with our demonstration that the cells were not able to grow 
under chloramphenicol selection, shows that ribosome interaction upstream of the psaA 
start in the N. gaditana chloroplast is sufficiently different to that in E. coli, and therefore 
efficient translation is not achieved in E. coli. 
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Figure 3.12 Investigate the translation initiation activity of ribosome-binding site for N. 
gaditana chloroplast in E. coli. 
(A) Analysis of 5’UTR from N. gaditana chloroplast in reference to the E. coli Shine-Dalgarno 
consensus (SD). The translational initiation regions of 35 nucleotides upstream from the start codon 
of cat, psaAC and psaAn were aligned for comparison, and core SD sequences (GGAGG), SD-like 
sequence (GGA and GGAG) on their position on the mRNA sequences, are highlighted in bold. The 
highly conserved residues A/U at position –3 are shown in red. The following means; cat: the 
upstream nucleotides from the start codon of cat gene on expression vector (pARG1.3), psaAc: 
P/5’UTR of psaA gene from C. reinhardtii, psaAn: P/5’UTR of psaA gene from N. gaditana. The P/5’UTR 
of psaAc and psaAn were present in pSRSapI and pUH.NCc2, respectively as chloroplast expression 
vectors. (B) Studying the expression of cat under the control of Nannochloropsis chloroplast 
promoter/5’UTR in E. coli transformants by spot test. The E. coli transformant with pUH.NCc2 was 
assessed for chloramphenicol resistance by scoring overnight growth of cells spotted onto 1.5% LB 
agar (w/v) containing increasing concentrations of chloramphenicol, with serial tenfold dilutions 
right to left. Other cells were spotted; pSRSapI transformants and pARG1.3 transformants. pSRSapI 
was used as a negative control since it does not contain cat, while pARG1.3 contains cat under the 
control of a bacterial promoter and is used therefore as a positive control.  
 
 
 
 
E. coli consensus:       *...GGAGGAU..A/U..AUG 
                             (-9/-4) (-3) 
  
        *   -30       -20       -10        0 
        *    .         .         .         . 
cat*    UAAGCUGUCAAACAUCAGGAGCUAAGGAAGCUAAAAUG 
psaAc   UUAAAUUAAAUAAUUGUUAUUAUAAGGAGAAAUCCAUG 
psaAn   UAACCAUUUUCUUUUGAUUUUAUUCACAAACGAACAUG 
(A) 
(B) 
  
Chloramphenicol  
concentration (μg/ml)            0                                       10                                  50                                     100 
pARG1.3 (cat) 
 
pUH-NCc2 (psaAn) 
 
pSRSapI (psaAc) 
10-3             10-2        10-1                    10-3           10-2          10-1             10-3            10-2            10-1                 10-3         10-2        10-1 
 
Promoter
/5’UTR 
Expression 
vector 
SD 
consensus 
(GGAGG) 
A/U at -3 
position 
Functionality 
in E. coli   
cat pARG1.3 Yes, 3/5 Yes + 
psaAc pSRSapI Yes, 4/5 Yes + 
psaAn pUH.NCc2 No Yes – 
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3.2.4. Attempts to transform Nannochloropsis chloroplast using  
pUH-NCc2 plasmid 
Although chloroplast transformation is the main goal in this study, nuclear transformation 
was used as a control along with chloroplast transformation attempts. The initial choice of 
nuclear selectable marker was based on sensitivity of N. gaditana to different antibiotics as 
demonstrated by Vieler et al. (2012), in which zeocin was shown to be the most effective at 
low concentration. The Sh ble gene confers resistance to zeocin, and therefore this gene was 
chosen as a selectable marker for the nuclear transformation experiments. This marker has 
been used successfully for nuclear transformation of N. gaditana (Radakovits et al. 2012) 
and other Nannochloropsis species (Kilian et al. 2011). The construct pQYZ1 (4611 bp) was 
kindly provided by Stephen Slocombe at SAMS. As shown in Figure 3.13A, pQYZ1 is a 
transformation vector for introducing a Sh ble gene into the Nannochloropsis nuclear 
genome under the control of VCP1 promoter/ 5’UTR and the FCP 3’UTR from 
Nannochloropsis oceanica 849/1 and Phaeodactylum plasmid pPha-T1, respectively. Several 
groups have developed an efficient transformation method based on electroporation of 
intact Nannochloropsis cells (Kilian et al. 2011; Radakovits et al. 2012; Vieler et al. 2012) 
and therefore the described protocol has been adapted initially to test the delivery of pQYZ1 
containing Sh ble gene into the nuclear genome. For all nuclear transformation experiments, 
the pQYZ1 plasmid was linearized with ScaI, cleaving in the ampicillin resistance gene 
(ampR).  
The electroporation experiment was conducted using the maximum voltage 2,500 V 
(12,500 V/cm) with either 5 or 10 μg DNA, yielding on average 28 and 70 colonies, 
respectively. This result is in agreement with other studies, in which increasing the amount 
of DNA leads to an increase in the number of transformants per transformation but within 
a specific range (Kilian et al. 2011). The employed electric field to transform N. gaditana, 
12,500 V/cm, is higher than is typically used for C. reinhardtii (approx. 1,800–2,300 V/cm) 
and Chlorella pyrenoidosa (approx. 3500 V/cm) (Run et al. 2016; Shimogawara et al. 1998). 
The highest transformation efficiency achieved for the pQYZ1 construct in our attempts was 
~ 2.5 x 10-7 per μg plasmid using a standard electroporator (Eppendorf). The putative 
nuclear transformants appeared 3 weeks later after incubation on solid medium 
supplemented with 3 μg/ml zeocin (Figure 3.13B). These colonies were picked after 4-6 
weeks and streaked onto fresh zeocin plates. To confirm the successful transformation of 
N. gaditana and the synthesis of a functional Ble protein, the putative transformants were 
further tested by spot test and PCR analysis. In the spot test (Figure 3.13B) all selected 
colonies (T1-T8) grew on medium supplemented with 3 μg/ml zeocin. Meanwhile, genomic 
PCR demonstrated the successful integration for the Sh ble gene into the nuclear genome, 
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as the transgene was detected in the selected colonies by a band of the expected size of 370 
bp, but not in the wild type (Figure 3.13B).  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13 Analysis of nuclear transformants obtained with pQYZ1 using electroporation. 
(A) The pQYZ1 construct for nuclear transformation, conferring resistance to zeocin, was used as a 
control along with chloroplast transformation attempts. (B) Left panel: putative nuclear 
transformants after four weeks incubation on 2% ASW medium supplemented with 3 µg/ml zeocin. 
Central panel: a number of putative nuclear transformants was selected and spotted on ASW 
containing 3 µg/ml zeocin. All selected putative nuclear transformants (T1 –T8) grew under zeocin 
selection. Right panel: PCR analysis for the transformant lines (T1-T2, T5-T6 and T8). The ble marker 
gene was detected in all tested transformants by a band at the expected size of 370 bp while no band 
was present in the wild type sample (WT). 
Following the success of optimizing the nuclear transformation for N. gaditana using 
electroporation, the same conditions were initially tested for chloroplast transformation 
with pUH.NCc2. Several attempts were made using the electroporation system of which 
none were successful. These attempts are summarized in Table 3.3 and Table 3.4, where 
different experimental conditions were tested using two different electroporators. In 
addition to electroporation attempts, a biolistic method was tested to deliver exogenous 
DNA into the nuclear and chloroplast genome. However, the initial attempts were not 
successful in generating either nuclear or chloroplast transformants. The unsuccessful 
attempts could be due to the small size of Nannochloropsis cells (approximately 2–4 μm 
diameter), which is relatively small in comparison to the gold microparticles used for 
biolistics, around 0.55 μm in diameter.  
 
 
 
Ble CDS fcp_3'UTRvcp1_prom
pQYZ1
100 bp  
A
 
B
 
 T1                       T2     
                T3                       T4 
               T5                         T6 
               T7                        T8 
     T1  T2  T5  T6 T8  WT -ve          1.2 kb 
  0.4 kb 
 Transformants     Spot test PCR analysis 
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Table 3.3 Summary of various experimental conditions to test the feasibility to transform 
the chloroplast of N. gaditana. 
A standard electroporator (Eppendorf) was used resulting in a nuclear transformation efficiency for 
the control construct pQYZ1 of ~ 2.5x10–7 per μg plasmid. The maximum voltage deliverable by the 
system, 2500 V, was used with a set resistance of 600 Ω and capacitance at 10 µF.  
 Plasmid  DNA  
(μg) 
Plasmid 
form 
MgCl2 
(mM) 
Selection  (μg/ml) 
 
Salmon 
sperm DNA 
(μg) 
A pUH.NCc2 10  Linear - Chloramphenicol  (50, 100) - 
B pUH.NCc2 10 Circular - Chloramphenicol  (50, 100) - 
C pUH.NCc2 10 Linearϕ - Chloramphenicol  (50, 100) - 
D pUH.NCc2 10  Linear 0.1, 0.3, 0.5 Chloramphenicol  (50, 100) - 
E pUH.NCc2 10  Circular  0.1, 0.3, 0.5 Chloramphenicol  (50, 100) - 
F pUH.NCc2 10 Linearϕ 0.1, 0.3, 0.5 Chloramphenicol  (50, 100) - 
G pUH.NCc2  10 Linear  - Chloramphenicol  (50, 100) 25 μg 
H pUH.NCc2  10 Linear  - Chloramphenicol  (50, 100) 25 μgδ 
I pQYZ1: 
pUH.NCc2 
6: 10  Linear  - Chloramphenicol (50)  
zeocin (3) 
- 
J pQYZ1: 
pUH.NCc2 
4: 8 Linear - Chloramphenicol (50)  
zeocin (3) 
- 
ϕ: PUH.NCc2 was double digested with XbaI and XhoI resulting two linear DNA fragments; a cassette with flanking  
regions ~ 3369 bp and pJet backbone ~ 2949 bp.  
δ: Salmon sperm DNA was denatured by heating at 99 oC for 10 min (Shimogawara et al. 1998)  
 
Table 3.4 Summary of employed conditions in the chloroplast transformation attempts by 
using a Gene Pulser XcellTM electroporation system.  
The highest transformation efficiency for the control construct pQYZ1 is 4.0 x 10-6 ~ per μg plasmid 
at 2400 V, 500 Ω and 50 μF. The selection was based on using two different concentrations of 
chloramphenicol; 50 and 100 μg/ml for each condition.  
 Plasmid  DNA 
(μg) 
Voltage  
(V) 
Capacitance 
  (μF) 
Resistance 
( Ω )  
MgCl2 
(mM) 
1 pUH.NCc2 5 2400 50 500 0.1, 0.3, 0.5 
2 pUH.NCc2 5 2400 50 500 -  
3 pUH.NCc2: pQYZ1 8: 4 2400 50 500 0.1, 0.3, 0.5 
4 pUH.NCc2: pQYZ1 8: 4 2400 50 500 - 
5 pUH.NCc2 5 2400 10 600 0.1, 0.3, 0.5 
6 pUH.NCc2 5 2400 10 600 - 
7 pUH.NCc2  5 480 50 800 0.1, 0.3, 0.5 
8 pUH.NCc2  5 480 50 800 - 
9 pUH.NCc2  5 2400 25 200 0.1, 0.3, 0.5 
10 pUH.NCc2  5 2400 25 200 - 
3.3. Discussion and conclusions 
Nannochloropsis gaditana CCMP 526 is a slow growing microalgae with a doubling time 
range from 21–24 hours, in comparison with the model green alga C. reinhardtii that 
requires 5–8 hours. The slow growth of Nannochloropsis species in general could be due to 
their oleaginous nature, where they tend to accumulate high lipid content and therefore the 
energy required for the cell division would be diverted for lipid accumulation. Such slow 
growth is noticeable among microalgae that are able to accumulate a substantial amount of 
hydrocarbons as is the case for Botryococcus braunii, where the doubling time is in excess 
of 48 hours (Yoshimura et al. 2013). Although, Nannochloropsis requires approximately a 
day to double, its high photoautotrophic biomass accumulation and high lipid content make 
this species a promising oleaginous microalga for metabolic engineering and therefore, the 
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direction of this research is to develop a transformation method for the chloroplast as there 
is no report on successful chloroplast transformation of this species yet.   
The key components for a successful chloroplast transformation for any photoautotrophic 
organism are: the prior knowledge of the plastome sequence; a suitable selection system, 
and appropriate method to introduce exogenous DNA into the chloroplast. The availability  
of a plastome sequence as reported by Radakovits et al. (2012) was the basis of designing 
the chloroplast transformation plasmid for N. gaditana, where the essential elements 
comprised an endogenous promoter, untranslated regions and homologous recombination 
regions were chosen and amplified from the chloroplast genome (Figure 3.10). The choice 
of endogenous promoter and 5’UTR was from the highly expressed psaA gene to ensure a 
high level of transgene expression. This promoter and regulatory element of the 
corresponding psaA gene from C. reinhardtii have already been demonstrated to allow the 
successful expression of transgenes in the chloroplast of this model alga (Wannathong et al. 
2016). The identification of a neutral site suitable for transgene integration into the 
chloroplast genome via homologous recombination is also a necessary requirement. A 
region between two tRNA genes that are transcribed in opposite directions was chosen for 
transgene insertion, which in theory should not interrupt the function of these chloroplast 
genes. These endogenous elements; promoter, regulatory elements and flanking regions 
were assembled along with a selectable marker, forming chloroplast transformation 
plasmid pUH.NCc2. In a similar approach to Goldschmidt-Clermont (1991), this plasmid 
would be initially used to demonstrate that we can introduce a foreign gene in the form of 
a selectable marker into the chloroplast genome, that it is expressed and confers the 
antibiotic resistant phenotype.  
 Another important component for a successful chloroplast transformation is the 
availability of a suitable selection system that facilitate the selection and analysis of 
transgenic lines. A number of selection systems have been used in algal chloroplast 
transformation, for example antibiotic resistance, herbicide tolerance, photoautotrophy 
and the complementation of metabolic mutants (Table 3.5). The initial choice for the 
selectable marker was based on the sensitivity of N. gaditana to different antibiotics as 
summarized in Table 3.2, where chloramphenicol was shown to be the most effective at low 
concentration. The chloramphenicol acetyl transferase gene (cat), conferring resistance to 
chloramphenicol was chosen as a selectable marker for the initial transformation 
experiments. This marker has been used successfully for chloroplast transformation of 
tobacco (Li et al. 2011), although attempts to express the marker in the green model alga C. 
reinhardtii were not successful (Wannathong 2012).  
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Table 3.5 A number of selectable marker genes are currently used in algal chloroplast 
technology, modified from Day & Goldschmidt-Clermont (2011). 
Marker  Selection  Algal species  References 
Photosynthesis  
atpB Photoautotrophy Chlamydomonas reinhardtii (Boynton et al. 1988) 
tscA, psbH Photoautotrophy Chlamydomonas reinhardtii (Kindle et al. 1991) 
psaA/B Photoautotrophy Chlamydomonas reinhardtii (Redding et al. 1998) 
petB Photoautotrophy Chlamydomonas reinhardtii (Cheng et al. 2005) 
Antibiotic resistance  
ereB Erythromycin Dunaliella tertiolecta Georgianna et al. 2013 
aadA Streptomycin, 
spectinomycin 
Euglena gracilis Doetsch et al. 2001 
rrnL Erythromycin Chlamydomonas reinhardtii (Newman et al. 1990) 
aphA-6 Kanamycin, 
amikacin 
Chlamydomonas reinhardtii (Bateman & Purton 2000) 
rrnS Spectinomycin, 
streptomycin  
Chlamydomonas reinhardtii (Kindle et al. 1991b; Newman 
et al. 1990; Roffeyt et al. 
1991) 
aadA Spectinomycin, 
streptomycin 
Chlamydomonas reinhardtii (Goldschmidt-Clermont 
1991) 
Herbicide resistance 
psbA DCMU, 
metribuzin 
Chlamydomonas reinhardtii (Newman et al. 1992; 
Przibilla et al. 1991) 
Metabolism     
ARG9 Arg auxotrophy  Chlamydomonas reinhardtii (Remacle et al. 2009) 
codA 5-fluorocytosine Chlamydomonas reinhardtii (Young & Purton 2016) 
 
The reported transformation of the Phaeodactylum tricornutum plastid with the cat gene 
and gfp gene by electroporation (Xie et al. 2014), opens up the possibility of using 
electroporation as a potential method for introducing exogenous genes into the chloroplast, 
especially for algal groups that harbour a secondary plastid. Therefore, the focus was testing 
and optimizing an electroporation transformation method to introduce the cat marker into 
the chloroplast genome of N. gaditana.  An initial plasmid, pUH.NCc2 carrying a bacterial 
chloramphenicol resistance marker failed to generate transformants using electroporation. 
Nonetheless, this method showed the success in delivering pQYZ1 containing Sh ble gene 
into the nuclear genome and therefore generating zeocin resistant transformants. The 
successful transformation of the nucleus by electroporation necessitates unusual high 
electric field strength ~ 12,500 V/cm, which could be explained by the very robust cell well 
of Nannochloropsis. Furthermore, this method has been demonstrated by several groups to 
be effective for stable nuclear transformation in different Nannochloropsis species 
(Radakovits et al. 2012; Kilian et al. 2011) yet there is no report of successful chloroplast 
transformation. The challenge in delivering the exogenous DNA into the Nannochloropsis 
chloroplast using electroporation methods could be due to the complexity of plastid 
membranes, where the chloroplast is surrounded by four membranes (Figure 3.14). In this 
case, for chloroplast transformation, the successful delivery of the exogenous DNA into the 
chloroplast genome relies on crossing the following biological barriers: cell wall, 
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cytoplasmic membrane and four plastid membranes. In contrast, the successful delivery of 
exogenous DNA into the nuclear genome requires overcoming solely two biological 
barriers: cell wall and cytoplasmic membrane. The question arises here as the possibility of 
electroporation to create transient pores across all four membranes, beside the plasma 
membrane and cell wall through which to allow DNA entry to the chloroplast stroma. 
 
 
Figure 3.14 Schematic representation of Nannochloropsis cell illustrating the biological 
barriers to the deliver of exogenous DNA.  
The biological barriers to exogenous DNA delivery before integration into either the nuclear or the 
chloroplast genome. The biological barriers for the chloroplast transformation are cell wall, 
cytoplasmic membranes and four chloroplast membranes. On the other hand, the biological barriers 
for the nuclear transformation are less, where the transgene has to go through the cell wall and 
cytoplasmic membranes only.  Abbreviations are: C; chloroplast, N; nucleus, M; mitochondrion and 
O, oil body. 
Alternatively, biolistics is an effective method for delivering exogenous DNA across the cell 
wall and multiple membranes and has been employed successfully for nuclear 
transformation in many species from green algae, red algae and diatoms (Doron et al. 2016). 
This method has demonstrated its robustness in delivering exogenous DNA into the 
chloroplast of algal species other than C. reinhardtii, for example Haematococcus pluvialis 
(Gutiérrez et al. 2012), Dunaliella tertiolecta (Georgianna et al. 2013), and Platymonas 
subcordiformis (Cui et al. 2014). In our search for an appropriate delivery method for the 
Nannochloropsis chloroplast, this method was tested for delivering the exogenous DNA into 
the nuclear and chloroplast genome. Surprisingly, our attempts failed to generate either 
nuclear or chloroplast transformants. An implication of this result is that the invasive nature 
of this method prevented the recovery of transformants in the case of Nannochloropsis due 
to the small size of cell (approximately 2–4 μm). The recent availability of gold 
nanoparticles with a diameter of 40 nm might be more convenient for small cells as these 
tend to cause less tissue damage. O’Brien & Lummis (2011) demonstrated that the use of 
nanoparticles caused less tissue damage than 1 µm during the biolistic transfection of 
human and mouse cells. However, the use of such nanoparticles may not be suitable for 
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chloroplast transformation of Nannochloropsis species because such small particles may not 
penetrate the cellulosic cell wall and plastid membranes efficiently, or may not even carry 
enough DNA copies to favour recombination.  
In general, for Nannochloropsis, the main challenges in delivering exogenous DNA into the 
chloroplast genome using commonly employed methods are the small size of the cell (and 
therefore the plastid) and the complexity of the plastid membranes. These challenges have 
been observed clearly in our transformation attempts using these delivery systems. The 
DNA delivery by electroporation resulted in successful nuclear transformants but not 
chloroplast, emphasizing the need for a more effective method to deliver DNA across more 
membranes. Nonetheless, the biolistic method failed to generate even nuclear 
transformants as the invasive nature of the employed method prevented the recovery of 
these small cells.   
Apart from DNA delivery methods, other aspects of molecular biology might lead to the 
failure to generate chloroplast transformants. In fact, once a transgene has been stably 
integrated into the plastome, there are still a number of other issues relating to foreign gene 
expression such as a failure of transcription, ribosomal stalling and protein misfolding to be 
overcome before exhibiting the desired phenotype, as is illustrated in (Figure 3.15). This 
could be the case for the chosen selectable marker, as the bacterial version of the cat gene 
could be affected by codon bias resulting in inefficient translation in the Nannochloropsis 
chloroplast, thereby a codon optimization version of the gene might be required for 
successful expression. Several studies have shown the importance of codon optimization in 
improving the heterologous expression of foreign genes in the host cell (Shao & Bock 2008). 
 
Figure 3.15 The central dogma of gene expression and potential problems.  
The figure is taken from Taunt (2013). 
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As mentioned earlier, attempts to use the cat gene as marker in the C. reinhardtii chloroplast 
were not successful although tobacco chloroplast transformation was achieved using this 
marker (Wannathong 2012; Li et al. 2011). One suggestion for the failure in the case of C. 
reinhardtii is that the mitochondrial translational machinery of this alga is sensitive to 
chloramphenicol. Expression of cat in the chloroplast therefore does not result in a 
chloramphenicol-resistant phenotype as the antibiotic is still able to kill the cell through its 
action in the mitochondria. It could be that this is also the case for N. gaditana.  
Generally speaking, the development of a chloroplast transformation method for a new 
species often requires significant effort. There are a number of potentials pitfall between 
introducing a foreign gene into chloroplast genome and successful expression of the gene 
to exhibit the desired phenotype. In spite of using two different delivery methods 
(electroporation and biolistics), the attempts were not successful as clearly demonstrated 
throughout this chapter. The reason behind such failure is normally difficult to determine 
due to the involvement of several factors. So, the next chapter aims to develop a more 
controllable approach in order to monitor the steps involved in developing a chloroplast 
transformation methodology. Such an approach relies on screening for chloroplast-specific 
compounds as a selection system and then developing an endogenous selectable marker to 
confer the resistance. This approach should remove some of the uncertainty regarding the 
expression of the marker and allow the focus to turn to identifying a successful delivery 
method. 
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An improved approach for developing chloroplast 
transformation methodology in N. gaditana 
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4. An improved approach for developing chloroplast 
transformation methodology in N. gaditana 
4.1. Introduction 
As discussed in Chapter 3, a plasmid carrying a bacterial chloramphenicol resistance 
marker failed to generate chloroplast transformants despite testing two DNA delivery 
methods – biolistics and electroporation. The development of a chloroplast transformation 
method necessitates monitoring of each step, as there are several potential pitfalls between 
introducing the foreign gene into the chloroplast genome and the successful expression of 
the gene resulting in the desired phenotype. Therefore, the focus of this chapter is on 
employing a more controllable approach to investigate these uncertainties, as illustrated in 
Figure 4.1. In this strategy, the design of the selection system is based on the screening for 
chloroplast specific compounds that target the photosynthetic machinery instead of the 
prokaryotic–like translational machinery (which is found in both chloroplast and 
mitochondria). Furthermore, the strategy involves the development of an endogenous 
marker based on a chloroplast gene to eliminate issues relating to foreign gene expression. 
Since the small size of the Nannochloropsis cell represented a further issue with respect to 
biolistic DNA delivery, an additional step – cell synchronisation at the mitotic stage – is 
included prior to biolistics transformation to increase the cell size of Nannochloropsis and 
allowing the exploitation of this high velocity delivery method with these enlarged cells. 
This is relevant since high velocities may be necessary to penetrate the multiple chloroplast 
membranes without killing the cells, as illustrated in Figure 4.2. 
 
 
 
Figure 4.1 Simplified flow chart for the proposed approach to develop a chloroplast 
transformation methodology.  
 
Evaluation of sensitivity to 
chloroplast-specific compounds 
Construct chloroplast 
transformation plasmid 
Cell synchronisation 
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Chloroplast transformation  
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Figure 4.2 Schematic representation of biolistics transformation of Nannochloropsis cells 
using two approaches. 
(A) The classical approach to deliver the exogenous DNA into the chloroplast genome using biolistics 
at high velocities tend to generate intracellular damage and have a higher probability of killing the 
Nannochloropsis cells due to their small size. (B) An alternative approach to deliver the exogenous 
DNA into the chloroplast genome of reversibly arrested cells at the mitotic stage, where they double 
their cytoplasmic and DNA content and so increasing the chances of generating chloroplast 
transformants. The size of gold particles will be used in 0.55 μm – the smallest size commercially 
available.  
4.1.1. D1 as a target site for herbicides 
Photosynthesis in cyanobacteria, algae and plants is initiated at photosystem II, a 
multisubunit protein-chromophore complexes embedded in the thylakoid membrane (see 
Figure 4.3). The light energy captured by antenna system chlorophylls is transferred rapidly 
to a unique chlorophyll molecule termed the reaction centre (P680), which initiates 
electrons transfer through a number of carrier molecules within photosystem II. The first 
stable electron acceptor is a bound quinone (QA), which carries a single electron and is 
closely associated with the two electron carrier, quinone QB, reversibly bound to the D1 
protein. The secondary acceptor QB transfers the electrons to the mobile plastoquinone pool 
and then the electrons pass through the cytochrome b6f complex to the copper containing 
plastocyanin, and then to photosystem I. The end point of electron transfer is reached when 
NADPH is formed on the stromal side of photosystem I. 
Photosynthesis is a distinct biochemical pathway found only in photosynthetic organisms: 
target sites for chemical inhibition of photosynthetic are therefore unique to these 
organisms. For example, photosystem II herbicides specifically inhibit the photosynthesis 
process by disrupting electron transfer within photosystem II. The extensive screening of a 
large number of synthetic compounds led to the development of several photosystem II 
herbicide classes such as ureas and triazines (Cobb & Reade 2010). The primary action of 
Gold particles ~ 0.55 μm 
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B 
Arrested cells 
Antimitotic agent 
Remove 
blocking agent Transformant 
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triazine-type herbicides such as atrazine and the chemically unrelated ureas such as 3-(3,4-
dichlorophenyl)-1,1-dimethylurea (DCMU or diuron), is to inhibit photosynthesis by 
disrupting the electron transfer within photosystem II reaction center by competing with 
QB on its binding site on D1 protein, encoded by the chloroplast psbA gene.  Interestingly, 
the D1 protein of photosystem II is also a common target for other chemically unrelated 
herbicides include bromacil and metribuzin (Mets & Thiel 1989). 
 
Figure 4.3 A schematic representation of the main complexes embedded in the thylakoid 
membrane of the chloroplast. 
These protein complexes are photosystem II (PSII), the cytochrome b6f complex (cyt b6f), 
photosystem I (PSI) and the ATP synthase complex. Electrons are transferred from photosystem II 
through cytochrome b6f to photosystem I, as indicated by arrows. The electrons transfer is ended by 
using the electrons for NADPH synthesis on the stromal side of photosystem I. Protons are generated 
during the process as a result of water photolysis on the luminal side of photosystem II and 
plastoquinone driven movement of protons into thylakoid lumen. The generation of such amounts 
of protons inside thylakoid compartment leads to an electrochemical gradient across the thylakoid 
membrane. Protons flow down their concentration gradient from the lumen into the stroma through 
the ATP synthase complex and therefore drives the synthesis of ATP. Each protein complex contains 
a number of associated subunits, though some of them have been removed for clarity. Each subunit 
is given a letter based on the name of the gene that encodes; for instance, protein K in PSII is the 
product of the psbK gene. Labeling from left to right: tyrosine residues on D2 (Yz/Yd), unique 
chlorophyll reaction centre (P680), reaction core proteins (D1 and D2), core antenna proteins CP43 
and CP47 (C and B, respectively), quinones bound to D1 and D2 (QB and QA, respectively), pheophytin 
(Phe), light harvesting chlorophyll binding proteins (LhcB1-6), mobile plastoquinone pool (PQ), 
iron-sulphur protein (ISP), plastocyanin (PC), light harvesting chlorophyll binding proteins (LhcA1-
4), reaction centre core proteins (A/B), unique chlorophyll reaction centre (P700), electrons 
acceptor and donor in PSII (A0 and A1), iron-sulphur centres (FX/FA and FB), ferredoxin (Fd) and 
oligomycin sensitivity conferral protein (OSCP).  The diagram is adapted from Pyke (2009). 
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Natural resistance to photosystem II inhibitors has been observed as a result of single 
amino acid substitutions in a highly conserved region of the D1 protein (i.e. the binding 
pocket for QB). In higher plants, the atrazine-tolerant biotype has been shown to occur as a 
result from a single substitution of amino acid at position 264 from serine to glycine 
(Goloubinoff et al. 1984b). Herbicide tolerance in C. reinhardtii and Synechococcus sp. PCC 
7942 was found to be caused by substituting a serine with alanine in residue 264 (Gingrich 
et al. 1988). The mutation at residue 264 in C. reinhardtii confers strong tolerance to 
atrazine, but not for Synechococcus sp. PCC 7942 where such a change confers strong 
tolerance to diuron. Changes in residues 219, 251, 255, 256, and 275 have been also 
reported to result in photosystem II herbicide tolerance in Chlamydomonas (Rochaix & 
Erickson 1988; Rand et al. 1985; Johanningmeier et al. 1987). To date, all these mutations 
have been shown to cluster in a small region of psbA gene around the codon for serine 264. 
However, the herbicide tolerance phenotype in general varies depending on the location of 
the mutation within QB binding pocket resulting in different level of tolerance towards 
different photosystem II herbicides. The most potent mutation reported by far is at residue 
264 itself. A single amino acid change at residue 264 in C. reinhardtii showed a very high 
level of tolerance to the herbicides atrazine and metribuzin – at a hundred times and five 
thousand times the wild type level, respectively (Pucheu et al. 1984). However, the 
magnitude of herbicide tolerance for this mutation (i.e. at residue 264) is variable between 
different species.  
Since many chemically diverse groups of photosystem II herbicides target the same binding 
site, i.e. the D1 protein, is not surprising that cross resistance is observed to other 
photosystem II herbicide classes. This is evident from characterization of cross tolerance in 
herbicide tolerant biotypes for C. reinhardtii, Synechococcus sp. PCC 794 and Amaranthus 
hybridus (Hirschberg & McIntosh 1983; Rand et al. 1985; Gingrich et al. 1988). Each tolerant 
biotype showed tolerance to other herbicides though these photosynthetic organisms have 
never been exposed to other herbicides. For instance, the mutation at residue 264 in C. 
reinhardtii confers tolerance to atrazine at hundred times the wild type level with a cross 
tolerance to diuron at ten times the wild type level (Rand et al. 1985). More examples of 
herbicide cross-tolerance are summarized in Table 4.1. 
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Table 4.1 Summary of reported mutations in the psbA gene product that result in herbicide 
tolerance and cross-tolerance. 
The tolerance factors represent relative to the minimal inhibitory concentration for the wild type, where X 
means times. The table is reproduced from Gingrich et al. (1988). The references are (Hirschberg & 
McIntosh 1983),  (Goloubinoff et al. 1984a), (Golden & Haselkorn 1985), (Johanningmeier et al. 
1987) and (Rochaix & Erickson 1988). 
Photosynthetic organism  Herbicide tolerance level 
Atrazine                   Diuron 
Mutation 
Chlamydomonas reinhardtii 100X 10X 264 Ser Ala 
 84X 10X 256 Gly Asp 
 25X 5X 251 Ala Val 
 15X 0.6X 255 Phe Tyr 
 1X 5X 275 Leu Phe 
 2X 17X 219 Val  Ile 
Synechococcus sp. PCC 7942  10X 100X 264 Ser Ala 
Synechococcus sp. PCC 7002 7X 2X 211 Phe Ser 
 2X 10X 219 Val Ile 
Amaranthus hybridus 1000X 1X 264 Ser Gly 
Solanum nigrum 1000X 1X 264 Ser Gly 
4.1.2. Development of a selectable marker based on herbicide resistance  
Photosystem II inhibitors such as those described above represent an attractive selection 
system for chloroplast transformation as they target specifically the photosynthetic 
machinery of the organelle instead of the prokaryotic-like translational machinery. The 
identification of herbicide-tolerant alleles within the chloroplast gene, psbA provide a 
potential endogenous marker in which introduction of the allele into the chloroplast results 
in replacement of the wildtype, herbicide-sensitive allele and allows selection for 
transformant colonies on plates containing the herbicide (Mets & Thiel 1989). The use of 
psbA as a selection system was demonstrated in C. reinhardtii by Boynton & Gillham (1993) 
who used different approaches. The first approach relied on phototrophic rescue of a non-
photosynthetic recipient strain having both copies of psbA deleted and was transformed 
with a plasmid carrying a wild type psbA. While the second approach relied on using a 
herbicide tolerant allele as a selectable marker to generate resistant colonies as described 
above.  
In addition to the use of psbA alleles for herbicide-based selection of chloroplast 
transformants of microalgae, several other approaches have been described. These 
approaches can be divided into two different strategies, as illustrated in Figure 4.4. The first 
strategy is to isolate a tolerant allele of an endogenous gene and use this to replace the wild-
type, sensitive allele; the second is to introduce a foreign gene encoding an enzyme that is 
involved in detoxification of the herbicide. As another example of the first strategy, Lapidot 
et al. (2002) reported the isolation of a Porphyridium strain that was resistant to 
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sulfometuron methyl (SMM. SMM is known to target acetohydroxyacid synthase (AHAS)), 
which is chloroplast-encoded in Porphyridium, and the resistance phenotype resulted from 
a mutation in AHAS. This mutant allele was used successfully as a selectable marker for the 
chloroplast transformation of Porphyridium. Alternatively, bar gene is an example of a 
foreign gene that can be used for herbicide detoxification. This gene encodes 
phosphinothricin acetyl transferase (PAT) and it has been isolated from Streptomyces 
hygroscopicus which is tolerant to its own toxic product, bialaphos. The bar gene indeed 
demonstrated its usefulness as a selectable marker in the chloroplast transformation of 
Platymonas subcordiformis (Cui et al. 2014). 
Since the possible markers for chloroplast genetic engineering of Nannochloropsis are 
limited, the use of a herbicide-tolerant psbA as a selection system could prove useful.  The 
simplest strategy to achieve this is a forward genetic approach, which depends on random 
mutagenesis by physical or chemical methods followed by the selection of strains with 
desirable properties. Such an approach has already been used to isolate nuclear mutants of 
various Nannochloropsis species where the haploid nature of the nuclear genome make the 
use of this approach more appealing as both dominant and recessive mutations can display 
a phenotype (Kilian et al. 2011). The psbA gene could then be isolated from herbicide 
resistant strains, checked for the presence of a DNA change and then tested as a selectable 
marker when introduced into the chloroplast of a wild-type strain. An alternative approach 
would be a reverse genetics strategy in which one of the psbA mutations known to confer 
herbicide resistance in other organisms (Table 4.1) is engineered into the cloned 
Nannochloropsis gene and then this is tested as a selectable marker.  
 
 
 
 
99 
 
 
Figure 4.4 Schematic representation of two different cloning strategies to use herbicides as a 
selection system. 
(I-a) A random mutagenesis to isolate herbicide tolerant mutants (MT) and identify the responsible 
allele/s for such herbicide tolerance. Gene encodes herbicide target protein is refereed as X, while 
the gene encodes altered herbicide site that confers herbicide tolerance is indicated by X*. (I-b) Site 
directed mutagenesis by homologous recombination (X – X) to replace the gene X in the wild type 
strain (WT) with X*, allowing the selection for herbicide tolerant transformants (TF). (II) 
Transformation with a plasmid construct contains a gene encoding (HDX) for an enzyme causing 
herbicide detoxification. The HDX gene is under the control of endogenous regulatory elements and 
the cassette is flanked by endogenous sequences called as the left and right homologous 
recombination region (LHRR and RHRR). The integration of the HDX gene into the WT plastome 
proceeds through homologous region resulting herbicide tolerant transformants. In both cases, a 
gene of interest could be added alongside X* or HDX. Abbreviations are HS: Herbicide sensitive strain, 
HR: Herbicide resistance strain, WT: wild type strain, MT: mutant strain and TF: transformant. 
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4.1.3. Cell synchronisation 
Cell synchronisation is a common approach to study the cell cycle regulatory mechanisms 
in eukaryotic cells and thus a number of methods have been developed to synchronise cells 
at a specific phase of the cell cycle (Blajeski et al. 2002; Yvon et al. 1999; Matsui et al. 2012). 
One of the most frequently used methods is a ‘block and release’ method using chemical 
agents. This method relies on using either a single chemical or a combination of chemicals 
to induce the cell synchrony by blocking the cell cycle progression at a specific stage and 
upon the removal of the chemical/s; the synchronized cells can proceed into the next stage 
of the cell cycle. In general, the blocking agents arrest the cell cycle by acting on essential 
proteins involved in cell cycle control such as cyclin-dependent kinase or enzymes involved 
in DNA replication, or by acting on the mitotic apparatus of the cell cycle (Planchais et al. 
2000). Cell synchronisation is also used for other purposes such as improving gene 
targeting and transfection efficiency (Tsakraklides et al. 2015; Grosjean et al. 2002). In this 
study, the aim is to use cell synchronisation as a means to increase cell size by arresting 
cells at the mitotic stage prior to biolistic transformation. Cell cycle progression is size 
dependent and arrested cells at the mitotic stage tend to be bigger in size because they have 
doubled their cytoplasmic content and DNA content (see Figure 4.5). Arresting the cells at 
the mitotic stage is relatively difficult due to the short period of this phase, however, there 
are a number of agents that have been routinely used to arrest various type of cells, as a 
summarized in Table 4.2.  
Nocodazole is an example of a widely used microtubule inhibitor in the cell cycle 
synchronization owing to its reversibility, efficiency and specificity compared to other 
microtubules inhibitors such as colchicine and colcemid, where a poor recovery has been 
reported (Zieve et al. 1980). The use of nocodazole in cell synchronisation studies is usually 
coupled with other chemicals that target a different phase in the cell cycle to generate 
synchrony of high numbers of cells. This is known as a two-step blocking method (Matsui 
et al. 2012). The most relevant example is the successful synchronisation of HeLaS3 cells in 
anaphase and telophase by using a combination of the  microtubule inhibitor nocodazole 
and myosin II inhibitor blebbistatin (Matsui et al. 2012). Although a two-step blocking 
method of cell synchronisation has shown to greatly enhance the efficiency in generating 
synchronised cells, a one-step method will be used in our initial investigation as there are 
no reported studies of algal cell synchronisation by blocking agents, with most studies 
carried out using yeast, mammal and plant cells. At present, the most common method of 
synchronising the model alga Chlamydomonas is by alternating light and dark cycles of a 
dividing culture growing phototrophically in minimal medium (Bernstein 1960; Kates & 
Jones 1964). There are other methods also reported to naturally synchronise 
Chlamydomonas such as an overnight dark starvation of the cells, a temperature shift, size 
 
 
101 
selection by cell sorting and alteration of light of different wavelengths (Rooney et al. 1977; 
Knutsen et al. 1973; Oldenhof et al. 2006). 
 
Figure 4.5 Schematic diagram demonstrates the cell cycle of Nannochloropsis. 
The changes in DNA content and cell size for the cell as progressing through the cycle are shown, 
where the cell start small in size with 1N and gets bigger with 2 N prior to cytokinesis. The site of 
action for microtubule inhibitor nocodazole is indicated, as it arrests the cell at metaphase by 
preventing the microtubule disassembly. The duration of phases (G1, S, G2 and M) does not reflect 
the actual duration for each phase.  
Table 4.2 A number of mitotic agents that are commonly used in cell cycle synchronization. 
+: Reversible arrest, –: irreversible arrest, and +/–: reversibility dependent on the duration of the treatment. 
 
Agent   Target  Block Reversibility  Reference 
Colchicine Microtubule 
inhibitor  
Metaphase +/– (Louis C. Morejohn 
Thomas E. Bureau 1984) 
Oryzalin Microtubule 
inhibitor 
Metaphase +/– (Hugdahl & Morejohn 
1993) 
Propyzamide Microtubule 
inhibitor 
Metaphase +/– (Akashi et al. 1988) 
Amiprophos-
methyl 
Microtubule 
inhibitor 
Metaphase +/– (Sree Ramulu et al. 
1991) 
Taxol Microtubule 
inhibitor 
Metaphase/anaphase + (Yvon et al. 1999) 
Nocodazole Microtubule 
inhibitor 
Metaphase + (Matsui et al. 2012) 
Blebbistatin Myosin II inhibitor Anaphase/telophase + (Matsui et al. 2012) 
MG132 Proteasome 
inhibitor 
Metaphase/anaphase – (Genschik et al. 1998) 
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4.1.4. Aims and objectives 
In order to be able to exploit the unique advantages associated with Nannochloropsis, the 
general aim of this chapter is to continue the investigation into developing a reliable 
chloroplast transformation method, but this time the focus will be solely on using biolistics 
as a DNA delivery method. The choice of biolistics as a delivery method to be tested is due 
to its robustness to deliver exogenous DNA across the multiple membranes.  
Specifically the aims of the work in this chapter are: 
1. Identify suitable selectable markers by evaluating N. gaditana sensitivity toward 
chloroplast-specific compounds. 
2. Develop an endogenous selectable marker based on a variant of the chloroplast psbA 
gene that confers herbicide tolerance using forward and reverse genetics 
approaches.   
Forwards approach 
 Develop a protocol for in vitro mutagenesis and isolation of chloroplast mutants. 
 Study the molecular basis of the mutations that are isolated from herbicide tolerant 
mutants. 
Reverse approach 
 Study the sequence homology of D1 sequence with other related species in order to 
identify the key residues in the algal D1 likely to give a herbicide tolerance 
phenotype when changed to another residue/s. 
3. Use the findings from both forward and reverse genetics approaches to aid the 
identification of tolerant psbA allele/s and therefore incorporate the potential allele 
into the chloroplast transformation plasmid. 
4. Test the possibility of synchronising N. gaditana chemically at the mitotic stage with 
microtubule inhibitor nocodazole, as a means to increase the cell size prior to 
biolistic transformation. 
5. Develop a nuclear transformation protocol for nocodazole-treated N. gaditana at 
high velocities as a proof of concept before applying the same conditions for 
chloroplast transformation.  
6. Test different biolistic conditions to transform the chloroplast of N. gaditana by 
replacing the wild type psbA allele with herbicide tolerant one. 
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4.2. Results 
4.2.1. Evaluation of herbicides and D-amino acid sensitivity  
Nannochloropsis gaditana demonstrated its robustness in resisting a wide range of 
antibiotics as demonstrated previously in section 3.2.2. So, in order to identify more 
selectable markers than those conferring resistance to antibiotics, the susceptibility of N. 
gaditana to herbicides was also evaluated by spot tests. In addition, sensitivity to D-alanine 
was also examined, since this has been exploited for selection in higher plant chloroplasts 
(Gisby et al. 2012). The results, as summarized in Table 4.3, indicate that N. gaditana is 
highly resistant to D-alanine at the tested concentrations of 10 to 200 μg/ml. As for the 
herbicide compounds, Nannochloropsis is tolerant to Harvest, glufosinate-ammonium and 
bialaphos (see Figure 4.6 for bialaphos spot test). In particular, N. gaditana shows high 
tolerance to both glufosinate-ammonium and bialaphos at tested concentrations from 10 to 
200 μg /ml, whereas the tolerance to the Harvest herbicide (formerly known as Basta) 
ranged from 10 to 100 μg/ml. As an example of herbicidal compounds, the tolerance of N. 
gaditana to bialaphos was further confirmed by testing the growth response at higher 
concentrations in liquid ASW as shown in Figure 4.6. Although the Harvest herbicide has 
been used successfully in chloroplast transformation of P. subcordiformis, such glutamine 
synthetase inhibitor herbicides cannot be used as a selection method for the chloroplast 
transformation in N. gaditana.  
Another category of herbicidal compounds including atrazine and diuron which target 
specifically the chloroplast as photosystem II inhibitors. N. gaditana is sensitive to atrazine 
and diuron as cell growth was inhibited from 10 µg/ml as shown in Figure 4.7. Although N. 
gaditana is most sensitive to diuron based on the spot tests, atrazine was chosen to be 
further studied as a potential selection method as it has been used widely to select 
transgenic plants in atrazine degradation studies (Wang et al. 2010; Wang et al. 2005).  In 
addition to that, two potential marker genes could be used to confer the tolerance against 
atrazine; a point mutation within an endogenous psbA gene and an atrazine 
chlorohydrolase gene from Pseudomonas sp. strain ADP (de Souza et al. 1998; Gingrich et al. 
1988; de Souza et al. 1995). Thus, the inhibitory effect of atrazine was further studied by 
more tests to determine the appropriate concentrations to inhibit growth of N. gaditana at 
high cell density over an extended period of time. Sensitivity of N. gaditana to atrazine at 
high cell densities was tested by spreading a culture at mid-log phase (5 x 108  cells per 
plate) on ASW containing 50 and 100 μg/ml of atrazine and the results, as shown in Figure 
4.8, confirmed the absence of any spontaneous resistance to atrazine. 
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Table 4.3 The effect of a number of selected chloroplast-specific compounds on N. gaditana 
based on spot test.  
The concentration of tested compounds are 10, 50, 100 and 200 µg/ml. “+” indicates the natural 
resistance to respective concentrations from low to high concentration. Resistance gene refers to a 
microbial gene conferring the resistance to the corresponding compound except for the mutations 
in psbA gene. The mutation is reported previously in other microalgae.  
Compounds  Resistance gene Resistance  
Amino acids 
D- alanine dao  ++++ 
Herbicides 
Harvest  pat +++ 
Glufosinate-ammonium pat ++++ 
Bialaphos pat ++++ 
Atrazine mutant psbA or AtzA + 
Diuron (DCMU) mutant psbA + 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 4.6 Growth response of N. gaditana to bialaphos in solid and liquid ASW at different 
concentrations. 
In left panel; aliquots of N. gaditana were spotted on 2% ASW medium containing increasing 
concentrations of bialaphos with serial tenfold dilutions left to right. * indicates non-diluted cells 
while 10 fold dilutions of cells in ASW are represented as 10-1, 10-2, 10-3 and 10-4. Plates were 
incubated under 30–50 μE for four weeks.  In right panel, an aliquot of 3 ml of a culture at mid-log 
phase into each well of a 12 well microplate. The cultures in three wells were used as control, and 
thus no bialaphos was added. Whereas, the rest were treated with different concentrations of 
bialaphos from 10 to 350 μg/ml. The cultures were incubated for four weeks under 30–50 μE. 
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Figure 4.7 Growth response of N. gaditana at high cell density that were spread onto ASW 
containing atrazine. 
Equal volumes of culture at mid-log phase were spread onto ASW medium (control) and on ASW 
containing 50 and 100 μg/ml of atrazine. The number of cells per plate was approximately 4.95 x 
108. The control plate has shown the growth of N. gaditana, whereas the cells on ASW plates 
containing atrazine were not able to grow. Plates were incubated under 30–50 μE for four weeks.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 Spot test of growth response of N. gaditana to different concentration of atrazine 
and diuron. 
Spot test demonstrated the sensitivity of N. gaditana to atrazine and diuron in which the inhibition 
of the cell growth starts from 10 µg/ml. Aliquots of N. gaditana were spotted on 2% ASW medium 
containing increasing concentrations of atrazine (left panel) or diuron (right panel), with serial 
tenfold dilutions left to right. The astrik (*) indicates non-diluted cells. An additional spot test was 
included for the DMSO solvent used with atrazine and diuron. Plates were incubated under ~ 50 µE 
for three weeks. 
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An additional test to confirm the effect of atrazine was carried out in liquid ASW to assure 
the evaluation of atrazine sensitivity has been conducted in both solid and liquid media. 
This test involved growing N. gaditana to mid-log phase and then the culture was split into 
two flasks. Atrazine was added into one of the flasks to give a final concentration 50 μg/ml, 
while the other flask was used as a positive control. The growth response of N. gaditana to 
this low concentration of atrazine, as shown in Figure 4.9, has a similar inhibition effect as 
illustrated earlier by the spot and spread tests results.  
The studies above confirmed that N. gaditana is sensitive to atrazine and therefore the 
bacterial gene, atzA that encodes the enzyme atrazine chlorohydrolase represents a 
promising selectable marker for chloroplast transformation. This marker gene was used for 
the selection of transgenic tobacco plants aimed at developing the plants for 
phytoremediation of atrazine-contaminated soils (Wang et al. 2005). Alternatively, there is 
the possibility of inducing several mutations in the psbA gene resulting in an atrazine 
tolerant biotype (Gingrich et al. 1988; Lambreva et al. 2013; Materna et al. 2009). The 
identification of such psbA alleles in Nannochloropsis would allow the use of these alleles as 
endogenous markers. 
 
 
 
 
 
 
 
 
Figure 4.9 Growth response of N. gaditana to atrazine in liquid at low concentration. 
A) N. gaditana grown in ASW as a control, where the culture looks healthy and green B) N. gaditana 
grown in ASW containing 50 μg/ml atrazine as the growth was inhibited due to presence of atrazine. 
Both cultures were left to grow under ~ 50 μE at 25 °C for 6 weeks. 
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4.2.2. Development of an endogenous marker using forward and reverse 
genetics approaches  
In order to use atrazine as a potential selection method for transformant clones, reverse-
and forward genetics approaches were employed to develop psbA as an endogenous 
marker.  
4.2.2.1 Mutagenising N. gaditana using a forward genetics approach  
To introduce a random mutation into the N. gaditana plastome, an appropriate method of 
mutagenesis was necessary. Several methods have been developed to introduce nuclear 
and chloroplast mutations, as reviewed (Harris 2009). One of these methods is ultraviolet 
(UV) mutagenesis, which has been used successfully for the introduction of both nuclear 
and chloroplast mutations. In one example, UV mutagenesis was used to generate nuclear 
auxotrophic and pigment deficient mutants in C. reinhardtii (Wang et al. 1975). As for the 
chloroplast mutations, there are only a few cases reported of successfully inducing these in 
Chlamydomonas (Hudock et al. 1979). The challenge of isolating chloroplast mutations is 
due to the polyploidy of the chloroplast genome and how the newly arising mutation would 
never reach homoplasmy since the majority of the organelle genomes would carry the wild 
type allele of the mutation. To reduce the chloroplast genome abundance, a 5-
fluorodeoxyuridine (FdUrd) treatment has been shown to work effectively when combined 
with other mutagens (Gingrich et al. 1988; Anthony et al. 2014). In addition,  FdUrd 
treatment has shown to facilitate the recovery of chloroplast mutants and appears to be 
mutagenic for chloroplast genes as well (Wurtz et al. 1979). The efficiency of this approach 
has been demonstrated in creating point mutations, deletions, duplications, and 
rearrangement of chloroplast DNA of C. reinhardtii (Harris 1989). The FdUrd-UV 
mutagenesis approach therefore was tested in N. gaditana to induce chloroplast mutations 
in the psbA gene.  
Besides this induced mutagenesis, an initial investigation into whether spontaneous 
mutagenesis was sufficient to introduce such a mutation into psbA was made. In this 
experiment, an attempt was made to isolate atrazine mutants by plating approximately 107 
cells per plate on selective ASW medium containing 50 and 100 μg/ml atrazine. None of 
these attempts were successful in recovering any resistant colonies (data not shown) 
suggesting that any spontaneous resistance to atrazine occurs at a frequency well below  
10–7, and also confirming the suitability of this herbicide as a potential selection tool for 
plastid transformation.   
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In order to use UV mutagenesis to induce random mutagenesis, the optimal dose was first 
determined by calculating the irradiation time needed to produce a culture with a viability 
reduced to 10%. This was carried out by irradiating cells with UV light at a distance of 15 
cm using an in-house built ultraviolet box, as described in section 2.6. As shown in Figure 
4.10, the colony count before mutagenesis was 4240 and upon UV light exposure it 
significantly reduced. At approximately 4 minutes the culture was reduced to a 10% viable 
count.  
 
Figure 4.10 Mutagenesis "kill curve" was carried out on N. gaditana to determine exposure 
time (t10) needed to produce a 10% viable culture. 
Over the course of 10 minutes, the cells were removed at 1 minute interval starting at 0 minute.  The 
cells were plated on ASW medium and the number of colonies was counted after approximately four 
weeks. The graph shows that on exposure to ultraviolet light for four minutes, the N. gaditana culture 
was reduced to a 10% viable count (420 colonies).   
To determine if FdUrd treatment would reduce the chloroplast content of N. gaditana as 
shown for C. reinhardtii (Wurtz et al. 1979), PCR was used to analyse nuclear and 
chloroplast DNA from exponentially growing cells treated with two different 
concentrations of FdUrd (0.5 mM and 1 mM). The treatment of cells with 1 mM FdUrd led 
to an apparent reduction in total amount of chloroplast DNA compared to nuclear as shown 
Figure 4.11 suggesting that reduction in ploidy of the chloroplast genome can be exploited 
as a means of increasing the frequency of chloroplast mutations in N. gaditana.  After 
determining the optimal dose of UV and confirming the efficacy of FdUrd on N. gaditana, a 
two-step approach was used in which the cells were treated first with 1 mM FdUrd and then 
subjected to UV mutagenesis. Around 40 putative atrazine tolerant mutants were recovered 
from FdUrd-UV mutagenesis. Eight mutants were picked and repeatedly re-streaked on 
media containing atrazine to ensure the mutants recovered are homoplasmic for the 
chloroplast genome before proceeding to subsequent analysis. These mutants (M1- M8) 
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were further tested by spot tests and analysed by PCR and sequencing of the entire psbA. In 
spot tests, M1–M8 were spotted onto an atrazine-containing plate; Figure 4.12 shows that 
all strains were able to grow in the presence of atrazine, unlike the wild type strain. So, the 
next step was identifying the changes in DNA sequences in these putative mutants by 
sequencing psbA. However, the sequence analysis did not reveal any changes in all of psbA 
gene sequence despite the atrazine tolerant phenotype (data is not shown). These results 
suggest that the phenotype is the result of other mutations at unknown loci and further 
investigation is necessary to determine whether these are affecting the uptake, action or 
stability of the atrazine within the N. gaditana cell.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 PCR to determine the effect of chloroplast DNA synthesis inhibitor on DNA 
content of N. gaditana cells.  
Analysis of the effect of chloroplast DNA synthesis inhibitor on DNA content of N. gaditana cells that 
were treated with various concentrations of 5-fluordeoxyuridine (FdUrd) at late log phase for 
approximately a month in the dark. The abundance of chloroplast and nuclear DNA content were 
determined by amplifying psbA and a region upstream of the nuclear TUB gene during exponential 
growth, respectively. Treatments are: C, control; T1, cells were treated with 1 mM FdUrd and T2, 
cells were treated with 0.5 mM FdUrd.  The number of cycles used to validate the effect of FdUrd 
treatment on chloroplast DNA content compared to the nuclear are 20, 22 and 24.  The control cells 
and treated cells were adjusted to equal cell densities before DNA extraction and then equal amount 
of temple DNA from each sample were used in PCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.12 Analysis of atrazine tolerant mutants obtained from UV mutagenesis by spot 
test. 
A number of atrazine tolerant mutants were selected, re-streaked and spotted onto ASW agar 
containing 50 µg /ml atrazine (left panel) and ASW agar (right panel).  All selected mutants (M1- M8) 
were able to grow in presence of atrazine, while the wild type strain (WT) failed to grow. Plates were 
incubated under 50 μE for 6 weeks.  
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4.2.2.2 Using a reverse genetics approach to develop an atrazine-resistant psbA allele 
Resistance to atrazine in higher plant and microalgae has been described previously to 
occur as a result of single amino acid substitutions in D1, encoded by psbA (Block et al. 1985; 
Hirschberg & McIntosh 1983; Gingrich et al. 1988). A mutation at residue 264 from serine 
to alanine has been reported by Gingrich et al. (1988) to produce the most profound effect 
with respect to herbicide tolerance in both C. reinhardtii and Synechococcus sp. PCC 7942. 
In order to study the conserved residues involved in the plastoquinone/herbicide binding 
pocket of D1 protein, the amino acid sequence of D1 from N. gaditana was compared to that 
from C. reinhardtii and Synechococcus sp. PCC 7002. The comparison involved the sequence 
retrieval of D1 for those species from the NCBI database and then alignment of amino acid 
sequences using MacVector. Figure 4.13, shows the alignment, and confirms that the region 
around serine 264 is highly conserved in all species. In addition, the crystal structure of 
photosystem II of Thermosynechococcus elongatus was used as a model to locate and 
highlight the interaction of these key residues within the binding pocket, as shown in Figure 
4.14. Serine 264 was therefore chosen for site directed mutagenesis with the aim of 
changing the codon to one encoding alanine and creating a version of psbA that can serves 
as a marker for the selection against atrazine in plastid transformation.  
An adapted method from triplet template PCR (Tian et al. 2004) was used to create the psbA 
allele. As shown in Figure 4.15, the gene was amplified into two fragments with primers 
containing the desired serine to alanine mutation at codon position 264 (i.e. AGT to GCT). 
The first fragment of psbA gene (psbA’) starts from approx. 20 bp upstream to the mutation 
site (i.e. between P 1 and P2), and the second fragment (psbA”) contains the rest of the 
coding sequences and approx. 20 bp of 3’UTR sequences (i.e. between primer P3 and P4).  
The PCR products of the first round of PCR share terminal sequence overlaps around the 
mutation site. The purpose of adding terminal sequence overlaps between psbA’ and psbA” 
is to enable the annealing of these two PCR products together and this can act as a template 
for the second round of PCR resulting in a full-length psbA gene with the desired mutation 
(psbA264A). The psbA264A was created successfully and the changes at codon position 264 
were confirmed by DNA sequencing. 
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Chlamydomonas      MTAILERRENSSLWARFCEWITSTENRLYIGWFGVIMIPCLLTATSVFIIAFIAAPPVDI  60 
Nannochloropsis    MTATLERRESTSLWERFCSWITSTENRLYIGWFGVLMIPTLLTATSCFIIAFIAAPPVDI  60 
Synechococcus 1    MTTLLQQQGSANLWERFCQWVTSTENRFYVGWFGVLMIPTLLTATICFILAFVAAPPVDI  60 
Synechococcus 2    MTTTLQQRGSASLWEKFCQWITSTENRIYVGWFGVLMIPTLLTATTCFIIAFIAAPPVDI  60 
                   **. *...  . ** .** *.****** *.*****.***.*****  **.**.******* 
 
Chlamydomonas      DGIREPVSGSLLYGNNIITGAVIPTSNAIGLHFYPIWEAASLDEWLYNGGPYQLIVCHFL 120 
Nannochloropsis    DGIREPVAGSLLYGNNIITGAVIPSSNAIGIHFYPVWEAASVDEWLYNGGPYQLVVLHFL 120 
Synechococcus 1    DGIREPVAGSLLYGNNIITAAVVPSSNAIGLHFYPIWDAANLDEWLYNGGPYQLIVFHFL 120 
Synechococcus 2    DGIREPVAGSLLYGNNIVSGAVVPSSNAIGLHFYPIWEAASLDEWLYNGGPYQLVIFHFL 120 
                   *******.*********.. **.*.*****.****.*.** .************.. *** 
 
Chlamydomonas      LGVYCYMGREWELSFRLGMRPWIAVAYSAPVAAASAVFLVYPIGQGSFSDGMPLGISGTF 180 
Nannochloropsis    LGVACYMGREWELSYRLGMRPWIFVAFSAPVAAASAVFLIYPIGQGSFSDGMPLGISGTF 180 
Synechococcus 1    LGIFSYMGREWELSYRLGMRPWIAVAYSAPVAAATAVLLVYSIGQGSFSDGLPLGISGTF 180 
Synechococcus 2    IGVFCYMGREWELSYRLGMRPWICVAFSAPVAAATAVFLIYPIGQGSFSDGMPLGISGTF 180 
                   .*. .*********.******** **.*******.** *.* *********.******** 
 
Chlamydomonas      NFMIVFQAEHNILMHPFHMLGVAGVFGGSLFSAMHGSLVTSSLIRETTENESANEGYRFG 240 
Nannochloropsis    NFMLVFQAEHNILMHPFHMAGVAGVFGGSLFSAMHGSLVTSSLIRETEDGVSANYGYKFG 240 
Synechococcus 1    NFMFVLQAEHNVLMHPFHMLGVAGVFGGALFSAMHGSLVTSSLIRETTETESQNSGYRFG 240 
Synechococcus 2    NFMIVFQAEHNILMHPFHMLGVAGVFGGSLFSAMHGSLVTSSLVRETTETESQNYGYKFG 240 
                   *** * *****.******* ********.**************.*** .  * * **.** 
 
Chlamydomonas      QEEETYNIVAAHGYFGRLIFQYASFNNSRSLHFFLAAWPVIGIWFTALGLSTMAFNLNGF 300 
Nannochloropsis    QEEETYNIVAAHGYFGRLIFQYASFNNSRALHFFLAAWPVVGIWLTALGISTMAFNLNGF 300 
Synechococcus 1    QEEETYNIVAAHGYFGRLIFQYASFNNSRALHFFLAAWPVIGIWFASLAVACFAFNLNGF 300 
Synechococcus 2    QEEETYNIVAAHGYFGRLIFQYASFNNSRSLHFFLGAWPVVGIWFTALGVSTMAFNLNGF 300 
                   *****************************.***** ****.*** ..* ... ******* 
 
Chlamydomonas      NFNQSVVDSQGRVLNTWADIINRANLGMEVMHERNAHNFPLDLAST-------NSSSNN- 352 
Nannochloropsis    NFNQSVVDSQGRVINTWADIINRADLGMEVMHERNAHNFPLDLAVSNVLPVALNAPAVNA 360 
Synechococcus 1    NFNQSLLDSQGRVINTWADILNRANLGIEAMHERNVHNFPLDLAAGDQAPVALQAPAING 360 
Synechococcus 2    NFNQSILDSQGRVINTWADILNRANLGFEVMHERNAHNFPLDLAAGEQAPVALQAPAING 360 
         *****..******.******.*** ** * ***** ********         .. . *  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 Sequence analysis of D1 protein in several species. 
(A) The D1 protein sequences for several species were aligned. The aligned sequences for the 
following algal species; N. gaditana CCMP 526, C. reinhardtii and Synechococcus sp. PCC 7002. C. 
reinhardtii has two identical copies of psbA whereas Synechococcus has two copies with 87.22% 
identity of amino acid sequences for the D1 protein. The sequences of D1 protein encoded by the 
cyanobacterial psbA copies were included in the alignment and indicated as Synechococcus 1 and 
Synechococcus 2. The conserved residues across different algae are indicated by an asterisk, located 
at the bottom of the alignment. The DNA changes in highlighted residues have been reported to result 
in herbicide tolerance. The serine residue at position 264 has been chosen for site directed 
mutagenesis, is shown by black box. The amino acid sequences were retrieved from the NCBI 
database. The NCBI reference sequence identifiers for D1 are in C. reinhardtii (YP_007317069.1), N. 
gaditana (YP_007317069.1), Synechococcus 1 (WP_012307764.1) and Synechococcus 2 
(WP_012305795.1). The grey arrows indicate the location of primers used to sequence the psbA gene 
from N. gaditana plastome (see Appendix.4 for more details). (B) The DNA sequence indicate the 
wild-type sequence from codons 260 to 268 and the change presents at 264 residue from serine to 
alanine, which leads to atrazine (AtT) and diuron (DuT) tolerance in Chlamydomonas and 
Synechococcus, respectively.  
 B) 
A) 
260                                        264                                        268 
Phe   Gln  Tyr   Ala   Ser   Phe  Asn   Asn Ser 
 TTC    CAA    TAC   GCA   AGT   TTC    AAC     ACC   TCA 
                                               GCT 
                                               Ala 
                                               AtT 
                                               DuT  
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Figure 4.14 Crystal structure of D1 protein shows plastoquinone QB binding pocket.  
Crystal structure of D1 protein shows plastoquinone QB binding pocket. The structure of D1 protein 
was obtained from the crystal structure of photosystem II based on T. elongatus model. The 
plastoquinone QB binding pocket is expanded (zoomed in), and the interacting residues of the 
binding pocket are labeled. Non-haem Fe2+ is depicted as a red sphere. The Nannochloropsis gaditana 
residue 264 (serine) was chosen for site directed mutagenesis and the corresponding plastoquinone 
QB binding pocket of Thermosynechoccus is zoomed in, highlighting the changes from serine to 
alanine. The protein structure was retrieved from the Protein Data Bank (PDB identifier 2axt), 
visualized and reproduced using PyMOL.  
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Figure 4.15 Schematic representation of PCR based method to create the herbicide tolerant 
psbA allele. 
A) Schematic representation to illustrate how PCR- based method has been used to create a mutant 
psbA by replacing AG with GC at codon position 264. The amplification reactions have been 
performed in two consecutive steps. In the first step, psbA was amplified as two separate pieces using 
two sets of primers (P1–P2 and P3–P4). The first primer set (P1–P2) amplifies psbA’ fragment that 
extends from approx. 20 bp upstream of the transcription start of psbA to 20 bp within the mutation 
site. The second set of primer (P3–P4) amplifies psbA” fragment from 20 bp upstream mutation site 
to approx. 20 bp downstream of psbA to include 3’UTR. The resulted PCR products – psbA’ and psbA”– 
were mixed in the reaction to act as a template for the second PCR reaction producing psbA with a 
mutation at codon position 264 from serine to alanine, (psbA264A). To facilitate the subsequent 
cloning steps of making the construct, primers 1 and 4 incorporate ~20 bp complementary 
sequences to P/5’UTR psbA and 3’UTR psbA, respectively. B) The PCR products generated during the 
amplification reactions to construct psbA264A. The arrows point out the expected band.  
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Having constructed the psbA264A allele, the next step was to make a transformation vector 
that will replace the wild type psbA with resistance allele in the Nannochloropsis chloroplast 
via homologous recombination, as illustrated in Figure 4.15.  In order to construct the 
vector, left and right flanking regions (with appropriate overlaps to the psbA264A gene) 
were amplified from the N. gaditana chloroplast and then these endogenous elements were 
assembled together in the pJet plasmid vector using the Gibson assembly method (Gibson 
et al., 2009). As shown in Figure 4.16, regions of the rbcS and chlN genes were included into 
the cassette during PCR amplification of the flanking regions. The final construct (pUH-
psbA264A) was confirmed by double digestion and DNA sequencing. 
 
Figure 4.16 Schematic representation of site directed mutagenesis to introduce a mutation 
into psbA gene. 
pUH-psbA264A comprises the psbA variant allele flanked by the 3’UTR and p/5’UTR sequences of 
psbA, together with upstream and downstream sequences for homologous recombination. The psbA 
variant is 1083 bp in length and the mutation has been introduced at codon position 264 by replacing 
the serine codon with that for alanine, indicated as mutation point. The promoter region and 5’UTR 
of psbA is 213 bp in length and the 3’UTR of psbA is 282 bp. Part of both chlN and rbcS genes were 
included into the cassette during cloning process. All elements were assembled together using 
Gibson assembly as one piece and then cloned into pJet. The successful delivery of DNA into 
chloroplast genome should enable the replacement of wild type psbA by double homologous 
recombination (X–X) generating herbicide tolerant transformants. Abbreviations are WT: wild type, 
TF: transformant, Ats: atrazine sensitive, Dus: diuron sensitive, AtT: atrazine tolerance and DuT: 
diuron tolerance.  
 
 
 
 
 
 
 
 
 
LHRR 
 
       RHRR 
 
    
rbcL rbcS psbA chlN 
 
chlL 
   
rbcS psbA chlN 
   3’UTR   P/ 5’UTR 
Mutation point
 
 
 
    
rbcL rbcS psbA chlN 
 
chlL 
Mutation point
 
 
Homologous 
recombination 
pUH-psbA264A  
   N. gaditana plastome WT 
N. gaditana plastome TF 
Ats Dus 
  AtT/ DuT 
 
 
115 
4.2.3. Mitotic cell synchronisation as a means to increase cell size 
In order to increase the cell size temporarily prior to biolistic transformation, a microtubule 
inhibitor was used to test the possibility of arresting Nannochloropsis cells at the G2/M 
phase where cells tend to double their size. To evaluate the initial effect of nocodazole on 
the N. gaditana cell cycle, actively dividing cells were treated with different concentrations 
(20 ng/ml and 3 μg/ml), either as a single dose or every 24 hours, and the growth of these 
nocodazole-treated cells was compared to untreated cells. Growth was monitored for a 
week to investigate the inhibitory and toxic effect of the treatment. As illustrated in Figure 
4.17, there is an observed effect on the growth in all treated cultures compared to the 
control cells starting from ~24 hours, which is typically the time required by N. gaditana 
cells to double. Interestingly, the cells treated with a single dose of either 20 ng/ml and 3 
μg/ml nocodazole showed no significant differences in growth. On the other hand, the 
culture exposed continuously to nocodazole showed more a profound effect in the growth 
in comparison to the single dose. In general, the tested concentrations and conditions of 
nocodazole treatments seem to have a limited inhibitory effect on cell growth as the cells 
continue to grow but slower. However, the single dose is reported to result in recovery of 
80% of mammalian cells from a nocodazole block thus allowing the cells to proceed 
normally through mitosis (Zieve et al. 1980). So, the focus on the subsequent experiments 
was based on a single dose.  
 
Figure 4.17 The effect of different concentrations of microtubule inhibitor nocodazole on 
actively dividing N. gaditana cells.  
All cultures were from the same master culture and nocodazole was added at various concentrations 
(0, 20 ng/ml and 3 µg/ml). The culture treated with 3 µg/ml nocodazole followed by addition of the 
same amount every 24 hours, is indicated by asterisk (*). The cultures were incubated at 25 °C with 
continuous illumination of 80 μE. The error bars represent the standard deviation (n=3).  
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The next step in evaluating the effect of nocodazole on N. gaditana was to observe the 
morphological features of treated cells at different time intervals by light microscope. This 
simple method is generally used to determine the cell cycle stage, and widely used in 
assessing the cycle synchrony of Saccharomyces cerevisiae (Walker 2011). During 
microscopic analysis of Nannochloropsis cells, the changes in the chloroplast were 
monitored as the cell  progressed through the cycle in presence of nocodazole, as shown in 
Figure 4.18. The cell starts small in size and the chloroplast occupies almost the whole cell 
volume. After 12 hours treatment, the cell gets slightly bigger in size while the chloroplast 
appears to be less compact within the cell. In the following 12 hours, the chloroplast begins 
to detach from the plasma membrane as preparatory stage for the formation of daughter 
plastids. Therefore, after 36 hours of treatment, the two-daughter plastids can be seen 
clearly within the cells. After 48 hours treatment, the cell is considerably bigger with two 
daughter plastids. In addition to the observed changes in the chloroplast, the cell size of N. 
gaditana increases as the cell is progressing through the cycle. Therefore, in this study the 
changes in the cell size and the chloroplast were used as a means to monitor the cell cycle 
synchrony since the visualization of nuclei and spindle require the use of fluorescence or 
electron microscopy. Furthermore, the nucleus and the plastid within Nannochloropsis 
species are physically connected forming a nucleus-plastid continuum (NPC) and such 
physical continuity is presumably maintained throughout the cell cycle as demonstrated by 
Murakami & Hashimoto (2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.18 Observed changes in the chloroplast as the cell progresses through the cell cycle 
in the presence of nocodazole.  
0 hour treatment: chloroplast can’t be distinguished 
easily, as it occupies the whole cell volume. 
12 hours treatment: chloroplast still can’t be 
distinguished but it starts to get loose within the cell.  
24 hours treatment: chloroplast starts to pull away 
from cell wall. 
36 hours treatment: the daughter chloroplasts can be 
distinguished within the cells and they look compact. 
46 hours treatment: the daughter plastids start to 
spread longitudinally along the cell side. 
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Although the growth experiment showed that there is little difference between cells treated 
with 20 ng/ml and 3 μg/ml nocodazole, the cell populations examined under the 
microscope demonstrated that large number of cells seemed arrested at G2/M phase when 
treated with 3 μg/ml nocodazole (data not shown due to technical error in zesis camera). 
So, the effect of treating N. gaditana with 3 μg/ml nocodazole upon single exposure was 
further examined by observing the morphological features of these cells under the 
microscope, measuring the changes in the cell size and DNA content. Initially, nocodazole 
was added to a dividing culture of N. gaditana to give the final concentration 3 μg/ml and 
then the morphological changes of nocodazole-treated cells were compared to untreated 
cells using the microscope. The microscopic analysis of cells treated for 48 hours as shown 
in Figure 4.19 revealed that most of nocodazole-treated cells become enlarged and display 
a distinct elongated shape with two daughter plastids. On the other hand, the cells in 
asynchronous culture (i.e. untreated cells) are a mixture of round and elongated shapes. 
The observed elongated shape upon nocodazole treatment could indicate a static 
metaphase spindle configuration of nocodazole-treated cells. In order to determine such 
changes more accurately, the cell size of 106 cells from each of the untreated and 
nocodazole-treated images was measured by length. This analysis, as demonstrated in 
Figure 4.20, illustrates the changes in the cell size and its distribution. The results indicate 
that nocodazole treatment increased the cell size by approx. 0.5 m. As for the cell size 
distribution, there is a general shift in the cell size in particular the cell’s size that represents 
50% of the population from 2.5 m in untreated cells to 3.1 m in nocodazole-treated cells. 
However, the range of cell size distribution of untreated cells is narrower compared to 
nocodazole-treated cells, which ranges from 2.2 to 3.1 m. Such a cell-size distribution of 
nocodazole-treated cells has been reported previously by Cooper et al. (2006).  
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Figure 4.19 Effect of nocodazole on cell division and cell morphology.  
A) N. gaditana was cultured in ASW medium in absence of nocodazole for 48 hours, as a control. B) 
N. gaditana cells were treated with 3 μg/ml nocodazole for 48 hours appear as enlarged cells with 
two daughter plastids. The bars represent 5 µm. The images were processed using Carl Zeiss 
software ZEN (blue edition). 
 
 
 
 
 
 
 
Figure 4.20 The effect of nocodazole on cell size and its distribution.  
In the left panel, the effect of nocodazole on N. gaditana size. N. gaditana cells were treated with 3 
µg/ml nocodazole for 48 hours, and the changes in the cell size was compared to untreated cells (i.e. 
control cells). The total number of measured cells per group is 106 and the error bars represent 
standard error of the mean. In the right panel, the cell size distribution of measured control cells and 
nocodazole-treated cells.  
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Flow cytometric analysis was carried out to investigate if the cells are actually arrested at 
G2/M phase when treated with nocodazole. This method enables the precise measurement 
of cellular DNA content, where the DNA content of the individual cells stained with 
propidium iodide (PI) in the population is measured. In theory, nocodazole arrests the cells 
at G2/M by preventing the disassembly of microtubules and subsequently the arrested cells 
tend to be larger with 2N DNA content. The flow cytometric results in Figure 4.21 do not 
reflect the expected results under the tested conditions, where the relative abundance of 
2N DNA content of nocodazole-treated cells is expected to be higher than untreated cells. 
The results indicate that the percentage of detected major populations of G1, S and G2/M 
phase were almost the same in untreated cells and 20 ng/ml nocodazole-treated cells. 
Whereas, the treated cells with 3 μg/ml nocodazole showed a constant distribution of the 
major populations of G1, S and G2/M phase throughout the different time intervals with G1 
the most prominent, representing 50% of the population. There is uncertainty when it 
comes to flow cytometry analysis though it may suggest there is another effect other than 
arresting the cells at G2/M phase. Possibly further optimization is required to test the ploidy 
state of nocodazole-treated cells using flow cytometry. Alternative approaches should be 
also considered to assess synchrony of the cells, such as studying the mitotic markers of 
nocodazole-treated cells by western blot. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120 
 Control  
(Untreated cells) 
Treated cells with 20 ng/ml 
nocodazole 
Treated cells with 3 μg/ml 
nocodazole 
1
2
 h
o
u
r 
tr
ea
tm
en
t 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2
4
  h
o
u
r 
tr
ea
tm
en
t 
 
 
 
 
 
 
 
 
 
 
 
 
  
4
8
  h
o
u
r 
tr
ea
tm
en
t 
   
 
Figure 4.21 The cell cycle profile of untreated cell and nocodazole-treated cells by flow 
cytometry. 
The DNA content of Nannochloropsis cells treated with nocodazole was compared to control cells at 
different treatment intervals; 12, 24 and 48 hours. The analyzed samples were untreated cells as a 
control (left column), treated cells with 20 ng/ml nocodazole (middle column) and treated cells with 
3 μg/ml nocodazole (right column). All cells were fixed in 70% ethanol and stained with propidium 
iodide (PI) as described in section 2.12. The fluorescence of the PI-stained cells was measured using 
a BD Accuri C6 flow cytometer. The detected fluorescence by FL2-A (band pass filter) is proportional 
to the amount of DNA present in the tested samples and thus it represents DNA content, which is 
mainly sorted into 1N and 2N populations. Each DNA histogram shows an estimated percentage of 
cells in G1, S, and G2/M phases of the cell cycle. The area between two peaks represents the cells in 
S phase, as the cells are synthesising DNA. 
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4.2.4. Development of biolistics transformation methodology for N. gaditana 
Nuclear transformation was initially used in our attempts as a control to standardize the 
method being tested on the Nannochloropsis cells. Currently, electroporation is the method 
of choice for nuclear transformation of Nannochloropsis species (Radakovits et al. 2012; O. 
Kilian et al. 2011). This method has been used successfully in this study to generate nuclear 
transformants, as described earlier in section 3.2.4. However, the electroporation attempt 
failed to generate any chloroplast transformants. Thus, biolistics is being attempted as the 
delivery method. It is likely that the principle difficulty of transforming Nannochloropsis by 
biolistics is due to its small cell size (discussed in section 3.3). So, this time a different 
approach was used in which the cells were treated with the microtubule inhibitor 
nocodazole for either 24 or 48 hours to increase the cell size temporarily prior to biolistic 
transformation. The pQYZ1 construct containing the Sh ble nuclear marker was used to test 
the applicability of the biolistics approach since this construct successfully generated 
nuclear transformants using electroporation (see section 3.2.4).  
Biolistic transformation was carried out by bombarding the cells either at 1350 or 1550 psi, 
6 cm from launch site with 5 µg DNA-coated gold particles (0.55 µm in diameter). This 
resulted in a nuclear transformation efficiency of 1.45 X 10-8 and 5.5 x 10-9 per µg plasmid, 
respectively. Although there is a report on delivering exogenous DNA into the nuclear 
genome of the Nannochloropsis (Kang et al. 2015a) at 500 psi, the focus in our attempts was 
based on testing higher delivery pressures assuming that the accelerated particles at higher 
pressure have better penetration power to cross the multiple chloroplast membranes. The 
success results in delivering exogenous DNA into the nuclear genome using high 
bombardment pressure are summarized in Table 4.4. The employed biolistic conditions are 
similar to those used for P. tricornutum, where a high pressure was also used to deliver the 
exogenous DNA into the nuclear genome (Apt et al. 1996).  
The highest transformation efficiency achieved for the pQYZ1 construct was 1.45 X 10-8 per 
µg plasmid by treating cells with 3 µg/ml nocodazole for 24 hours and then bombarding 
these cells at 1350 psi and 6 cm from launch site with 5 µg DNA-coated gold particles. 
Putative nuclear transformant colonies appeared three weeks later after incubation on ASW 
medium containing 3 µg/ml zeocin, as shown in Figure 4.22. After 4–6 weeks, eight of these 
putative transformants, T1–T8 were picked and re-streaked for further analysis. In order 
to determine if these colonies were true transformants, they were further tested by spot 
test and PCR analysis. Figure 4.22 confirms that all the transformants were able to grow in 
the presence of zeocin. The PCR analysis indicated the successful integration for the Sh ble 
marker gene into the nuclear genome, as the transgene was detected by PCR in all screened 
strains with a band at the expected size of 370 bp which was absent for the wild type strain.    
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Table 4.4 A number of tested conditions resulted in nuclear transformants using biolistics. 
The variables tested were helium pressure (1350 and 1550 psi) and distance between particles 
launch site and target cells (3, 6 and 9 cm).  
Condition Rupture disk 
(psi) 
Distance  
(cm) 
Number of 
transformants  
Transformation efficiency¥ 
(per µg DNA) 
A 1350 3 6 4.0 X 10-9 
B 1350 6 29 1.45 X10-8 
C 1350 9 13 6.5 X 10 -9 
D 1550 6 11 5.5 X 10-9 
¥ Transformation efficiency is based on colony number per total plated cells per µg DNA. The highest transformation efficiency for 
corresponding condition is shown in the table.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.22 Analysis of nuclear transformants obtained with pQYZ1 using biolistics. 
(A) Putative nuclear transformants appeared after four weeks’ incubation on zeocin containing 
plates. A number of putative transformants colonies were selected, re-streaked and spotted onto 
ASW medium containing 3 µg/ml zeocin. As shown in B) All selected putative transformants (T1-T8) 
were able to grow under zeocin selection when compared to wild type which failed to grow. (C) PCR 
analysis; the ble marker gene was detected in all selected transformants (T1-T8) by a band at the 
expected size of 370 bp, while no band was detected in the wild type sample (WT).  
In order to establish a stable plastid transformation in N. gaditana, our attempts aimed to 
substitute the wild type psbA gene with a variant carrying the Ser264Ala point mutation, 
as described in section 4.2.2.2. The transformation was initially tested using the same 
conditions that were developed to transform the nuclear genome by biolistics. In the first 
attempt, N. gaditana cells were treated with 3 μg/ml nocodazole for 48 hours followed by 
bombardment with DNA-coated gold particles at 1350 psi and 6 cm from the launch site. 
After seven weeks of incubation on solid medium supplemented with 50 µg/ml atrazine, 
putative colonies appeared, as shown in Figure 4.23. Nine of these putative colonies were 
re-streaked and spotted onto an atrazine containing plate along with the wild type strain. 
Figure 4.23 shows that all putative chloroplast transformants were atrazine tolerant, 
although there was an observable variation in tolerance levels. To test if the atrazine 
tolerance phenotype was due to the successful replacement of the wild-type psbA allele the 
target region was sequenced in each line. The sequence analysis as shown in Figure 4.24 
reveals changes at codon position 264 in lines T2 and T6, but no changes to psbA in lines 
T1, T3–T5, and T7–T9. However, the observed mutation in both T2 and T6 was a single base 
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      0.5 kb ---  
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substitution at codon position 264 from G to A resulting in a change in amino acid from 
serine to asparagine. This mutation is not the point mutation carried on the pUH-psbA264A 
plasmid, demonstrating that T2 and T6 are not transformants but spontaneous resistance 
mutants. Nonetheless, this result indicates the involvement of amino acid residue at codon 
264 in herbicide tolerance in N. gaditana, and suggests that the SerAsp variant of psbA 
could be used as a selectable marker. The effect of this mutation on atrazine tolerance levels 
in strains T2 and T6 was further tested by spotting all strains (T1–T7) on increasing 
concentrations of atrazine. As shown in Figure 4.25, all the strains were able to grow in the 
presence of atrazine at the tested concentrations, but strain T2 and T6 were found to grow 
slowly, suggesting that photosynthetic performance was compromised in these mutants. 
Mutations to codon 264 have been reported previously to reduce electron transport within 
photosystem II and so affect the growth rate, which could be the case for N. gaditana 
(Oettmeier 1999; Ohad & Hirschberg 1992). Further attempts were made to obtain true 
transformants using the pUH-psbA264A plasmid, however none of the obtained resistant 
lines carried the expected mutation for the successful transformation. In these attempts, a 
control plate with no DNA was included, where several colonies appeared especially for the 
nocodazole-treated cells for 48 hours (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 23 Attempts were made to transform the chloroplast of Nannochloropsis using 
biolistics. 
The cells were initially treated with 3 µg/ml for 48 hours and then transformed with pUH-psbA264A. 
The colonies appeared after 7 weeks incubation on ASW containing 50 µg/ml atrazine. Putative 
colonies were isolated, re-streaked and spotted onto 2% ASW and 2% ASW containing 50 µg/ml 
atrazine. All selected transformants, T1–T9, were able to grow under atrazine selection, while the 
wild type failed to grow in presence of atrazine. Two putative transformants were found to grow 
slowly, T2 and T6.  
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Figure 4.24 Analysis of psbA sequence in putative chloroplast transformants in reference to 
the wild type. 
(A) Sanger sequencing chromatograms for psbA of wild type and two putative transformants; T2 and 
T6. The chromatograms of T2 and T6 show a different point mutation from the one expected of 
chloroplast transformants (GCT). The red arrows show the site of the actual base changes (GA) 
and the codon of interest is highlighted by the orange box. (B) Brief summary on the analysis of psbA 
sequence for the selected putative transformants (T1–T9). The changes at codon position 264 have 
been identified in T2 and T6, but is a different point mutation. T* refers to putative transformants 
number (1, 3–5, 7–9), and no changes have been detected in psbA sequence in spite of an atrazine 
tolerant phenotype. Abbreviation are WT: wild type, P: predicted by reverse genetics and T2, 6: 
putative transformant number 2 and 6.  
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psbAT* AGT Serine 
 
A 
B 
W
il
d
 t
y
p
e 
(W
T
) 
T
ra
n
sf
o
rm
an
t 
(T
2
) 
T
ra
n
sf
o
rm
an
t 
(T
6
) 
 
 
125 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.25 Testing the growth response of atrazine tolerant colonies on ASW agar plates 
containing increasing concentrations of atrazine. 
For growth tests, Nannochloropsis strains T1–T7 and wild type (WT) were adjusted to equal optical 
densities and spotted onto 2% ASW agar containing no atrazine (top panel), 60 and 80 µg/ml 
atrazine (middle panels), and 100 µg/ml (bottom panel), with serial tenfold dilutions. The growth 
tests demonstrating that strains T1–T7 were able to grow at higher concentrations of atrazine, 
however, strains T2 and T6 were found to grow slowly. The wild type strain grew on ASW agar but 
not on atrazine containing plates. Plates were incubated under 50 μE for 6 weeks.  
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4.3. Discussion  
Throughout the initial investigation into developing a chloroplast transformation method - 
as discussed at length in Chapter 3 (section 3.3)- the main challenges were: i) delivering 
exogenous DNA into the chloroplast genome of Nannochloropsis using commonly employed 
methods are the small size of the cells and the complexity of the plastid membranes; ii) 
slection for stable transformant lines. To address these challenges, a second approach was 
employed this time, which relies firstly on screening for more effective selection systems, 
secondly developing endogenous marker to overcome issues relating to foreign gene 
expression and thirdly, investigating the possibility of increasing the cell size so the use of 
biolistics method would be possible for small size cells such as Nannochloropsis. The use of 
such a powerful transformation method offers the possibility of delivering exogenous DNA 
across a thick cell wall and several membranes. 
A number of selection systems have been developed for algal chloroplast transformation 
with the most widely used selection systems based on antibiotic resistance markers. 
However, Nannochloropsis has shown high resistance to a wide range of antibiotics 
(described in section 3.2.2) and therefore there is an obvious need for alternative selection 
systems that target the chloroplast specifically. So the choice of selectable marker this time 
was based on the results of sensitivity tests to several herbicides and to D-amino acid, as 
summarized in Table 4.3.  Two herbicides, atrazine and diuron were shown to be effective 
at low concentrations. These herbicides target this photosynthetic machinery by disrupting 
the electron transfer within the photosystem II reaction centre. A number of studies have 
reported algal chloroplast transformation using herbicides as a selection system, including 
gluofosinate (Cui et al. 2014), diuron (Przibilla et al. 1991; Newman et al. 1992) and 
sulfometuron methyl (Grundman et al. 2012; Lapidot et al. 2002). Atrazine was chosen as a 
potential selection system in our investigation given the established molecular basis of 
resistance through changes to the D1 protein of photosystem II encoded by psbA. There is a 
possibility to use a marker gene encoding for an enzyme that inactivates atrazine such as 
atrazine chlorohydrolase gene (AtzA), however the focus in this study was principally on 
developing psbA as an endogenous marker to overcome issues related to foreign gene 
expression in the Nannochloropsis chloroplast.  
Initially a forward genetics approach was taken. Unfortunately, the isolated atrazine-
tolerant mutant strains from FdUrd-UV mutagenesis did not show any changes in psbA so it 
was not possible to identify psbA allele/s that could be used as a selectable marker. Such 
atrazine tolerant phenotypes in the absence of changes in psbA suggest that other mutations 
have occurred at unknown loci. It is likely these strains have developed a way to overcome 
atrazine either by reducing the permeability of the cells or by direct efflux of atrazine, as is 
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often the case with bacterial resistance to antibiotics (Llarrull et al. 2010). The unsuccessful 
attempts in forward genetics approach led us to rely on a reverse genetics approach in 
which an atrazine tolerant psbA allele is designed and tested. In this approach, the study of 
the sequence homology of the Nannochloropsis D1 sequence with other related species 
aided the identification of a key residue at position 264 in the algal D1 that was likely to 
give the desired phenotype – atrazine tolerance – when changed from serine to alanine 
residue. This point mutation i.e. psbA:264A was chosen as a selectable marker, presuming 
to confer the tolerance to atrazine.  Therefore, a plasmid carrying this point mutation (pUH-
psbA264A) was created and used to investigate the possibility of developing a chloroplast 
transformation method by substituting the wild type psbA in the chloroplast genome with 
the atrazine tolerant allele.  
In an attempt to increase the cell size, a microtubule inhibitor nocodazole was used to arrest 
N. gaditana cells at G2/M phase prior to biolistic transformation without killing the cells. 
Although it was not possible to validate the degree of synchronisation of nocodazole-
treated cell using flow cytometry, the microtubule inhibitor nocodazole demonstrated its 
usefulness in producing larger cells. For this reason, the feasibility of using biolistics on 
nocodazole-treated N. gaditana cells was tested with nuclear transformation vector, pQYZ1. 
The employed conditions were based on testing high velocities using the smallest gold 
particle available ~ 0.55 μm in the hope of increasing the chances of particle penetration 
into the plastid in subsequent chloroplast transformation attempts. Employing these 
conditions in nocodazole-treated cells successfully generated nuclear transformants. As a 
proof of concept, this nocodazole-mediated biolistic transformation approach 
demonstrated its success in delivering exogenous DNA into the nuclear genome. To-date, 
these conditions have not been reported for Nannochloropsis, In fact, all the studies report 
the use of electroporation as a method of choice for nuclear transformation with the 
exception of Kang et al. (2015). This study reported the success in generating the nuclear 
transformants using the biolistics but the DNA-coated particles were accelerated at low 
velocity using ~ 500 psi rupture pressure.  
Nonetheless, there are some key issues to be addressed before considering this approach 
as a tool for metabolic engineering purposes in microalgae. The chemical treatment prior 
to transformation might have a mutagenic effect on the cells in spite of the reported minimal 
effects of nocodazole treatment on cells by Zieve et al. (1980). This is possibly seen in our 
chloroplast transformation attempts in which false positive colonies appeared, despite the 
absence of spontaneous mutation to atrazine when plating high densities of cells on the 
herbicide. The occurrence of these mutants is most likely due to the mutagenicity of the 
transformation process, either where the cells were treated with nocodazole or bombarded 
with gold particles. Most of isolated colonies showed no changes in psbA sequence. 
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However, two out of nine psbA mutants from transformation attempts showed a change at 
codon position 264 to that encoding asparagine. This raises the question as to whether a 
serine to alanine change, as designed in pUH-psbA264A would confer resistance in 
Nannochloropsis and suggests that a serine to asparagine change could be used for 
successful transformation. In addition, the photosynthetic capacity of the mutants could be 
further characterized to gain some insight into photosystem II function in Nannochloropsis. 
Similar mutagenesis results were reported by Materna et al. (2009) in which the ultimate 
aim of the study was to establish stable plastid transformation in P. tricornutum by mutating 
the wild type psbA gene with a modified psbA allele at codon 264. Their attempts in 
developing plastid transformation were unsuccessful but instead a number of distinct 
mutants in psbA were isolated and characterized.  
4.4. Conclusion and future works 
Biolistic transformation for a wide range of algal chloroplasts involves bombarding the cells 
with DNA-coated particles at different velocities depending on cell size and structure of the 
organism that is being transformed, (see Table 4.5). The direct use of biolistics is not 
possible for N. gaditana mainly due to the small cell size and therefore an additional step 
was tested prior to biolistic transformation. The additional step relies on increasing the cell 
size by treatment with the reversible microtubule inhibitor nocodazole. This 
transformation approach proved a successful strategy for nuclear transformation of N. 
gaditana. Successful nuclear transformation demonstrated that using high pressure did not 
kill all the cells, and this is relevant since high pressure may be necessary to penetrate the 
multiple chloroplast membranes despite the unsuccessful attempts in generating 
chloroplast transformants using pUH-psbA264A. Further studies are required to isolate and 
characterize atrazine tolerant mutants, which will help to provide more information about 
psbA alleles and their potential use as selectable markers. Similarly, a codon optimized atzA 
gene that confers tolerance to atrazine could be used.  
The process of herbicide selection requires a long time to validate the employed conditions, 
especially with slow growing microalgae. In addition, the cells are prone to spontaneous 
mutations. The use of a reporter gene coupled with fluorescence-activated cell sorting 
(FACS) would facilitate testing various conditions for chloroplast transformation within a 
reasonably short period of time.  There are a number of reporter genes that have developed 
for the nucleus of Nannochloropsis and might be useful for such high throughput screening 
for chloroplast transformants. These reporter genes include purple chromoprotein gene, β-
glucuronidase gene, green fluorescent protein gene and the gene encoding sfCherry 
fluorescent protein (Shih et al. 2015; F. Li et al. 2014; Kang et al. 2015a; Moog et al. 2015).  
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Use of such reporters would be particularly useful for Nannochloropsis given the limited 
number of selection systems available due to its high resistance to a wide range of tested 
compounds that target aspects of chloroplast biology, as demonstrated clearly in both 
chapter 3 (section 3.2.2) and chapter 4 (section 4.2.1).  
Alternative natural approaches could also be considered to increase the cell size of 
Nannochloropsis. One example is studying the effect of the spectral light conditions on N. 
gaditana and examining the possibility of increasing the cell size. For example, cell cycles 
studies of Chlamydomonas demonstrated that blue light has an inhibitory effect on the 
initiation of cell division resulting in cells growing for longer period associated with an 
increased in the cell size (Oldenhof et al. 2006; Oldenhof et al. 2004). The chloroplast 
transformation in microalgae relies on direct transfer of the gene into the chloroplast 
genome where the transgene integration proceeds through homologous recombination. 
Nonetheless, given the current lack of chloroplast transformation methodology for 
Nannochloropsis, nuclear transformation with genes encoding chloroplast-targeting 
proteins might offer an alternative approach for now. Such indirect chloroplast 
transformation might give some insights into industrially relevant pathways that take place 
in the chloroplast and the gained insights may also help to develop a chloroplast 
transformation method. There are a number of studies reporting success in targeting the 
protein into the chloroplast mediated by endogenous N-terminal transit peptides, thus 
encouraging further studies in this direction (Gruber et al. 2007; Moog et al. 2015; Sunaga 
et al. 2014).  
Table 4.5 Reports of chloroplast transformation in microalgae using biolistics.  
Algal species Transformation conditions 
Rupture disk      Reported distance 
(psi)                        (cm) 
Selection References 
Haematococcus 
pluvialis 
1,350 psi 7 Spectinomycin Gutiérrez et al. 2012 
Chlamydomonas 
reinhardtii 
1,100 psi 6 Photoautotrophy Randolph-Anderson et al. 
1995 
Dunaliella 
tertiolecta 
300 psi 4 Erythromycin Georgianna et al. 2013  
Platymonas  
subcordiformis 
900 psi 
 
6  Basta Cui et al. 2014 
Porphyridium sp. 1,350 psi 9 Sulfometuron 
methyl  
Lapidot et al. 2002 
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CHAPTER 5 
Metabolic engineering of the C. reinhardtii chloroplast 
as a platform for high value terpenoid production 
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5. Metabolic engineering of the C. reinhardtii chloroplast as a 
platform for high value terpenoid production 
5.1. Introduction 
As discussed in Chapter 1, terpenoids are a diverse class of naturally occurring compounds 
consisting of more than 50,000 structurally different molecules, and are found in all living 
organisms (Pateraki et al. 2015). Many terpenoid compounds in particular those isolated 
from plants are of high value to humans in various aspects such as medicine, agriculture 
and cosmetics. However, these high value terpenoids are produced in relatively small 
quantities in their natural hosts and their chemical synthesis for large scale production is 
indeed costly and complicated (Putignani et al. 2013). Therefore, there is much focus on 
producing these compounds in biological hosts using metabolic engineering technologies 
that have been advanced greatly in the past few decades (Misawa 2011). A number of 
biological systems have been exploited for the commercial production of terpenoids 
including classical microbial systems and plant cells (Roberts 2007; Putignani et al. 2013). 
Currently exploited systems have shown some success in producing terpenoids with 
pharmaceutical applications such as artemisinin, paclitaxel and vincristine (Roberts 2007; 
Ikram et al. 2015).  
In spite of the significant progress that has been made in elucidating, transferring and 
reconstituting terpenoid biosynthetic pathways in microbial systems and plant cells, there 
is still a considerable work to be done before terpenoid production becomes economically 
viable. Moreover, there is a need for alternative biosynthetic production hosts to overcome 
the encountered challenges with heterologous production of some terpenoids in the 
existing systems. The exploitation of microalgae as heterologous systems for production of 
high value terpenoids seems an attractive alternative owing to their inherently desirable 
characteristics, in which they combine the high growth rate and ease of cultivation of 
microorganisms with the ability to perform post-transcriptional and post-translational 
modification of plants. The unicellular green alga C. reinhardtii is of particular interest as 
the most well studied model alga with well-established molecular tools for genetic 
manipulation (Franklin & Mayfield 2004; Purton 2007). However, the direct manipulation 
of terpenoid biosynthetic pathways in C. reinhardtii necessitates a thorough understanding 
of the basic terpenoid metabolism. Therefore, the focus of this research is to gain a better 
understanding of the methylerythritol phosphate pathway that leads to terpenoid 
biosynthesis in C. reinhardtii by investigating the effect of overexpressing dxs on plastidic 
downstream terpenoids, and also determining if this step is one of the rate limiting steps in 
the MEP pathway of C. reinhardtii.  
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5.1.1. Terpenoid biosynthetic production platforms 
In plants, both MEP and MVA pathways are responsible for biosynthesis of secondary 
metabolic terpenoids of industrial interest as pharmaceuticals, agricultural chemicals, 
flavour and fragrance additives (Bohlmann & Keeling 2008). Examples of pharmaceutical 
use of these terpenoids are the anti-malarial artemisinin (sesquiterpenoid) from Artemisia 
annua and the anti-cancer paclitaxel (diterpenoid) from Taxus brevifolia (Li et al. 2015; Liu 
et al. 2006). Although some terpenoids are produced in relatively large quantities from 
natural sources such as essential oils and waxes, other terpenoids with high impact on 
human health, also called high value terpenoids, are found in low abundance in nature – 
normally less than 2-3% of total dry weight (Roberts 2007). The extraction efficiency of 
these high value terpenoids from plant tissue is variable depending on plant source, location 
and season of harvest, which is normally associated with high extraction costs and low yield 
recovery (Maury et al. 2005). This can be exemplified with paclitaxel (or Taxol®): 
approximately 3 kg of yew tree bark is required to provide 300 mg of paclitaxel, which is 
approximately a single dose. This is an inefficient production method, considering the 
destructive nature of the extraction process to the mature yew trees that required 200 years 
to develop fully (Horwitz 1994). Since the production of terpenoids for human consumption 
needs large amounts of plant tissue, researchers have developed alternative methods of 
chemical synthesis (Mukaiyama et al. 1999; Danishefsky et al. 1996). Chemical synthesis 
has been used successfully to produce some monoterpenes and carotenoids (Ernst 2002). 
As a matter of fact, the most industrially relevant carotenoids currently available in the 
market are chemically synthesised though they are also available to a small extent as 
natural products (Sandmann 2015). Nevertheless, the complexity and chirality of the 
majority of these compounds have generally prevented the development of cost effective 
chemical synthesis methods (Putignani et al. 2013; Lange & Ahkami 2013).  
Since all living organisms contain the metabolic precursors needed for terpenoid 
production, the heterologous expression of terpene synthase in microbial hosts may offer 
sustainable platforms for terpenoid production (Lange et al. 2000). The most popular 
heterologous hosts used for industrially relevant terpenoids are E. coli and S. cerevisiae. 
These organisms in particular are genetically tractable with well-established molecular 
tools and can be cultured at large scales and high density with the current developed 
fermentation infrastructure (Kirby & Keasling 2009; Kirby et al. 2015; Gruchattka & Kayser 
2015). There has been some success in exploiting these heterologous expression systems 
for terpenoid supply, where a modified E. coli strain has been used to produce an 
artemisinin precursor called amorphadiene (Tsuruta et al. 2009). The further production 
of complex terpenoids has been extended to yeast due to the difficulty of expressing plant 
cytochromes P450 hydroxylases in E. coli, which are often required to further modify the 
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carbon skeleton of complex terpenoid metabolites (Putignani et al. 2013), as illustrated in 
Figure 5.1. As such, the yeast cells can assist in the hydroxylation reactions by natively 
providing the required P450 reductase, as demonstrated by the successful biosynthesis of 
a second paclitaxel pathway intermediate in a yeast system, which needs the activity of a 
P450 enzyme (Engels et al. 2008). However, in some cases, there is a need to express a plant 
cytochrome hydroxylase and its redox partner in the yeast system to enable the production 
of the desired terpenoid or terpenoid precursors, which is feasible only if one plant 
cytochrome P450 is involved. An example is the successful creation of a S. cerevisiae strain 
that is capable of producing high levels of the anti-malarial precursor artemisinic acid by 
expressing genes for artemisinic acid biosynthesis along with genes for the corresponding 
plant cytochrome P450 and its redox partner (Ro et al. 2006). This study reported titres of 
artemisinic acid that exceeded the expression level in A. annua, a natural producer of 
artemisinin. In spite of the success in heterologous expression of terpene biosynthetic genes 
in the established microbial systems, some plant terpenoid metabolic pathways are either 
too complex or still unknown thereby making the use of microbial systems difficult in these 
cases. Furthermore, the production of complex terpenoids requires a number of 
cytochrome P450 enzymes to confer bioactivity, and the expression of redox partners for 
these P450 enzymes is considered a key challenge in microbial systems, limiting the 
progress of terpenoid production (Kirby & Keasling 2009; Putignani et al. 2013). 
 
Figure 5.1 Schematic representation of engineering the biosynthetic pathway of artemisinin 
from A. annua. 
A semi-synthetic route to produce artemisinin by devising strains that are capable of high flux to 
artemisinin precursors through metabolic engineering. The process starts with metabolic 
engineering of the relevant terpenoid biosynthetic pathway in microbial hosts to produce 
artemisinin precursors. The metabolic engineering of E. coli was successful to accumulate 
amorphadiene but not artemisinic acid due to the difficulty of expressing cytochrome P450, whereas 
the engineered yeast was successful to accumulate artemisinic acid that can be easily processed to 
the artemisinin by chemical synthesis in a cost effective process for large scale production. 
Abbreviations are ADS; amorphadiene synthase, CPR: cytochrome P540 reductase, CYP71AV1; 
cytochrome P450 monooxygenase. Multiple arrows indicate the steps carried out by chemical 
synthesis. The diagram was taken  from Bohlmann & Keeling (2008). 
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In such circumstances, the production of complex terpenoids in plant cells by metabolic 
engineering of terpenoid biosynthetic pathways is a more viable option compared to the 
microbial systems, as plants already contain native P450-related biosynthetic pathways 
involved in decorating the carbon skeleton of complex terpenoid metabolites (Kolewe et al. 
2008). Additionally, the lack of complete knowledge of many terpenoid biosynthetic 
pathways prohibits the transfer of these biosynthetic pathways into the microbial hosts 
(Markus Lange & Ahkami 2013). Therefore, efforts have focused on producing these 
compounds in undifferentiated plant cell suspension cultures to drive heterologous 
terpenoid production. The production of many terpenoid and terpenoid-derived 
compounds in plant cell culture suspension has been investigated especially for high value 
pharmaceuticals such as artemisinin from A. annua (Liu et al. 2006), taxanes from Taxus 
spp. (Frense 2007; Li et al. 2015) and the terpenoid indole alkaloids from Catharanthus 
roseus (Pasquali et al. 2006). In parallel, a number of cell based culture processes have been 
developed using plant suspension cultures to make terpenoid production economically 
viable (Fett-Neto et al. 1994; Xu et al. 1998; Kwon et al. 1998). The most successful example 
of plant cell culture technology is the commercial production of paclitaxel as a powerful 
diterpenoid anti-cancer drug using Taxus spp. cell suspension culture to supply the 
precursor that can be readily converted chemically into paclitaxel by a cost effective process 
(Zhong 2002), and more examples are summarised Table 5.1. The progress in exploiting 
plant cell culture technologies for more terpenoids with industrial applications is limited 
due to the fact that undifferentiated cultures normally accumulate less terpenoid 
metabolites compared to specialised tissues, and in most cases not at all (Kolewe et al. 
2008). As for now, the key challenges to the commercial production of terpenoids using 
plant cell culture technology are low and variable yields of metabolite accumulation (Beum 
et al. 2004). This has been encountered in the use of Taxus spp. cell cultures for the 
commercial supply of paclitaxel, where a ten-fold difference in the accumulated levels of 
paclitaxel has been observed within the cell lines over time (Ketchum & Gibson 1996).  
Table 5.1 Summary of suspension plant cell culture based pharmaceuticals. 
The table is adapted from Eibl & Eibl (2002). 
Terpenoid species Application  Manufacturer 
Scopolamine Duboisia spp. Anticholinergic Sumitomo Chemical Industries 
(Japan) 
Protoberberines Coptis japonica 
Thalictrum minus 
Antibiotic,  
anti-inflammatory 
Mitsui Petrochemical Industries 
(Japan) 
Rosmarinic acid Coleus blumei Anti-inflammatory Nattermann (Germany) 
Shikonin Lithospermum 
erythrorhizon  
Anti-HIV, antitumor 
anti-inflammatory 
Mitsui Petrochemical Industries 
(Japan) 
Geraniol Geramineae spp. 
 
Anti-tumour Mitsui Petrochemical Industries 
(Japan) 
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With such interest in the use of terpenoids in a variety of industrial and therapeutic 
applications, eukaryotic microalgae may offer an attractive alternative to suspension cell 
culture (Lohr et al. 2012). There are a number of microalgae capable of accumulating 
industrially relevant carotenoids under adverse environmental conditions, which can be 
exemplified by β-carotene in Dunaliella salina and astaxanthin in Haematococcus pluvialis 
(Lohr et al. 2012; Eonseon et al. 2006; Ramos et al. 2011).  In addition, microalgae have the 
ability to achieve high cell densities thereby enabling the production of more compound per 
unit of land area (Georgianna & Mayfield 2012). A large scale cultivation of several algal 
species has already proven the possibility of producing high value terpenoids such as 
carotenoids (Gómez et al. 2013). The natural capacity of terpenoid production in these algal 
species can be improved by using genetic engineering strategies. However, the metabolic 
engineering of these microalgae is notoriously difficult due to the limited availability of 
molecular tools. Furthermore, too little is known about their biosynthetic pathways. From 
a biotechnological standpoint, C. reinhardtii is the most developed algal species with well-
established transformation methods and molecular tools (Franklin & Mayfield 2004; Purton 
2007). Therefore, a number of metabolic engineering efforts have been attempted in this 
alga, as summarised in Table 5.2. Most of these attempts focused on proof of concept 
experiments using simple molecular tools to demonstrate transgene expression and 
confirm the functionality of heterologous proteins within the cells (Vila et al. 2008; Couso 
et al. 2011; León et al. 2007). In addition, the fundamental concepts of these attempts for 
metabolic engineering of terpenoids in the algae are largely based around strategies that 
were developed for higher plants. Although there is still much to be done before 
exploitation of microalgae for biotechnological applications, a recent study reported by 
Lauersen et al. (2016) demonstrated the potential of C. reinhardtii as a chassis for 
sesquiterpenoid production, encouraging more research in this direction.  
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Table 5.2 Reports on terpenoid metabolic engineering in C. reinhardtii. 
* Mutant version of endogenous phytoene desaturase in which a leucine residue in codon position 505 is substituted with a phenylalanine to confer tolerance to the herbicide norflurazon. 
** The endogenous phytoene desaturase was post-transcriptionally silenced by antisense RNA.  
 
 
Metabolic engineering 
approach 
Target 
genome 
Transgene /Target gene 
(Source) 
Notes Reference 
Upregulation   Nuclear  Phytoene desaturase*  
(Chlamydomonas 
reinhardtii)   
A significant increase in carotenoid content in some 
transformants 
(Liu et al. 2013) 
Redirect metabolic flux towards 
non-native ketocarotenoid  
Nuclear β -carotene ketolase  
(Haematococcus pluvialis) 
Detection of relatively small amount of novel 
ketolutein  
(León et al. 2007) 
Upregulation   Nuclear Phytoene synthase  
(Dunaliella salina) 
A significant increase in carotenoid content ranging 
from 120% - 260%  
(Couso et al. 2011) 
Downregulation  Nuclear Phytoene desaturase ** Minimal change on the carotenoid profile  (Vila et al. 2008) 
Upregulation  Nuclear  Phytoene synthase  
(Chlorella zofingiensis) 
A significant increase in carotenoid content ranging 
from 200% - 220% 
(Cordero et al. 2011) 
Redirect metabolic flux towards 
non-native astaxanthin 
Chloroplast β-carotene hydroxylase 
(Haematococcus pluvialis) 
A significant increase in carotenoid synthesis, in 
particular xanthophylls under high light conditions 
(Tan et al. 2007) 
Redirect metabolic flux to produce 
non-native cis-abienol 4 
Chloroplast cis-abienol synthase  
(Abies balsamea) 
Absence of cis-abienol 4 traces (Zedler et al. 2014) 
Redirect metabolic flux to produce 
non-native patchoulol  
Nuclear  Patchoulol synthase  
(Pogostemon cablin) 
Successful production of patchoulol up to 922 g/g 
cell dry weight 
(Lauersen et al. 2016) 
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5.1.2. Aims and objectives 
The overall aim of this chapter is to genetically modify the MEP pathway in the C. reinhardtii 
chloroplast by overexpressing a heterologous dxs gene, and to investigate if the DXS enzyme 
is able to catalyses this key rate limiting step in the MEP pathway.  
Specifically, the aims of the work in this chapter are:  
1. Engineer C. reinhardtii lines carrying an additional copy of the dxs gene from the 
cyanobacterium Synechocystis 6803. 
2. Investigate the possible toxicity of dxs by mutating the gene and then introducing 
the mutated dxs copy into the chloroplast genome. 
3. Study the effect of over-expressing dxs on C. reinhardtii growth. 
4. Test the possibility of measuring DXS enzyme activity in vitro using fluorometry. 
5. Analyse the terpenoid profile of the genetically engineered C. reinhardtii compared 
to a control strain, and identify if over-expression of dxs results in enhanced 
accumulation levels of plastidic terpenoids. 
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5.2. Results 
5.2.1. Chloroplast transformation of C. reinhardtii with plasmid pRY134a  
DXS catalyses the first biosynthetic step of the chloroplast localised MEP pathway and has 
been reported to be a rate limiting step for the production of the terpenoid precursor IPP 
in bacteria and plants (Khemvong & Suvachittanont 2005; Gong et al. 2006; Estévez et al. 
2001; Heider et al. 2014). To investigate the effect of overexpressing this enzyme on 
downstream terpenoid metabolites in C. reinhardtii, a construct (pRY134a) containing the 
dxs gene from Synechocystis 6803 under the control of the C. reinhardtii psaA exon 1 
promoter was constructed by Dr Rosie Young in the Purton group (Figure 5.2A). This gene 
from Synechocystis 6803 is more suitable for heterologous expression in the chloroplast 
rather than the nuclear-encoded native copy from C. reinhardtii because of its codon bias 
and GC content since the nuclear genome of C. reinhardtii has a high GC content of 64% 
compared to the chloroplast genome value of 34% (Grossman et al. 2003). 
The initial investigation in the Purton group highlighted the difficulty of generating 
chloroplast transformants of dxs, suggesting that the introduction of an extra copy of dxs 
gene into the chloroplast genome might have a deleterious effect on the C. reinhardtii cells, 
as the high levels of prenyl phosphate precursors (DMAPP/IPP/FPP) was reported to be 
toxic in E. coli cells (Sivy et al. 2011; Martin et al. 2003). To investigate such a possibility, 
the pRY134a construct was modified so that dxs in pRY134a was mutated by deleting 114 
bp of the coding sequence. The deletion was performed by digesting the pRY134a with NcoI 
at two sites to drop out the 141 bp region, and then re-ligating the plasmid. The resulting 
plasmid, called pRY134aΔdxs, was initially checked by test digestion resulting in the 
expected fragment sizes, 4599 bp and 3488 bp (Figure 5.2B). DNA sequencing confirmed 
the successful deletion of 114 bp in the gene (Figure 5.2C). 
The pRY134a and pRY134aΔdxs were then used to transform C. reinhardtii TN72 (a non-
photosynthetic psbH mutant) by agitating the cells with glass beads in the presence of the 
DNA, as detailed in section 2.7.2. The expression cassette in both constructs was flanked by 
homologous sequence that contains an intact copy of psbH, so homologous recombination 
into the chloroplast genome results in restoration of functional psbH and integration of the 
transgene, and subsequently allows the selection of restored photosynthetic transformants 
on minimal medium in the light (Figure 5.3). In total, six putative chloroplast transformants 
appeared after four weeks of incubation. Four of these colonies (named L13, L3, L4 and L5) 
were obtained from pRY134a and the rest (named dL1 and dL2) were obtained from 
pRY134aΔdxs. These colonies were picked and then re-streaked for a further three rounds 
                                                             
3 The C. reinhardtii line L1 was kindly given by Dr Rosie Young 
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of phototrophic selection on minimal medium to ensure the homoplasmic state of the 
chloroplast genome since C. reinhardtii has approximately 80 copies per cell. The 
integration of the transgene and homoplasmy of the genome in all transgenic lines were 
then examined by PCR using a specific set of three primers, as illustrated in Figure 5.4. The 
successful transgene integration in all transgenic lines was confirmed by the presence of a 
1134 bp band, while the homoplasmic state was indicated by the absence of the 880 bp band 
that arises from the untransformed copies of the parental plastome. A control strain (H1) 
was included from previous studies and this strain was created by transforming the TN72 
strain with the corresponding vector but without carrying a transgene, referred as an empty 
pSRSapI vector (Young & Purton 2014). This strain will be used as a control in subsequent 
experiments throughout the investigation. 
 
 
Figure 5.2 Analysis of partial deletion of dxs in pRY134aΔdxs plasmid. 
A) The schematic representation of pRY134a, a cloning vector for introducing a cyanobacterial dxs 
into the Chlamydomonas chloroplast genome under the control of the psaA exon 1 promoter and the 
rbcL 3’UTR. The coding sequence of a nine reside haemagglutinin epitope (HA tag) was added to C- 
terminal of the dxs gene before the stop codon so that the Dxs protein could be detected using anti-
HA antibody. The HA tag is indicated by an asterisk. The region to be deleted of dxs coding sequences 
is between NcoI restriction sites, as shown in the physical map with their locations. The flanking 
regions required for homologous recombination within the chloroplast genome is indicated as LHRR 
and RHRR, and the intact psbH acts as a selectable marker. The rest of the pRY134a plasmid is 
depicted as a dashed black line. TrnE2 is abbreviated as E2. B) Test digestion showing the successful 
deletion of 114 bp in dxs gene resulting in fragments of the expected sizes, 4599 bp and 3488 bp, as 
indicated by red box. The lanes 1, 2, 3, and 4 represents different colonies tested for digestion C) 
Sanger sequencing chromatograph confirms the deletion of 114 bp in dxs for the clone number 2 
using designated primers. The dashed lines indicate the deletion site within the coding sequence of 
dxs. 
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Figure 5.3 Schematic representation for chloroplast transformation strategy to generate 
marker-less transformants using the TN72 recipient. 
Chloroplast transformation plasmid consists of the gene of interest (GOI) under the control of the 
psaA promoter/5’UTR and the rbcL 3’UTR. The expression cassette is flanked by homologous 
sequence that contains wild type psbH. The homologous recombination takes place between 
homologous sequence shared between the plasmid and TN72 plastome, resulting in restoration of 
psbH, loss of aadA and the integration of the GOI into the plastome. Thus, the resulting transformants 
restore their photoautotrophic growth on acetate-free medium but they are sensitive to 
spectinomycin (SpcS). Homologous recombination is represented by X–X. The diagram is reproduced 
from Stoffels (2014). 
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Figure 5.4 Three primer PCR to confirm transgene integration and homoplasmy of 
transformants. 
Left panel: schematic representation of PCR based method to confirm the integration of GOI and 
homoplasmy of transformants. PCR was performed using three primers in one reaction (F1, R1 and 
R2). The first primer pair (F1 and R1) amplifies part of the recipient line TN72 plastome, resulting in 
an 850 bp band, whereas the second primer pair (F1 and R2) amplifies part of the transformant 
plastome, resulting in a 1135 bp band. The successful integration of the gene of interest is indicated 
by the presence of a 1135 bp band and the homoplasmy is indicated by the absence of the 850 bp 
band that normally arises from the untransformed copies of the TN72 plastome. The C. reinhardtii 
lines are TN72 recipient strain, L strains contain the dxs gene, dL strains contain the mutant dxs gene 
and H1 strain is an empty-vector as a positive control. TF is an abbreviation of transformant. Right 
panel: PCR confirming homoplasmic integration of the transgene into the C. reinhardtii chloroplast 
genome. 
 
5.2.2. Analysis of the DXS protein in the C. reinhardtii chloroplast 
Western blot analysis was performed to check for the accumulation of the DXS protein in all 
transgenic lines including L1 and L3–L5 for intact DXS protein, dL1-dL2 for mutant DXS 
protein and H1 as a control. The accumulation of the DXS protein (~ 70.4 kDa) in the L 
strains was demonstrated clearly by immunoblotting with an anti-HA antibody as shown in 
Figure 5.5. Surprisingly, there is variation in the expression level of the DXS protein in L 
lines in which the transgenic lines L4 and L5 showed a high expression level of the protein 
compared to L1 and L3 lines. These transgenic lines would normally be expected to have 
similar expression levels, since the transgene was targeted into the chloroplast genome by 
homologous recombination into a specific locus so they should be genetically identical. This 
result was further investigated by sequencing the expression cassette of dxs amplified from 
the plastome by PCR, to identify any mutation that might cause the difference in expression 
level of the protein in the C. reinhardtii lines. However, the DNA of the target region from 
the plastome of the transgenic lines had the expected nucleotide sequence (data not shown). 
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The variation in the expression levels is presumably due to mutations outside of the dxs 
region.  In the dL cell lines, the accumulation of the mutant DXS protein was not detected at 
65 kDa though the deletion does not cause any frameshift as shown in Figure 5.6. 
Nonetheless, such a deletion might result in conformational changes of the protein structure 
thereby affecting the protein stability and making the protein more vulnerable to 
degradation.  
 
Figure 5.5 Expression of the dxs gene in the C. reinhardtii lines is demonstrated by Western 
blot analysis with anti-HA antibody. 
Western blot analysis of equalised lysate for L strains containing an intact dxs gene, dL strains 
containing a mutant dxs gene and H1 strain as a negative control (i.e. TN72 transformed with an 
empty vector). Western analysis with anti-HA antibody shows different expression levels of the dxs 
gene in cell lines (L) that is clearly illustrated by a strong band running at an apparent mass of 70.4 
kDa in cell lines L4 and L5 but not in L1 and L3. The H1 line does not show any accumulation of the 
DXS protein, as expected. The immunoblot was visualised by ECL with one-minute exposure (top 
panel) and Odyssey® Infrared Imaging System (bottom panel). Protein size was determined using 
the PageRulerTM Prestained Protein ladder (Thermo Scientific). 
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DXS     1 MHISELTHPNELKGLSIRELEEVSRQIREKHLQTVATSGGHLGPGLGVVELTVALYSTLD  60 
mDXS    1 MHISELTHPNELKGLSIRELEEVSRQIREKHLQTVATSGGHLGPGLGVVELTVALYSTLD  60 
          ************************************************************ 
DXS    61 LDKDRVIWDVGHQAYPHKMLTGRYHDFHTLRQKDGVAGYLKRSESRFDHFGAGHASTSIS 120 
mDXS   61 LDKDRVIWDVGHQAYPHKMLTGRYHDFHTLRQKDGVAGYLKRSESRFDHFGAGHASTSIS 120 
          ************************************************************ 
DXS   121 AGLGMALARDAKGEDFKVVSIIGDGALTGGMALEAINHAGHLPHTRLMVILNDNEMSISP 180 
mDXS  121 AGLGMALARDAKGEDFKVVSIIGDGALTGGMALEAINHAGHLPHTRLMVILNDNEMSISP 180 
          ************************************************************         
DXS   181 NVGAISRYLNKVRLSSPMQFLTDNLEEQIKHLPFVGDSLTPEMERVKEGMKRLVVPKVGA 240 
mDXS  181 NVGAISRYLNKVRLSSPMQFLTDNLEEQIKHLPFVGDSLTPEMERVKEGMKRLVVPKVGA 240 
          ************************************************************ 
DXS   241 VIEELGFKYFGPIDGHSLQELIDTFKQAEKVPGPVFVHVSTTKGKGYDLAEKDQVGYHAQ 300 
mDXS  241 VIEELGFKYFGPIDGHSLQELIDTFKQAEKVPGPVFVHVSTTKGKGYDLAEKDQVGYHAQ 300 
          ************************************************************ 
DXS   301 SPFNLSTGKAYPSSKPKPPSYSKVFAHTLTTLAKENPNIVGITAAMATGTGLDKLQAKLP 360 
mDXS  301 SPFNLSTGKAYPSSKPKPPSYSKVFAHTLTTLAKENPNIVGITAAMATGTGLDKLQAKLP 360 
          ************************************************************ 
DXS   361 KQYVDVGIAEQHAVTLAAGMACEGIRPVVAIYSTFLQRGYDQIIHDVCIQKLPVFFCLDR 420 
mDXS  361 KQYVDVGIAEQHAVTLAAGMACEGIRPVVAIYSTFLQRGYDQIIHDVCIQKLPVFFCLDR 420    
          ************************************************************ 
DXS   421 AGIVGADGPTHQGMYDIAYLRCIPNLVLMAPKDEAELQQMLVTGVNYTGGAIAMRYPRGN 480 
mDXS  421 AGIVGADGPTHQGMYDIAYLRCIPNLVLMAPKDEAELQQMLVTGVNYTGGAIAMRYPRGN 480 
          ************************************************************ 
DXS   481 GIGVPLMEEGWEPLEIGKAEILRSGDDVLLLGYGSMVYPALQTAELLHEHGIEATVVNAR 540 
mDXS  481 GIGVPLMEEGWEPLEIGKAEILRSGDDVLLLGYGS------------------------- 514 
          ********************************** 
DXS   541 FVKPLDTELILPLAERIGKVVTMEEGCLMGGFGSAVAEALMDNNVLVPLKRLGVPDILVD 600 
mDXS  515 ----------------------MEEGCLMGGFGSAVAEALMDNNVLVPLKRLGVPDILVD 553 
                                ************************************** 
DXS   601 HATPEQSTVDLGLTPAQMAQNIMASLFKTETESVVAPGVS 640 
mDXS  554 HATPEQSTVDLGLTPAQMAQNIMASLFKTETESVVAPGVS 593 
          ****************************************          
 
Figure 5.6 Sequence alignment of the DXS and mDXS proteins. 
Sequence of the DXS protein highlighting the amino acids that were deleted to create the mutant DXS 
protein, abbreviated as mDXS. The deleted amino acid sequence is highlighted in yellow. The 
sequence of the protein from Synechocystis sp. PCC 6803 was retrieved from the NCBI database 
(sequence identifier: WP-010871718). 
 
5.2.3. Studying the effect of overexpressing dxs on C. reinhardtii growth 
After confirming the accumulation of DXS protein in the L strains, the next step was to 
investigate the effect of overexpressing dxs on transgenic lines. The growth of the transgenic 
and control cell lines was therefore compared using the Algem® system. A representative 
from each group was taken, such as L4 representing transgenic lines that showed high 
expression level, L3 representing transgenic lines that showed low expression level, and 
dL1 representing transgenic lines containing non-functional dxs. The growth of these 
representative transgenic lines was compared to a control line H1 that contains was 
transformed with the empty vector to assure the same genetic background. As illustrated in 
Figure 5.7, the growth of transgenic lines L4 and L3 was not retarded compared to both the 
H1 and dL lines, suggesting that the presence of a cyanobacterial DXS protein in addition to 
the native one does not have a deleterious effect. In fact, all transgenic lines grew normally 
and the liquid culture of these lines looked healthy. To confirm the obtained result, the 
experiment was repeated by growing all transgenic lines (L) in comparison with the control 
H1 strain, as shown Figure 5.8. Clearly the transgenic lines show a normal and healthy 
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growth pattern. An interesting trend was observed in which the overexpression of dxs gene 
seemed to enhance the growth rate of the transgenic lines in particular in L4 and L5. 
However, such assumption is too early to state, as there is a need for more analysis. In 
general, the introduction of dxs gene into chloroplast genome did not lead to a reduction of 
the overall fitness and robustness of the transgenic strain compared to the control strain, 
so excluding any negative impact of overexpressing the dxs gene in the C. reinhardtii cells.  
 
Figure 5.7 The effect of expressing dxs gene from Synechocystis PCC 6803 on C. reinhardtii 
growth. 
The growth curves of C. reinhardtii cell lines show similar growth rates compared to the control line 
H1. All cultures were grown in TAP (acetate containing) medium using the Algem® system and the 
optical density was measured at 740 nm. The growth conditions were 25 °C, 200 µE light, and 
continuous shaking at 120 rpm 
 
Figure 5.8 Growth curves of C. reinhardtii cell lines with and without the dxs gene from 
Synechocystis 6803. 
All cultures were grown in TAP (acetate containing) medium using the Algem® system and the 
optical density was measured at 740 nm. The growth conditions were 25 °C, 200 µE light, and 
continuous shaking at 120 rpm. Error bars represents ± standard deviation of triplicate cultures. 
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5.2.4. A fluorometric analysis to assess the DXS enzyme activity 
A number of methods have been reported for determination of DXS enzyme activity such as 
fluorimetry and high-performance liquid chromatography (HPLC) (Querol et al. 2001; Han 
et al. 2003). A fluorometric assay was used in this study to assess the activity of endogenous 
and ‘endogenous+transgenic’ DXS enzyme present in the crude extracts from the C. 
reinhardtii strains. This assay relies on the reaction of 1-deoxy-xylulose 5-phosphate (DXP) 
as reaction product with 3, 5-diaminobenzoic acid in an acidic medium to form a fluorescent 
quinidine derivative, which produces an emission spectrum with maximum intensity at 510 
nm using an excitation wavelength of 396 nm (Querol et al. 2001), as illustrated in Figure 
5.9. The activity of DXS enzyme in vitro was assessed by using a crude preparation of 
enzyme, in which the C. reinhardtii cells were broken by repeated cycles of freezing and 
thawing. After centrifugation, the supernatant was obtained as a crude enzyme extract, for 
more details refer to section 2.9.1. The activity of the DXS protein in the crude enzyme 
extract was then analysed in three ways: (a) to study the relationship between the amounts 
of added supernatant and corresponding emission; (b) to compare the activity difference of 
DXS enzyme between crude extract from the H1 and L strains, (c) to assess the efficiency of 
a freeze-thaw method for crude extract preparation. 
 
Figure 5.9 Schematic representation of the reaction catalysed by DXS synthase in fluorometric 
assay.  
The DXS activity in the crude extract was firstly assessed by studying the relationship 
between the amount of added crude enzyme extract of H1 strain and the corresponding 
emission intensity. Figure 5.10 shows the results of analysing the crude enzyme extract of 
H1 cells that yielded fluorescent products showing two different maximal fluorescence 
intensities at different wavelengths: 450 nm and 510 nm. The presence of the emission peak 
at 510 nm suggests that the DXS enzyme is active, in which DXP was formed and reacted 
with DABA yielding a fluorescent product that emitted at the expected wavelength. On the 
other hand, the observed maximal fluorescence intensity at 450 nm in the emission 
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spectrum may indicate the presence of other fluorescent derivatives in the crude enzyme 
extract and it is most likely to be the excitation of chlorophyll b (Welschmeyer 1994). The 
relationship between the amount of added crude enzyme extract of H1 strain and the 
corresponding emission intensity was clearly demonstrated in this experiment, as the 
intensity of emitted fluorescence increased linearly with the amount of crude extract in the 
reaction mixture. This result may suggest the activity of the enzyme in the crude extract, 
whereby increasing the amount of crude extract led to increased catalysis and so formation 
of more DXP to react with DABA to give more fluorescent derivatives. Negative control 
results are discussed later in this section. 
 
Figure 5.10 Analysis of emission spectra of the reaction product DXP catalysed by the crude 
enzyme extract of H1. 
Emission spectra of the reaction product of DL-glyceraldehyde 3-phosphate and sodium pyruvate in 
the presence of crude extract of H1 cells. The crude extract of H1 cells was prepared by breaking the 
cells with repeated cycles of freezing and thawing, and then centrifuging the broken cells. The 
supernatant fraction, known as crude extract, was used as the source of DXS enzyme and different 
amounts of crude extract were used in the reaction; 50 and 100μl.  The emission spectra show 
maximal intensities at different wavelength, 450 nm presumed for chlorophyll b and 510 nm for DXP. 
The fluorescence intensities increase linearly with the added amount of crude lysate. The negative 
control (–ve) does not contain the crude extract. The excitation wavelength was 396 nm.   
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Although the emission spectrum showed an additional emission peak at 450 nm, the 
presence of a peak at the expected wavelength (510nm) encouraged more tests to assess 
the enzyme activity in the C. reinhardtii lines. So, the next part to be investigated was 
whether the L1 strain showed more enzyme activity than the H1 strain, which lacks the 
additional dxs gene. The cell line L1 was used as the only cell line generated with dxs at that 
point. Figure 5.11 shows the level of fluorescence emission of reaction product catalyzed by 
the H1 strain is more than L1. However, the comparison between the fluorescence 
emissions was based on the amount of added crude extract rather than actual 
concentration. Therefore, in order to demonstrate the dxs activity difference between the 
control strain and transgenic strains, further studies are required in which the number of 
cells is equalised between extracts, and also the cell lines should be used that expressed 
more DXS. Alternatively, the enhanced activity of dxs in the transgenic lines could be 
demonstrated indirectly by analyzing the profile of downstream terpenoids using HPLC. 
Such analysis is useful to demonstrate the functionality of DXS in vivo and its effect on 
downstream metabolites at the same time. The use of the HPLC method to assess the effect 
of overexpressing dxs will be discussed in the next section.   
Figure 5.11 Assessing DXS enzyme activity of crude enzyme extracts from H1 and L1 cells. 
Emission spectra of the reaction product of DL-glyceraldehyde 3-phosphate and sodium pyruvate in 
presence of either crude enzyme extract from H1 and L1 strains. The fluorescence intensities 
increase linearly with the added amount of crude lysate in both H1 and L1 crude enzyme extract. The 
negative control (–ve) does not contain the crude extract. The excitation wavelength was 396 nm.  
 
The efficiency of freeze and thaw method for crude preparation was also assessed by 
examining the DXS activity in different cell fractions; lysed cells, pellet and supernatant. As 
shown in Figure 5.12, the supernatant fraction yielded the highest emission as expected for 
a soluble enzyme though no clear peak could be detected.  
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Figure 5.12 Emission spectra for the DXS assay performed using different cell fractions of C. 
reinhardtii cell line L1. 
Emission spectra of the reaction product of DL-glyceraldehyde 3-phosphate and sodium pyruvate in 
the presence of different fractions that resulted during preparing the crude extract of L1 cells. The 
fractions are lysed cells (L), pellet (P), and supernatant (S). The supernatant is the fraction used in 
the DXS enzyme assays earlier. The excitation wavelength was 396 nm.  The negative control (–ve) 
does not contain DABA. 
To eliminate the possibility that the resulting fluorescence spectrum is due to other 
components rather than the fluorescent product from DXS activity, two different negative 
controls were used during the fluorometric analysis. The first negative control included all 
reaction components except the cell supernatant (Figure 5.10 and Figure 5.11), while the 
second control contains all reaction components except the DABA in Figure 5.12. Both 
control samples yielded a fluorescent product showing an emission around the same 
wavelengths but at lower intensities. In order to identify the component in the reaction 
mixture that could possibly result in the background emissions in negative control samples, 
the emission spectrum of reaction mixture without crude enzyme extract were examined 
by increasing the concentration of DL-glyceraldehyde 3-phosphate from 0 mM to 20 mM. 
The result in Figure 5.13 suggests indeed that the emission spectrum of negative control 
samples at low fluorescence intensities is due to other components in the reaction mixture 
and it is not possible to get a straight line in the negative control spectrum. In addition, the 
emission spectrum of the negative control sample (without lysate) yielded fluorescence 
products showing an emission spectrum with similar peak wavelengths to samples 
containing crude enzyme extract but far less in intensity. Such background emission from 
the DABA substrate discouraged us from continuing to investigate the DXS activity using 
this method. Due to the differences of the detected maximal intensities at different 
wavelength (450 and 510 nm) between the control sample (without lysate) and the sample 
with crude enzyme extract, a different approach was taken to investigate the activity of the 
enzyme. The approach relies on introducing the dxs gene into the Escherichia coli DH5α to 
get a chlorophyll free crude enzyme extract for enzyme activity assay. The promoter/5’UTR 
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of psaA used to drive the expression of dxs gene has maintained bacterial features of its 
regulatory elements and therefore the expression of dxs gene in E. coli is possible, discussed 
in section 3.2.3.2. So, the following constructs; pRY134a, pRY134aΔdxs and pSRSapI were 
transformed into E. coli DH5α and western blot analysis with anti-HA antibody was 
performed to check the accumulation of DXS protein in E. coli. The result in Figure 5.14 
illustrates that the protein has been expressed successfully as an intense clear band is seen 
at 70.4 kDa. This result encouraged an enzyme activity assay using crude extract from cells 
carrying the different plasmids (pRY134a [+dxs], pRY134aΔdxs [Δdxs] and pSRSapI [–dxs]). 
It is important to note that the crude extract from pRY134a transformants is expected to 
give higher fluorescence, whereas less fluorescent product is expected for the extracts from 
both pRY134aΔdxs and pSRSapI since E. coli has an endogenous dxs. As illustrated in Figure 
5.14, there is no sign of enzyme activity in the emission spectrum for any of the extracts as 
they all showed similar signal intensities at 510 nm. This suggests that the DXS protein 
detected in the western blot of the pRY134a extract is either not functional, or that the assay 
is flawed. The main reason behind using the E. coli expression system was to minimize the 
interfering absorbance related to other components in the algal extracts such as chlorophyll 
b. Nonetheless, the unsuccessful attempts to detect the fluorescent product in emission 
spectra from the E. coli crude extracts leaves open the possibility that the recombinant DXS 
produced in the C. reinhardtii cells is functional. 
 
 
Figure 5.13 Analysis of emission spectra demonstrating the interference absorbance from 
reaction substrates. 
Emission spectra of the reaction product of DL-glyceraldehyde 3-phosphate and sodium pyruvate, 
without adding any crude extract. Background signal in emission spectra of the reaction product of 
DL-glyceraldehyde 3-phosphate and sodium pyruvate were examined by using different 
concentrations of DL-glyceraldehyde 3-phosphate. Arrow indicates DL-glyceraldehyde 3-phosphate 
concentration that was used in the reaction mixture for DXS assays. The excitation wavelength was 
396 nm.   
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Figure 5.14 Analysis of crude enzyme from E. coli transformants. 
Left panel: Western analysis with anti-HA antibody show a strong band running at an apparent mass 
of 70.4 kDa in the crude enzyme extract of pRY134a transformant (+dxs), whereas no band was 
detected in either pRY134aΔdxs transformant (Δdxs) or pSRSapI transformant (–dxs). Right panel: 
emission spectra of the reaction product of DL-glyceraldehyde 3-phosphate and sodium pyruvate 
demonstrate the absence of the DXS activity in all crude enzyme extracts though a band at 70.4 kDa 
was detected in Western blot analysis with anti-HA tag antibody in +dxs. The negative control does 
not contain a crude enzyme extract and the excitation wavelength was 396 nm. The wavelengths of 
peaks are indicated by arrows.  
After failing to demonstrate DXS enzyme activity from the E. coli extracts, an attempt was 
made to obtain a clearer form of extract from Chlamydomonas by breaking the cells by a 
freeze–thaw method and then spinning the cells at 100,000 x g for 1 hour to pellet 
membrane material, as details in section 2.9.1. Unfortunately, the attempt was not 
successful as this treatment resulted in a poor recovery of DXS protein in the soluble extract 
as illustrated in western blot analysis (Figure 5.15). However, a change in the extract colour 
was observed as a pale yellow in the control strain H1 and an orange colour in the 
transgenic strain L4, as shown in Figure 5.16. Such colour change in the crude enzyme 
extract as a result of overexpressing the dxs gene provides a visual indication that the 
exogenous dxs gene is expressed and produces a functional enzyme. Therefore, this result 
primarily suggests the functionality of DXS enzyme and its effect on increasing downstream 
metabolites in particular carotenoids. In order to support the observed effect of 
overexpressing the dxs gene in the transgenic lines compared to the control strain H1, the 
carotenoid level was further analysed using HPLC.  
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Figure 5.15 Western blot analysis demonstrating a poor recovery of DXS protein in the 
supernatant after breaking the cells. 
The C. reinhardtii cells H1 and L4 were broken by repeated cycles of freezing and thawing. The 
efficiency of lysis process was determined by western blot analysis with anti-HA antibodies. The 
presence of HA-tagged DXS protein in L4 cell line was detected as a band at 70.4 kDa in the following 
fractions; whole cell lysate (W), broken cells (B), supernatant (S) and pellet (P). H1 strain was 
included as a negative control, which as anticipated does not show a band in any fractions.  
 
 
 
 
Figure 5.16  The colour changes in the crude enzyme extract of the transgenic line L4 
suggesting the activity of the DXS enzyme.  
In left panel, the colour differences of the crude enzyme extract from the control strain H1 as a pale 
yellow and the transgenic strain L4 as an orange. In right panel, schematic representation of 
terpenoid biosynthetic pathway in the chloroplast. The red arrow indicates the introduced additional 
copy of dxs and its subsequent effect on downstream metabolites in particular carotenoid level, as is 
indicated from crude enzyme extract colour. Multiple arrows indicate that more steps are involved 
but not shown.   
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5.2.5. Analysis of terpenoid profile of the genetically engineered C. 
reinhardtii  
In order to determine the impact of expressing an additional dxs gene on terpenoid content, 
the quantity of plastidic terpenoids such as violaxanthin, lutein, α-carotene and β-carotene 
was measured in the transgenic lines and compared with the levels found in the control line 
H1. All algal strains were grown in moderate light conditions then harvested and freeze-
dried as described in section 2.10. The freeze-dried algal samples were sent to Royal 
Holloway University of London for HPLC analysis, where carotenoids were extracted by 
methanol extraction using an equal amount of freeze-dried algal. The results in Figure 5.17 
show an overall increase in the carotenoid levels in mg/g DW in all transgenic lines based 
on peak area. The expression of the additional dxs gene results in increased levels of 
neoxanthin/loroxanthin, lutein, α-carotene, β-carotene and cis-β carotene, though there is 
variation between the transgenic lines. Interestingly, the increase in lutein and cis-β-
carotene levels in transgenic lines is consistent with the accumulated amount of DXS protein 
detected by western blot analysis in Figure 5.5, where more DXS protein was detected in 
both L4 and L5 compared to L1 and L3. This result is expected since an additional copy of 
the dxs gene was introduced into the chloroplast genome to increase the supply of 
IPP/DMAPP and so increase the flux towards downstream metabolites. Such a result was 
demonstrated for higher plants in which the over-expression of the dxs gene is correlated 
with increased accumulation of β-carotene in the oil palm Elaeis guineensis and carotenoid 
accumulation in Arabidopsis thaliana (Khemvong & Suvachittanont 2005; Munoz-Bertomeu 
et al. 2006; Gong et al. 2006; Estévez et al. 2001). In general, the levels of carotenoid in the 
transgenic lines indicates the additional activity of DXS in the chloroplast, though further 
analysis is required to validate the difference.  
 
Figure 5.17 Carotenoids analysis of transgenic lines demonstrating the effect of expressing 
an additional dxs gene on downstream metabolites.  
Carotenoids level in the C. reinhardtii lines were determined by HPLC analysis.  
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5.3. Discussion and conclusion 
Because of the biotechnological application of terpenoids in animal feed, human nutrition, 
pharmaceuticals and biofuels, this chapter aimed at gaining a better understanding of the 
MEP pathway that leads to terpenoid production in the green microalga C. reinhardtii. A 
number of studies have proven that the DXS enzyme catalyses one of the rate limiting steps 
in the MEP pathway in a variety of systems. For example, the overexpression of dxs led to 
increased accumulation of essential oil in lavender, β-carotene accumulation in the oil palm 
Elaseis guineensis and carotenoid accumulation in Arabidopsis thaliana (Khemvong & 
Suvachittanont 2005; Munoz-Bertomeu et al. 2006; Gong et al. 2006; Estévez et al. 2001). 
Similarly in Corynebacterium glutamicum, where the overexpression of dxs improved the 
lycopene accumulation (Heider et al. 2014). All these studies used a common strategy to 
genetically engineer terpenoid metabolism by enhancing flux to increase the precursor pool 
of IPP and DMAPP, and thus enhance the accumulation levels of downstream terpenoids. To 
extend these studies further in the algal chloroplast and investigate the fundamental 
aspects of flux through the MEP pathway in C. reinhardtii, a reverse genetic approach was 
used to introduce a second dxs gene into a neutral site within the chloroplast genome and 
then study the corresponding changes in the downstream terpenoid profile.  
Several transgenic lines were created, in which an additional dxs gene from Synechocystis 
PCC 6803 was integrated successfully into the chloroplast genome under the control of the 
promoter/5’UTR from psaA exon 1, and the 3’UTR from rbcL. Another set of transgenic lines 
carrying non-functional dxs was also created to examine the possibility that overexpressing 
the dxs gene in C. reinhardtii has a toxic effect on the cells, as only low numbers of dxs 
transformants were obtained by the glass bead method. Nonetheless, the growth analysis 
indicated that there was no toxic effect of overexpressing the dxs gene in C. reinhardtii as 
demonstrated by normal growth rate and healthy appearance in all transgenic lines. In 
principle, the over-accumulation of DXS provides the ‘push’ to increase the precursor pools 
for downstream metabolites, as opposed to the ‘pull’ of introducing a downstream enzyme 
that competes with other pathways for the same precursor pool. An example of undesirable 
collateral effects is the introduction of a phytoene synthase cDNA in tomato fruit as a first 
committed step in a carotenoid biosynthesis pathway. The overexpression of phytoene 
synthase severely affected the transgenic lines resulting in dwarfism and reduce 
chlorophyll content due to the alteration in the synthesis of both abscisic acid and phytol 
from the precursor GGPP shared with carotenoids, as illustrated in Figure 5.18 (Fray et al. 
1995).  Also, some terpenoids have a  toxic effect on the cell; for instance, the diversion of 
terpenoid intermediates by introducing a geraniol synthase in the grapevine, Vitis vinifera 
to produce geraniol resulted in severely impaired cells and ultimately led to cell death 
(Fischer et al. 2013). 
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Figure 5.18 Schematic representation of the effect of overexpressing phytoene synthase on 
other terpenoid biosynthetic pathways in plant. 
The overexpression of phytoene synthase (PSY) direct the metabolic flux towards carotenoid 
production as indicated by red arrows at the expense of ent-kaurene and phytol synthesis that share 
the same GGPP pool. The increase in carotenoid levels is represented by , whereas the decrease in 
the level of both phytol and ent-kaurene is represented by  . The pathway in blue is found in plant 
but not in microalgae. The black multiple arrows indicate that more steps are involved but not shown.   
The current direction of research on algal terpenoid metabolism is to genetically engineer 
pathways to increase the productivity or enable the production of novel terpenoids with 
industrial applications (see Table 5.2). However, most of these attempts relied on targeting 
non rate-limiting endogenous enzymes to alter the productivity level of the desired 
terpenoid, resulting in no or little effect. The most relevant example is the genetic 
manipulation of the carotenogenic pathway in C. reinhardtii by heterologous expression of 
the -carotene ketolase gene from H. pluvialis. This attempt was not successful in obtaining 
a transgenic microalga capable of synthesising ketocarotenoids (León et al. 2007). Another 
unsuccessful attempt is reported by Vila et al. (2008) where the post-transcriptional 
silencing of phytoene desaturase by RNA interference led to under expression of the target 
gene but did not show any changes on the carotenoid profile. As for producing non-native 
metabolites in the C. reinhardtii, a recent study aimed at producing cis-abienol 4 in the C. 
reinhardtii chloroplast genome for its important role in the fragrance industry, in particular 
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to produce Ambrox®. This study was not successful as transplastomic lines did not show 
any detectable levels of cis-abienol 4 though the recombinant protein was successfully 
detected (Zedler et al. 2014).   
As evident from these attempts, the genetic manipulation of terpenoids has not been free of 
difficulties as a result of a poor understanding of these biosynthetic pathways. Therefore, in 
this study a different approach was used to alter terpenoid levels by targeting an enzyme 
called DXS, which has been reported by a number of studies as a rate-limiting enzyme in 
the MEP pathway for plastidic terpenoid production in bacteria and plants (Estévez et al. 
2001; Heider et al. 2014). In principle, the alteration of dxs levels should result in changes 
in several plastidic terpenoids, unless it is not a rate-limiting step in the MEP pathway of C. 
reinhardtii. The analysis of the transgenic lines that overexpressed dxs showed an overall 
increase in the levels of several plastidic terpenoids such as neoxanthin/loroxanthin, lutein 
and β-carotene. However, some the plastidic terpenoids include violaxanthin and α-
carotene did not show any changes in their levels highlighting the complexity of the 
pathways and possibility of the presence of co-limiting steps for specific terpenoids.  
Generally speaking, an overall increase in a number of downstream terpenoid metabolites 
as a result of alteration in the dxs levels demonstrates that DXS catalyses one of the rate 
limiting steps in the production of the plastidic IPP (and hence of terpenoids) in C. 
reinhardtii. It is worthy to note that, although each plastidic group of terpenoids has distinct 
biosynthetic pathways that might be targeted for genetic manipulation, the output of these 
pathways could be confined by the available amount of IPP that is normally produced in the 
chloroplast (Estévez et al. 2001). Nevertheless, some studies have shown the success in 
redirecting the metabolic flux into a single endogenous downstream product, as is the case 
for the C. reinhardtii lines that overexpress phytoene synthase with a resulting 1.8–2.6 fold 
carotenoid increase (Couso et al. 2011).  
The overexpression of dxs increases the precursor pools of IPP and DMAPP for the 
downstream terpenoid metabolites, where three main pathways are most likely to be 
affected by such increase in both IPP and DMAPP pools. These pathways share the same 
precursor GGPP and include phytol, carotenoid and plastoquinone. Ent-kaurene is an 
additional biosynthetic pathway that is found in plants and is involved in the synthesis of a 
group of plant hormones called gibberellins. However, hormone studies have been 
neglected in microalgae and there is a possibility of involvement of some these terpenoid 
hormones in algae but have not been identified yet (Lohr et al. 2012). Although there are 
three pathways that diverge from the GGPP precursor, and so all three pathways could be 
assessed upon the upregulation of the DXS enzyme activity in the MEP pathway, the main 
focus was to analyse the quantitative changes in the carotenoid levels of various classes due 
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to their industrial applications. Nonetheless, the analysis of other pathways that share the 
same precursor pools such as phytol – e.g. by analysing phytol-derived chlorophyll 
compounds – would provide additional information, and therefore increase our chances of 
genetic engineering these pathways in the algal chloroplast more successfully. The most 
relevant example that highlighted the significant of understanding these pathways is the 
initial unsuccessful attempt to generate tomato fruit accumulating more phytoene by 
overexpressing the phytoene synthase gene (Fray et al. 1995). Though it was unsuccessful, 
it sheds light on the regulation of particular pathways that share the same precursor pools 
(GGPP). Such understanding led to a success in a 43-fold average increase of β-carotene in 
Arabidopsis by overexpressing the phytoene synthase gene under the control of a seed 
specific promoter to avoid the undesirable effects of these metabolites in the plant cells 
(Lindgren et al. 2003). 
In summary, the strategy used here for engineering terpenoid biosynthesis relies on 
enhancing the flux to increase the precursor pools of IPP and DMAPP by introducing an 
additional transgenic copy of the gene for DXS, which is involved in catalysing the first step 
in the plastidic MEP pathway. The overexpression of dxs influenced the level of several 
plastidic terpenoid such as neoxanthin/loroxanthin, lutein and β-carotene suggesting that 
DXS catalyses one of the rate limiting steps of the MEP biosynthetic pathway in the C. 
reinhardtii. The identification of such a limiting step in the MEP pathway might ultimately 
enable the use of a combinatorial “push-pull” approach to increase the productivity of 
endogenous terpenoids without depleting precursor pools and inhibiting other precursor 
dependent pathways. This would involve engineering the MEP pathway to enhance the 
precursor pools through overexpressing the rate limiting enzyme, as well as re-directing 
the pathway toward producing the desired terpenoid molecules by introducing the enzyme 
involved in the committed step for the specific terpenoid, see Figure 5.19. 
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Figure 5.19 Engineering terpenoid synthesis in the C. reinhardtii chloroplast. 
The terpenoid pathway is indicated with black arrows. Examples of potential pathways that could be 
coupled with overexpressing the rate-limiting DXS enzyme (green) to direct the metabolic flux to the 
desired terpenoid products. The endogenous DXS and PSY could be upregulated to direct the 
metabolic flux to produce more carotenoids (red). Another potential pathway that could be 
introduced to produce novel terpenoid such as cis-abienol (blue), where the upregulation of DXS 
increase the GGPP pool that required for cis-abienol synthesis. The flux increase of the corresponding 
product/s is represented by , while the introduced additional copy of the gene is indicated by +. 
Abbreviations are DXS: 1-deoxy-D-xylulose-5-phosphate synthase; GGPP: geranylgeranyl 
diphosphate; PSY: phytoene synthase; CAS: cis-abienol synthase. The diagram was modified from 
Vranová et al. (2012) 
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6. Final discussion 
6.1. Summary of main findings 
Nannochloropsis are promising oleaginous species with potential to serve as phototrophic 
platforms for the commercial production of advanced biofuels and high value compounds. 
However, the biotechnological exploitation of these microalgae necessitates the 
development of molecular tools and technologies. Of particular interest is the development 
of molecular tools for chloroplast engineering, as the organelle is the site of photosynthesis 
and key biosynthetic pathways for fatty acid and terpenoid production. In an effort to 
exploit these industrially relevant microalgae, an attempt was made to develop a reliable 
chloroplast transformation methodology for Nannochloropsis gaditana. Results presented 
in Chapter 3 demonstrated the main steps required for the development of a chloroplast 
transformation methodology for a new species. These steps were the optimisation of 
growth conditions, identification of a suitable selectable marker for the chloroplast, the 
construction of a transformation vector and testing of the different transformation 
methodologies. This chapter also highlighted the main challenges in delivering exogenous 
DNA into the chloroplast genome of N. gaditana as a result of the small size of the cell (and 
therefore its plastid) and the complexity of the plastid membranes. Even though the 
antibiotic chloramphenicol was identified as a potential selectable marker, the chloroplast 
transformation attempts were not successful in spite of testing two delivery methods: 
electroporation and biolistics. Nuclear transformation was carried out alongside 
chloroplast transformation as a control, and transformants were obtained by 
electroporation, but not biolistics. The preliminary results of these chloroplast and nuclear 
transformation attempts suggested that the conditions employed for electroporation were 
not sufficient to allow the passage of the DNA across the plastid membranes, while the 
invasive nature of biolistics prevented the recovery of viable cells. However, the definite 
reason behind such unsuccessful attempts was difficult to determine due to the 
involvement of several factors between introduction of the foreign DNA into the chloroplast 
genome and successful expression of the gene to exhibit the desired phenotype. As such, the 
lack of success could be due to poor expression of the chosen selectable marker or the 
possibility that chloramphenicol adversely affects the prokaryotic–like translational 
machinery of the mitochondria, thereby preventing the recovery of resistant transformant 
lines. Or failure could simply reflect the inability to deliver the DNA to the chloroplast, as 
mentioned above. 
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Therefore, Chapter 4 focused on developing a more controllable approach to monitor the 
steps involved in developing the chloroplast transformation methodology and addressing 
uncertainty regarding gene expression of the marker. This approach relied on i) screening 
chloroplast-specific compounds to identify alternative selection strategies that would not 
impact on the mitochondrion, ii) developing an endogenous selectable marker using 
forward and reverse genetics to eliminate issues associated with foreign gene expression 
and iii) increasing the cell size temporarily prior to biolistic transformation to maximise the 
chances of delivering DNA-coated microparticles across multiple barriers without killing 
the cells. These attempts as presented in Chapter 4 demonstrated the sensitivity of N. 
gaditana to the photosystem II inhibitors atrazine and diuron, and identified a psbA 
mutation that is likely to confer atrazine tolerance (and which may enable the use of 
atrazine as a selective agent). In addition, the results in Chapter 4 demonstrated the 
development of a method to increase the average cell size using the microtubule inhibitor 
nocodazole and, most importantly, demonstrated that the biolistics conditions developed 
for the best chance of chloroplast transformation allowed nuclear transformants to be 
isolated, thereby showing that DNA-coated microparticles were able to enter the cell 
without killing every cell. 
The ultimate aim of developing a chloroplast transformation methodology in N. gaditana is 
to allow the genetic manipulation of the key biosynthetic pathways in the chloroplast, such 
as those for terpenoid and fatty acid production. Since chloroplast transformation of 
Nannochloropsis species is not yet possible, metabolic engineering of the model microalga 
C. reinhardtii is the current option to further our understanding about these biosynthetic 
pathways until molecular tools become available for those microalgae with industrial 
potential. Therefore, Chapter 5 describes metabolic engineering of the MEP pathway that 
leads to terpenoid biosynthesis in the chloroplast of C. reinhardtii. The metabolic 
engineering approach relied on increasing the precursor pools for terpenoid biosynthesis 
by introducing the cyanobacterial version of the dxs gene involved in catalysing the first 
step in the plastidic MEP pathway. The chloroplast engineering successfully resulted in 
transgenic lines carrying this additional copy of dxs and the expression of DXS was 
detectable in all transgenic lines in spite of variation in levels of accumulated DXS. 
Furthermore, these transgenic lines showed normal growth and healthy appearance, 
exempting any negative effect of such genetic manipulation. The over-expression of the dxs 
gene appeared to show an overall increase in the downstream terpenoid metabolites lutein, 
β-carotene, cis-β-carotene and neoxanthin/loroxanthin, suggesting that the DXS enzyme 
catalyses one of the rate limiting steps of the MEP pathway in C. reinhardtii. 
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6.2. Metabolic engineering of the algal chloroplast: challenges and 
potential 
Because of the biotechnological applications of terpenoids in animal feed, human nutrition, 
pharmaceuticals and biofuels, this study ultimately aimed at exploiting algal chloroplast as 
a terpenoid production platform through metabolic engineering technologies. However, the 
biotechnological exploitation of algal chloroplast necessitates the development of genetic 
engineering tools for more algal species, particularly those with industrial potential to allow 
the genetic manipulation of terpenoid biosynthesis pathway, at the same time, the 
development of advanced engineering tools and new strategies to engineer terpenoids 
pathways in established laboratory algal species such as the model microalga C. reinhardtii. 
With a view to enabling the sustainable production of terpenoids, the genetic manipulation 
of terpenoid biosynthesis pathway in the algal chloroplast of two different species has been 
investigated in this study; i) N. gaditana as a novel microalga with industrial potential and 
ii) C. reinhardtii as a model microalga with well-established genetic engineering tools.   
The biotechnological exploitation of N. gaditana chloroplast as a terpenoid production 
platform is not possible at present due to the absence of a reliable delivery method. The 
attempts in Chapter 3 and 4 were not successful highlighting the main challenges associated 
with the development of a reliable chloroplast transformation methodology for this 
oleaginous microalga as a result of the complexity of the plastid membranes and the small 
cell size (therefore the chloroplast). This could be an explanation as to why there are no 
reports yet on successful chloroplast transformation of Nannochloropsis species or other 
microalgae that harbour secondary plastids (with an exception Phaeodactylum 
tricornutum)(Al-Hoqani et al. 2016; Xie et al. 2014). As most of the progress is being made 
in the plastid transformation technology for those microalgae with a primary plastid such 
as C. reinhardtii and H. pluvialis (see Table 3.1 for more examples).  
Although there are no reports yet for a successful chloroplast transformation in 
Nannochloropsis species, there is still ongoing interest to improve the intrinsic features of 
Nannochloropsis for biotechnological exploitation through classical mutagenesis and 
nuclear genetic engineering (Al-Hoqani et al. 2016). In fact, many studies reported their 
attempts to improve the lipid productivity and/or profile for Nannochloropsis species 
(Table 6.1). One of these studies reported strain improvement in lipid profile by 
overexpressing N. oceanica microsomal-like Δ12-desaturase (NoD12) as a committing step 
for omega-3 long-chain polyunsaturated fatty acids (LC-PUFA) (Huang et al. 2014). While 
another study focused on improving the light penetration in a dense culture for large scale 
cultivation by reducing light harvesting apparatus (Perin et al. 2015). This study 
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successfully isolated a mutant with a reduced light harvesting apparatus demonstrating an 
improved photosynthetic activity and productivity in the lab-scale cultures.  
Table 6.1 Reports on strains improvement and nuclear engineering to improve lipid profile/ 
productivity. 
 Abbreviations are: EPA, eicosapentaenoic acid; FAME, fatty acid methyl esters; PUFAs, 
polyunsaturated fatty acids; TAG, triacylglycerol. Table was modified from Al-Hoqani et al. (2016) 
Species Approach used for strain 
improvements 
Notes Reference 
Nannochloropsis 
sp.  
Classical mutagenesis  
(ethyl methanesulfonate) 
A 30% increase in palmitoleic acid 
(16:1) and a 45% decrease of EPA 
Increase 
(Doan & 
Obbard 2012) 
Nannochloropsis 
salina  
Classical mutagenesis  
(ethyl methanesulfonate) 
Increase in total FAME production 
and reduced levels of PUFAs 
(Beacham et al. 
2015) 
Nannochloropsis 
oceanica IMET1 
Classical mutagenesis (Heavy 
ion radiation) 
High growth rate and 14% 
increase in TAG  
(Ma et al. 2013) 
N. salina The overexpression of basic 
helix-loop-helix isoform 2 gene  
in the nuclear genome 
Increase biomass productivity by 
36% under normal condition and 
FAME productivity by 33% under 
nitrogen starvation 
(Kang et al. 
2015b) 
N. gaditana ¥  The heterologous expression 
of Long-chain acyl-CoA 
synthetase (LACS) gene in S. 
cerevisiae as a host 
Accumulation of eicosapentaenoic 
acid and docosahexaenoic acid  
(Zheng et al. 
2014) 
Nannochloropsis 
strain NIES-2145 
The overexpression of 
Diacylglycerol acyl-CoA 
acyltransferase type-2 gene in 
the nuclear genome 
Increased TAG accumulation by 
1.7 fold under phosphorus 
starvation 
(Iwai et al. 
2015) 
¥ In this study, the LACS gene was isolated from N. gaditana to be studied and characterised.  
It is also worthy to note that the absence of genetic tools for engineering the chloroplast 
genome has not prevented the growing sector of exploiting wild type Nannochloropsis as a 
base of the food chain in the aquaculture industry due to the its high lipid content. A number 
of companies – such as Algaspring, Archimde, Monzon Biotech and Proviron ‒ use the wild 
type Nannochloropsis as a PUFA-rich aquaculture feed for the cultivation of shrimps, 
molluscs and marine fish, or alternatively for production of rotifers, which in turn are used 
as a food source for fish hatcheries (Camacho-Rodríguez et al. 2014; Lubzens et al. 1995). 
The use of Nannochloropsis as an aquaculture feed comes up with potential opportunities 
to use transgenic lines as an oral delivery system for pharmaceutical proteins to improve 
both the growth rate of fish and survival rate during infection by pathogens. An example of 
such opportunities has been demonstrated by an improved survival rate of medaka fish 
infected with a bacterial pathogen as a result of feeding them with an engineered transgenic 
line that produced the anti-microbial peptide bovine lactoferricin (Li & Tsai 2009). In 
addition to being used as an aquaculture feed, is also used as a feed for farmed animals to 
improve the nutritional value such as the addition of Nannochloropsis biomass to the feed 
of laying hens has greatly improved the nutritional value of egg yolk (Lemahieu et al. 2013).   
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Nevertheless, to establish Nannochloropsis as an effective production platform for 
industrial applications, genetic tools for engineering the chloroplast genome are also 
required to facilitate the investigation into the chloroplast biosynthetic pathways and allow 
genetic engineering strategies to further improve this alga. This commercially grown 
Nannochloropsis could be also ‘functionalised’ through chloroplast engineering to produce 
oral vaccines, hormones, anti-bacterial proteins, etc. More efforts therefore should focused 
on the development of genetic engineering tools for the chloroplast, where most efforts 
currently focused on genetic engineering of the nuclear genome and the development of 
advanced engineering tools such as CRISPR-Cas9 (Wang et al. 2016; Al-Hoqani et al. 2016). 
The development of the genetic engineering tools for the nuclear and chloroplast genome 
should allow the exploitation of Nannochloropsis in a wide range of industrial applications. 
As such, the development of full set of genetic engineering tools for Nannochloropsis could 
further improve the production capacity of secondary metabolites and biomass 
accumulation (Figure 6.1).  
 
 
 
 
 
  
 
 
 
 
 
 
Figure 6.1 The contribution of genetic engineering tools to improve Nannochloropsis for 
industrial applications. 
The development of genetic engineering tools for both the nuclear and chloroplast genome could 
contribute greatly in improving the production capacity of secondary metabolites and biomass 
accumulation. Diagram was modified from Gimpel et al. (2015).  
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In contrast to N. gaditana, the genetic manipulation of terpenoid biosynthetic pathway in 
the C. reinhardtii chloroplast is possible since the genetic engineering tools for this 
microalga are highly developed including well-established genetic transformation methods 
for the chloroplast and standardised expression systems. The advent of genetic engineering 
tools facilitated the investigation undertaken in Chapter 5 that aimed at gaining a better 
understanding of the MEP pathway that leads to terpenoid production in the C. reinhardtii 
chloroplast. The results presented in Chapter 5 demonstrated that the over-expression of 
dxs influenced the level of several plastidic terpenoid such as neoxanthin/loroxanthin, 
lutein and β-carotene suggesting that DXS catalyses one of the rate limiting steps of the MEP 
biosynthetic pathway in the C. reinhardtii (Figure 5.16). The identification of this limiting 
step in the MEP pathway offer opportunities to use a combinatorial “push-pull” approach to 
increase the productivity of endogenous terpenoids without depleting precursor pools and 
inhibiting other precursor dependent pathways (Figure 5.18). It also offers the possibility 
of transferring the strategy tested for engineering terpenoid biosynthesis pathway to other 
industrially relevant microalgae such as N. gaditana once the molecular toolkit becomes 
established. It is worth mentioning that C. reinhardtii has been used as a model organism 
for other industrially relevant species including higher plants, where the plastid 
transformation technologies were initially developed in C. reinhardtii and then these 
technologies were transferred into higher plants (e.g. Nicotiana tabacum) (Scaife et al. 
2015; Day & Goldschmidt-Clermont 2011). C. reinhardtii has also become a model alga for 
other productive algal species that are naturally high producer of biomass and lipid 
including Nannochloropsis species (Al-Hoqani et al. 2016; Radakovits et al. 2012).  
Although C. reinhardtii is not an inherently exceptional producer of biomass or lipid, it has 
potential as a production platform for human therapeutic proteins including human growth 
hormones, vaccines, antibodies, immunotoxins and antibacterial proteins (Stoffels et al. 
2017; Wannathong et al. 2016; Tran et al. 2013; Mayfield et al. 2003). For example, a full 
human monoclonal antibody was expressed in the chloroplast of C. reinhardtii, and was 
demonstrated to have antigen binding activity similar to the same antibody expressed in 
mammalian cells (Tran et al. 2009). Most recently, Stoffels et al. (2017) reported a 
successful synthesis of two antibacterial proteins against a major human pathogen 
streptococcus pneumoniae in the chloroplast of C. reinhardtii, and the lytic activity was 
demonstrated against several serotypes of S. pneumoniae. This encouraging progress in the 
exploitation of the C. reinhardtii chloroplast as a production platform for human therapeutic 
proteins has recently led to the establishment of start-up companies. A company named 
Triton (http://www.tritonhn.com/) exploits an engineered C. reinhardtii chloroplast as a 
viable platform to produce recombinant proteins as nutraceuticals, therapeutics and 
cosmetics. Because of the GRAS state of microalgae in general including C. reinhardtii, Triton 
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is indeed able to provide its products as an oral dietary supplements:  for example, the 
digestive health comfortinTM 
The development of C. reinhardtii as a production platform is not limited to the production 
of therapeutic proteins, as several studies investigated also the possibility of engineering 
biosynthetic pathways in C. reinhardtii to allow the production of other industrially relevant 
molecules such as triacylglycerols and terpenoids (Gimpel et al. 2015; Scaife et al. 2015). 
The primary focus of these studies is to genetically engineer pathways in C. reinhardtii to 
increase the productivity or enable the production of designer molecules with industrial 
applications. For example, a recent study was successful in down regulating a key enzyme 
in the citric acid cycle using a CRISPRi system to direct the carbon flux towards lipid 
synthesis and therefore, enhance the lipid production in the C. reinhardtii (Kao & Ng 2017). 
Another example is engineering the glycerol acylation step in C. reinhardtii by 
overexpressing endogenous Acyl-CoA:diacylglycerol acyltransferases to improve 
triacylglycerol production (La Russa et al. 2012). To harness C. reinhardtii as a cell factory 
for the production of novel molecules, a study attempted to introduce a bifunctional 
diterpene synthase from balsam fir into the C. reinhardtii chloroplast, where this enzyme 
catalyses the formation of industrially relevant cis-abienol 4 from GGPP (Zedler et al. 2014). 
This study could not detect cis-abienol 4 in spite of the successful heterologous expression 
of the diterpene synthase gene. On the other hand, Lauersen et al. (2016) reported the 
successful production of the non-native sesquiterpenoid patchoulol from FPP in engineered 
C. reinhardtii with a patchoulol synthase from the plant Pogostemon cablin, achieving 
productivities up to 922 ± 242 µg/g dry weight in six days. As evident from the above 
studies, the conventional metabolic engineering strategy of modifying individual gene/s for 
the production of desired molecules is not always successful, where sometimes no changes 
could be detected in the genetically engineered C. reinhardtii. This could be mainly due to 
the involvement of several limiting steps in the pathway especially in the case of secondary 
metabolites. A transcriptional engineering strategy has therefore recently been developed 
in algal metabolism as a means to allow the manipulation of multiple targets of a metabolic 
pathway by engineering regulators such as transcription factors as illustrated in Figure 6.2 
(Bajhaiya et al. 2016). Specifically, a patent from Sapphire Energy, Inc demonstrated an 
overexpression transcriptional factor (SN03) can cause a lipid-trigger effect in C. reinhardtii 
and result in an increase of 11% of total neutral lipids under nutrient-replete conditions 
(Gimpel et al. 2015). Such transcriptional engineering strategy holds real promise in the 
metabolic engineering of complex metabolic pathways in C. reinhardtii and other algal 
species with industrial potential. 
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Figure 6.2 Schematic representation for different strategies to engineer carotenoid 
biosynthesis pathway.  
Biosynthetic pathways for carotenoids in green microalgae. (A) Conventional metabolic engineering 
strategy relies on the overexpression of a single gene or multiple genes. (B) Transcriptional 
engineering strategy can allow the activation of multiple genes in a metabolic pathway by the 
overexpression of transcription factor (TF), or by the introduction of a mutation in cis element where 
then the genetic activation would be possible by a specific TF; DNA-binding domain (DBD); Signal-
sensing domain (SSD); transactivation domain (TAD). Abbreviation for the key enzymes: phytoene 
synthase (PSY), phytoene desaturase (PDS), z-carotene desaturase (ZDS), lycopene e-cyclase (LCY-
E), lycopene b-cyclase (LCY-B), cytochrome P450 e-hydroxylase (CYP97C3), cytochrome P450 b-
hydroxylase (CYP97A5), carotene b-hydroxylase (CHY-B), b- carotene oxygenase (BKT), zeaxanthin 
epoxidase (ZEP), violaxanthin de-epoxidase (VDE). The diagram is adapted from Bajhaiya et al. 
(2016).  
In general, the current genetic engineering efforts for the manipulation of biosynthetic 
pathways in C. reinhardtii are largely based on proof of concept experiments using simple 
molecular tools to demonstrate transgene expression and confirm the functionality of 
heterologous protein within the cells (Couso et al. 2011; Vila et al. 2008; León et al. 2007). 
These initial experiments are necessary to gain a better understanding of metabolic process 
and the genetic controls underpinning algal metabolisms. Such understanding, in 
combination with the development of advanced metabolic engineering strategy (e.g. 
transcriptional engineering) would allow the successful regulation of complex biosynthetic 
A B 
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pathway in algal metabolism to produce the desired molecules with industrial applications, 
though it necessitates a lot of research to make this stage possible (Figure 6.3). Most 
importantly, the advances in the field of metabolic engineering for C. reinhardtii could 
enable the development of genetically engineered strains that suits industrial applications 
and so make for instance, the production of human therapeutic proteins more practical and 
economically viable.  
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 6.3 Schematic representation of the metabolic engineering stages organised into the 
levels of increasing complexity. 
The essential stages in the manipulation of biosynthetic pathway in C. reinhardtii highlighting the 
efforts and knowledge required to achieve tangible outputs. The core steps for each stage 
necessitates to follow the cycle of design in silico, build the target pathway, test the productivity of 
the desired product and the overall effect of pathway manipulation on the host cell and learn from 
the outcomes of engineering the target pathway. Several rounds of such cycle will provide the 
knowledge required to proceed to the next level of the complexity, where the ultimate goal to achieve 
the desirable outputs. The diagram was reproduced from Scaife & Smith (2016); Schmidt-Dannert & 
Pisarchik (2008).  
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6.3. Next step in engineering the MEP pathway in the algal chloroplast 
To further investigate the potential of microalgae as a production platform for terpenoids, 
the next step is to couple the overexpression of the rate limiting DXS enzyme with terpene 
synthase enzymes involved in the production of novel terpenoids with industrial 
applications. Sclareol is an example of an industrially important plant derived-diterpenoid 
that is used as a precursor for Ambrox® or the related ambroxide fragrance (Zerbe & 
Bohlmann 2015). Since sclareol is mainly obtained from clary sag plants, the current supply 
for this terpenoid is not stable. The biosynthetic pathway of sclareol in its natural host relies 
on the sequential action of two monofunctional diterpenoid synthases, which together form 
sclareol from GGPP, as illustrated in Figure 6.4 (Schalk et al. 2012).  
 
Figure 6.4 Semi-synthetic route for the production of Ambrox® from sclareol. 
The biosynthesis of sclareol in the clary sag plant. The diterpenoid sclareol is used as a starting 
material to produce Ambrox® by chemical synthesis. The abbreviations are a class II diterpene 
synthase (SsLPS), labda-13-en-8-ol diphosphate (LPP) and a class I diterpene synthase (SsSCS). 
Diagram was modified from Ignea et al. (2015). Abbreviation of enzymes according to Zerbe & 
Bohlmann (2015).  
The identification of diterpenoid synthase in sclareol biosynthesis should enable the genetic 
engineering of the MEP pathway in the chloroplast of C. reinhardtii to investigate the 
possibility of producing sclareol in the algal chloroplast as an alternative platform for 
commercial production. The reconstruction of this pathway can be undertaken by 
heterologous expression of a codon optimised version of the diterpene synthases into an 
engineered strain with an additional copy of the DXS enzyme (Figure 6.5). Alternatively, the 
heterologous expression of multiple genes (dxs, SsLPS and SsSCS) in the C. reinhardtii 
chloroplast in a single transformation is possible as demonstrated in Saul Purton’s group 
(Marco Larrea-Alvarez, unpublished).   
Chemical synthesis   
      SsLPS 
      SsSCS 
         LPP 
     Ambrox® 
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Figure 6.5 Metabolic engineering of the terpenoid biosynthetic pathway for sclareol 
production in the C. reinhardtii chloroplast. 
The terpenoid pathway in the C. reinhardtii chloroplast is indicated by black arrows. The 
overexpression of rate-limiting DXS enzyme (blue) to increase GGPP precursor pool that required 
for sclareol synthesis by introduced pathway (red).  The flux increase of the corresponding product/s 
is represented by, while the introduced additional copy of endogenous gene is indicated by +. 
Abbreviations are G3P: D-glyceraldehyde 3- phosphate; DXP: -deoxy-D-xylulose-5-phosphate; DXS: 
1-deoxy-D-xylulose-5-phosphate synthase; GPP: geranyl diphosphate, FPP: farnesyl diphosphate; 
GGPP: geranylgeranyl diphosphate; a class II diterpene synthase (SsLPS), labda-13-en-8-ol 
diphosphate (LPP) and a class I diterpene synthase (SsSCS).  
It is worth noting that the reconstruction of the sclareol pathway has been reported in 
different expression systems demonstrating the feasibility of producing this compound 
using a heterologous platform (Pan et al. 2015; Ignea et al. 2015; Schalk et al. 2012). 
However, some of these expression systems are not ideal for diterpenoid production. 
Genetic engineering of diterpenoid pathways in yeast often necessitates extensive 
modification to allow the production of a desired terpenoid. This was demonstrated in 
sclareol production, where an engineered yeast containing farnesyl diphosphate synthase 
(Erg20p) to produce geranylgeranyl diphosphate was initially used as a chassis for 
diterpene production and then this was further modified to produce sclareol (Ignea et al. 
2015). Metabolic engineering of the terpenoid biosynthesis pathway in the chloroplast of 
plants is normally associated with side effects, for instance the successful production of 
sclareol in the moss Physcomitrella patens led to growth impairment (Pan et al. 2015). 
Although C. reinhardtii is not an exceptional biomass producer and sclareol production is 
expected to be far less than 1.5 g/L – the highest titre reported in engineered E. coli (Schalk 
et al. 2012), the reconstruction of the sclareol biosynthetic pathway in C. reinhardtii would 
shed light on the possibility of exploiting the algal chloroplast as a terpenoid production 
platform.  
   G3P + Pyruvate 
    DXP 
   GPP (C10) 
              FPP (C15) 
               GGPP (C20) 
LPP Sclareol  
  + DXS  
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This gained knowledge could also guide rational design in other algal species with industrial 
potential like Nannochloropsis for sclareol production, which would be possible after the 
establishment of a reliable chloroplast transformation methodology. The establishment of 
a chloroplast transformation methodology for such oleaginous algae suited for industrial 
cultivation is necessary not only to enable the genetic manipulation of biosynthetic 
pathways including terpenoids, but also to help in building our understanding about lipid 
biology in response to different growth conditions such as nutrient levels, light, 
temperature and salinity. Such understanding, together with genetic manipulation tools for 
both chloroplast and nuclear genomes, can help in genetically modifying various aspects of 
Nannochloropsis biology to improve lipid profiles, productivity levels of desired products or 
performance for industrial cultivation. 
Enzyme engineering is another aspect that should be considered along with pathway 
engineering in the algal chloroplast to further improve the productivity of the desired 
terpenoid, as the engineered pathway could be limited by inherent capacity of imported 
pathway to catalyse conversion of the precursors (Leonard et al. 2010). This could be 
improved by engineering the recombinant enzymes to achieve the desirable functions such 
as higher catalytic activity, better substrate affinity and decreased product inhibition 
(Marcheschi et al. 2013). An example for such a case was reported by Leonard et al. (2010), 
where the initial attempt to produce the diterpene levopimaradiene in engineered E. coli 
co-expressing GGPP synthase and levopimaradiene synthase resulted in production of a 
small amount (0.15 mg/L) of levopimaradiene. This was followed by another attempt by 
the same group to further increase levopimaradiene levels in E. coli by overexpressing 
several rate limiting enzymes in the MEP pathway. This approach was used to improve 
terpenoid production levels up to 92 mg/L, as further improvement of levopimaradiene 
levels through metabolic engineering was not possible due to the limited capacity of the 
downstream pathway. The level of levopimaradiene of engineered E. coli was only 
significantly improved when combined with protein engineering of GGPP synthase and 
levopimaradiene synthase, achieving a maximum titre of 700 mg/L in a bench scale 
bioreactor.  
It is anticipated that future advances in genetic engineering technologies for microalgae will 
see similar impressive results in which ‘designer algae’ are created using a synthetic biology 
approach of predictive design in silico followed by efficient engineering in the laboratory. 
This will allow production using a truly sustainable approach in which these photosynthetic 
organisms produce a valuable metabolite in photobioreactors using just CO2 and basic 
nutrients, with the whole process driven by sunlight. 
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Appendix. 1 Compounds used in the sensitivity tests for N. gaditana 
Compound Mode of action Resistance gene 
Antibiotics   
Kanamycin Protein synthesis inhibitor aphA‐6 
Spectinomycin Protein synthesis inhibitor aadA 
Streptomycin Protein synthesis inhibitor aadA 
Paromomycin Protein synthesis inhibitor aphVIII 
Erythromycin Protein synthesis inhibitor ereB 
Chloramphenicol Protein synthesis inhibitor catA1 
Herbicides   
Harvest  Inhibitor of glutamine synthetase activity  pat 
Glufosinate-ammonium  Inhibitor of glutamine synthetase activity  pat 
Bialaphos Inhibitor of glutamine synthetase activity  pat 
Atrazine Inhibitor of photosystem II Point mutation in psbA or AtzA  
Diuron  Inhibitor of photosystem II Point mutation in psbA 
Amino Acids    
D-alanine Interfere with amino acid metabolism dao  
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Appendix. 2 Details of primers used for either PCR or DNA sequencing 
Microalgae Primer name Primer sequence (5’3’) 
N. gaditana UH-NCc 1. F AGT AAG CAG ACA CAA ATA GGC 
N. gaditana UH-NCc 2. R GCC TTG ACG ACT AAT TGA ACC 
N. gaditana UH-NCpA.1F TGG TAG ATT AGA CGA TAG CG 
N. gaditana UH-NCpA.1R AGAGAATTGACCAGGTTTGG 
N. gaditana UH-NC3pbA.1F GCTTTTGATAATGCTCGTGGAAC 
N. gaditana UH-NC3pbA.5R TTAGACCAATGCCGTGCAGC 
N. gaditana UH- GA 1F ACAAGAAAGGCTTTAAAGGGTGGTAGATTAGACGA 
N. gaditana UH- GA 1R TATCCAGTGATTTTTTTCTCCATGTTCGTTTGTGAATAAAATC 
N. gaditana UH- GA 2F GATTTTATTCACAAACGAACATGGAGAAAAAAATCACTGGATA 
N. gaditana UH- GA 2R CTCATATGTAATTAAATATTCTTACGCCCCGCCCTGCC 
N. gaditana UH- GA 3F GGCAGGGCGGGGCGTAAGAATATTTAATTACATATGAG 
N. gaditana UH- GA 3R GTAATTGAATGAGACATATTCTATAATACATAACAACTA 
N. gaditana UH- GA 4F TAGTTGTTATGTATTATAGAATATGTCTCATTCAATTAC 
N. gaditana UH- GA 4R TCGTCTAATCTACCACCCTTTAAAGCCTTTCTTGT 
N. gaditana CaflII. 1F AGTATCCTTAAGGGTGGTAGATTAGACGATAG 
N. gaditana CaflII. 1R GAAGAACTTAAGCTATAATACATAACAACT 
N. gaditana UH-CAS 1F CTTAAGGGTGGTAGATTAGACG 
N. gaditana UH-CAS 1R CCAACTGAACTAAAGACGC 
N. gaditana UH-mCAS1F CGCAAGATGTGGCGTGTTAC 
N. gaditana UH-mCAS1R GTAACACGCCACATCTTGCG 
N. gaditana UH- psbA 1F AGACCTAACACATTGTACG 
N. gaditana UH-psbA 1R CCC TAT TTA TTC TAG TACTC 
N. gaditana UH-psbA SEQR GCAATGCACGGTTCTCTTGT 
N. gaditana UH-psbA SEQF ACA AGA GAA CCG TGCATTGC 
N. gaditana pJET1.2 F CGACTCACTATAGGGAGAGCGGC 
N. gaditana pJET1.2 R AAGAACATCGATTTTCCATGGCAG 
N. gaditana TUBpPst1_F ATGCCTGCAGACTGCGCATGGATTGACCG 
N. gaditana TUBpMsc1.R GCATTGGCCATGCTTCACAAAAAAGACAGCTTCTTGAT 
C. reinhardtii Flank 1 GTCATTGCGAAAATACTGGTGC 
C. reinhardtii atpA.F CAAGTGATCTTACCACTC 
C. reinhardtii rbcL.R CAAACTTCACATGCAGCAGC 
C. reinhardtii RbcL fn CGGATGTAACTCAATCGGTAG 
C. reinhardtii RY-psaR ATAGGCTCTTCTCATGGATTTCTCCTTATAATAAC 
C. reinhardtii RY-psaSEQ AACTATTTGTCTAATTTAATAACC 
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C. reinhardtii RY-dxsF2 CCATGTTTCCACCACCAAG 
C. reinhardtii RY-rbcR2 GAACGAATTACGTCGCCACC 
C. reinhardtii RY123a GGAGGGAAGTAGGCAGTAGC 
C. reinhardtii psbH.R GCAACAGGAACTTCTAAAGC 
C. reinhardtii UH-5’DXS R 1 AAT ACT TGT GGA AGC GTG CC 
C. reinhardtii UH-5’DXS R 2 CTT GGT GGT GGA AAC ATG G 
C. reinhardtii UH-DXS 3’UTR F1 AAT TAC TCC ACG AAC ACG GC 
C. reinhardtii UH-DXS 3’UTR R1 TCC ACT TAA CTC AGA AGC AGG 
C. reinhardtii UH-mDXS F GGCACGCTTCCACAAGTATT 
C. reinhardtii UH-mDXS 1R CCATAGCAGCCGTGATACCG 
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Appendix. 3 Potential neutral sites for tansgene integration into the chloroplast genome of 
N. gaditana.  
Chloroplast genome of N. gaditana CCMP526, where the genes located on the inside are transcribed 
clockwise and the genes on the outer side are transcribed anti-clockwise. The chloroplast genome 
map is taken from Radakovits et al. (2012).The insertion site used in this study for the chloroplast 
transformation attempts is indicated by blue arrow, whereas, other insertion sites which potentially 
could be used for the transgene integration are indicated by magenta arrows.  
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Appendix. 4 Primers used to sequence the psbA gene from N. gaditana plastome.  
Key: rbcS (green), psbA on reverse orientation (red), chlN on reverse orientation (blue). Primers 
used are highlighted in yellow. 
GCTTCTGGTGCAACAGCGAATCGTGTGGCTATGGAATGTGTACTTTTAGCTAAATACGAAGGTAAAGATTACATTAACGAAGGACCAAAAATTTTACGTG
CTGCTGCAGAAAGCTGTGCTCCATTACGTACTGCTTTAGATCTTTGGAAAGATATTGCTTTCAACTATACATCAACAGATACTGCAGATTACGTTGAAACA
ACAACTAAACAGTAATCGTAAAAAAACAATATCAATCAGTTTAACATACTAAAGGAGTATTTGAAGAGTGAGATTAACACAAGGTGCATTTTCGTACTTA
CCAGATTTAACAAACGAACAAATTTTAGGACAGCTTAAGTATATTTGTAGCAAAGGATGGGCTTGTAGTATTGAATGGACAGAAGATCCTCATCCGCGTA
ACACTTACTGGGAGCTTTGGGGTATGCCTTTATTCGATATTAAAGACGCTTCAGTAATTATGTATGAGTTAGACCAATGCCGTGCAGCTCACCCTACAACG
TACATCAAAATCAATGCTTTTGATAATGCTCGTGGAACTGAAAGCTGCGCATTATCTTTCATTGCTCAACGTCCTTACGAAGAACCAGGTTTCTACTTAGA
ACGTCAAGAAACTGAAAGTCGTAACATTCGTTACACTATTCATAGTTATGTTGTTAATAAGTATCCTCCAGGAGAACGTTACGTTTTATAATCTATAATA
CATAACAACTAAAACCAAACAAAACCCACTATTCCATCCTTTACTTGATGAAATAGTGGGTTTAATTTTTTAAATTAATATTAAATTAACAAAGAAAATC
TGAATATATAAATTATACAAATGCTACTTTACTTGGAGACTTTAGATTTTTAATGTTTTTTTACAGGATTTGTAAGACCTAACACATTGTACGACATAAT
ATTTTTTATCAGTCAATCTAAAAAAATATTACATACGAGTGATTAAAAATCACTCATATGTAATTAAATATTCTTAAGCATTAACAGCTGGAGCGTTTAA
TGCAACTGGAAGAACATTAGATACCGCTAAATCTAGAGGGAAGTTGTGCGCGTTACGTTCGTGCATTACTTCCATACCTAAATCAGCACGGTTGATAATGT
CAGCCCAAGTGTTGATCACACGACCTTGGCTATCAACAACTGATTGGTTGAAGTTGAATCCGTTTAAGTTGAATGCCATTGTGCTAATTCCAAGAGCAGTT
AACCAGATACCTACAACTGGCCAAGCAGCTAAGAAGAAGTGTAAAGCACGTGAGTTGTTGAAACTTGCGTATTGGAAGATTAAACGTCCAAAGTAACCGT
GTGCAGCTACGATGTTGTAAGTTTCTTCTTCTTGTCCAAATTTGTAACCGTAGTTAGCAGATACACCGTCTTCAGTTTCACGGATTAAACTAGATGTTACA
AGAGAACCGTGCATTGCACTGAATAAAGATCCACCAAACACACCAGCAACACCAGCCATATGGAATGGGTGCATAAGAATGTTGTGTTCTGCTTGGAATAC
TAACATGAAGTTGAAAGTACCAGAGATACCTAAAGGCATACCATCAGAGAAGCTACCTTGTCCGATTGGGTAAATTAAGAATACTGCACTTGCTGCAGCT
ACTGGAGCTGAGAAAGCTACGAAAATCCAAGGACGCATCCCTAAACGGTAGCTAAGTTCCCATTCACGTCCCATGTAGCAAGCTACACCTAATAAGAAGTG
TAATACTACAAGTTGGTAAGGACCACCGTTGTAAAGCCATTCGTCTACAGACGCAGCTTCCCAAACTGGGTAGAAGTGAATACCAATAGCGTTAGAACTTG
GAATAACCGCACCTGTGATAATGTTGTTTCCGTATAAAAGTGATCCAGCCACTGGTTCACGGATACCATCGATATCTACTGGAGGTGCTGCGATGAAAGCG
ATGATGAAGCAGCTTGTAGCTGTTAATAATGTAGGGATCATTAAAACACCGAACCAACCGATGTATAAACGGTTTTCTGTGCTAGTGATCCAAGAGCAGA
AGCGCTCCCATAAGCTAGTACTTTCTCTTCTTTCTAAAGTTGCTGTCATAATGAGTACTAGAATAAATAGGGAAATAAACTTCCTAGGATCATAGGTCTGG
CATTAATTGCAAGAGTCTATTTTGCAAAGGATGAATATTTCGTGTATGATGAGGGGGGATAACAGGAATTTCTACAAAGCTGTCTTATTTAAATTAATTG
TACAATAATTTTATAAATCTTACGGGTTAAATACTTTAGTGTTTTAGTCAACAACAAAAATTTAAACGAGTGTATGGTAGTTTTTCCAGCCTAGCTCTTT
AAAAGTTGTTTGTCTTTGTAATGGTTTAGAAATTAATTCCAAAATATTTTTAGCATTTGTAAAACCATGAATTTGCGAAAATGTAAATTCAACAGACCAT
TTTGTATTTATACCTCTGGCTTCTAAAGGATTTGCGTGAGCCATTCCAGTTATAACTAAGTCAGGATGTAAATCTTTAATACGGTTTAGTTGGTTGTAATT
ATCGGGCTTCTCAACGATTACAGGTAAGAAAGTACCCATTTCTTTACAAGTCTTTTCAAGTAAAGCTAGTTCCCCTCCTTGATAACGTTTATCTAAGTATG
GGATACCAATTTCATAGACAGACATACCACATTTTATAAAAAATCTTGCCAAAGAAATTTCTAACAAATTATCCCCCATAAAAAAGACAGATTTTCCTCTT
AAAAGTTTAAGATAAGACTCTAAATTTTTCCAAGCTTTTTCTTCTCTATCATTAAGACCAGGTGTAGGTTTATTAAAAACAGAACAAATTTTTTCAATCC
ACGCCTTAGTCCCATCTGGTCCAATAGGAAAAGGAGAACCTATAAGTTGACATTTACGTCTACGCATTAAAGTCGTTGCAGTACGACTTAAGTAGGGATTA
ACACCACATACAAAATCTTTTTCATTTAAAATAGGAAATTCTGTATATCTTTTTGCCGGAAGCCATCCTTTTATTTCTATACCGTACGTTTTTAACTCATT
ACCTAACTCGTAAACTACTGAATTAGGTACTGAACCAAATATAACTAAATTAGGGGTATTTTCAGATTTAGTACCGTTATCGGAAGTCGTTGACTTTTTTC
CAAATGTTTGTGCCAATGCTGCCAAAACTGTATCTTCACCTTGTGTAAAGGCATAGTCTAATCCATTTGCTCTGGCAACAATGATAGGAACACCAAGTTCG
TTTTCTAATTTTGGCGCAATACCTTCAAGATCCATTTTAATAATCTCTGTGGTGCAAGTACCAATCCAAAAAATAACACTAGGATTTCGATCTTTTTTTAT
AAGTGTACATAAACGCTTTAATTCCATATAGTCATTTAAATGCGCGGATATATCAGCTTCTTCCAGTTCTGCCATTGCATATCTCGGTTCAGCAAATATCA
TTACACCAAGAGCATTTTGTAAAAAGTAACCACATGTTTTTGTACCAATTACTAAGAAAAAGCTATCTTCAATTTTTTGATATAACCACGCAACACAACTG
ATTGGGCAGAATGTATGATAGTTACCAGTTTCACATTCAAAAGTAATGGAGTTAGAATTAATTAATGATCCTTGTTCAATATTCATATTATTTAGATTGC
CTTTTAATTCTTTTCAAAATTTAGTTTAGTTGTTAAAAAGGTCCATTTCTAAATCTTCAACATTTTGCTCAGAATTAGCAGGTTTTAAATAAAA 
 
Details of the primers highlighted in yellow:  
Primer  Sequence ( 5’3’) Tm (°C) 
UH-psbA 1F AGACCTAACACATTGTACG 53        
UH-psbA 1R CCCTATTTATTCTAGTACTC 52.3   
UH-psbA seq F§ ACAAGAGAACCGTGCATTGC 58.4   
UH-psbA seq R§ GCAATGCACGGTTCTCTTGT 58.4  
§ Primers anneal to the same sequence 
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Appendix. 5 Plasmids used in this study 
A) Plasmid pUH.NCc2 
Key: psbk on reverse orientation (red), trnT (purple), trnL (blue), P/5’UTR psaA (highlighted in 
green), cat (highlighted in yellow), 3’UTR psbA (highlighted in turquoise), trnW (pink) and part of 
rpl11(orange), AflII restriction sites (underlined and bolded).  
GCCCCTGCAGCCGAATTATATTATTTTTGCCAAATAATTTTTAACAAAAGCTCTGAAGTCTTCTTCATTTAAATTCTTAGATGATACTTCATCTGGAAAAT
TGTCCCAATTAGTAGCATCACGCTGTGAGTAAGTTCTAAACCATTTTTTTATTGTTGTATTATCTCTAATCTTACTACTCGATGAGTTTTCGGTATTATCT
CTATTTTTAACTTGGAGCAGGTTCCATTCATTGTTTTTTTCATCATAGTGAATAAAATCAACTGCTTTAACACTTGTGCCTGAACACCATATCCATCCGGC
GTAATACGACTCACTATAGGGAGAGCGGCCGCCAGATCTTCCGGATGGCTCGAGTTTTTCAGCAAGATGTAAGCAGACACAAATAGGCCTATTAAAGTAAC
AACAATTAGTCCTAAAACAATTCCAAATAATAGAGGTTCAATCATAATATAGCTTTATGCATATTTTCAAGAATTCTTTACAACCTTTGGTTTAAAGTTA
TCTAAATCCTACTGCTGCTTGCCATACGAAAGCTAATAGTAAAAATAAAACTGGAATTACCGGTAAAATATCAACTATAGGACTGAAAACGGCAAACACA
TCTGGTAGTTTCGCAAGAAGAATTTCGGGCATGGCGAAGAACCTTGTTATTCGACTACAAAGGATTTTGTTTCAACGAATAAAATTTTAATATTAATTTT
TTAGAGATTTTTTTTTTAATTAAACTTAAAACTAAAGCTTTTATAAGATTTTTACTTTTTAAATTTAATTTTACGTAAGATTTATGCTCATTTAATAAAT
ATTCTGCTTTTTTAACCATATTTACTTATATGATTAGCACTACAACATTAGTTATTATACACTACTTTCGAGGACTTAGGAGGAATATCTATGGTTAGTCT
TGTCCAATCACTCACTTTATTATTTGTAATTTGTTCTCTTCTTCTTATTATTTTAATTCCAATTTTACTTGCTACAGGTGATGAATCAGGAAATACAAAAG
GAGCGGTTTCAGGCTTAGCTACTTTTTGGGGAAGTTTACTTATCGCAACAAGTATTGCAAATTCATTTTTATAAATTATAAAAATTAAATGAAAGCTAGT
GAAGGGAATTGAACCCCCAACCTACTGATTACAAATCAGTTGCTCTACCAGTTGAGCTACACCAGCAATATCTTATTCTGCATATTTACTATTATGCAGAG
GTAATGTAAGAATACAAGGATTTTAACTTTATTTATATAGTACATAACCTGCGGATGGAGAGACTCGAACTCTCAAGGAATTACCCACTGGATTCTAAGT
CCAGCGCGGCTACCAATTTCGCCACATCCGCTATATAAATTGGACTTGAACCTTTGTTTACCACTTTATTAATAAGCTAAGCGTCTTTAGAGGATTATCTT
AAAAACCTTTTAATTTTACTAGCTTAAAATTTATCTCACTATATTTATATAAAATTTTATTTATTTTATCAAAAAATTAACATATAATTTAATATAACGT
AATACAAGAAAGGCTTTAAAGATATGTCTCATTCAATTACTCTTTTTAATGAGTTAAACTTAACAAATAAGCTTCTTATTTTAGTAAATTACTCGAATCA
GGCTAATACTAAGATTCGTATTAGACAATCAGAAATTTTAACAAAGACTAATGATAACTCAGGGTATAAATTAGATCCAAATGGTACTTTAACCTTTATG
GAAAACCATTTAGGAATTTCTAAAAGTAAAGAAAAAACAAAATTATTGAATCAATTTCTTCAAGAAATAAAACAGGTTGATATTAAATCAAAAATTAAT
ATTAAAGAGTTACAAAGATCTAAAAACTTAAGGGTGGTAGATTAGACGATAGCGATATTGAAGATGTTGCAAATTACGTATTATCACAATCAGAAAAGG
GTTGGGACTAAATTAATTTAACGCAAAATTTAAAATAAGTACAAAAGGTTAAATACGAAAATTCCTTCCCCTTCTGGGATCGTGAGGGAGTATTTCATTG
CTTGTGAAACTTGATTTTATAGTTTCACATTTTTAACCATTTTCTTTTGATTTTATTCACAAACGAACATGGAGAAAAAAATCACTGGATATACCACCGTT
GATATATCCCAATGGCATCGTAAAGAACATTTTGAGGCATTTCAGTCAGTTGCTCAATGTACCTATAACCAGACCGTTCAGCTGGATATTACGGCCTTTTT
AAAGACCGTAAAGAAAAATAAGCACAAGTTTTATCCGGCCTTTATTCACATTCTTGCCCGCCTGATGAATGCTCATCCGGAATTCCGTATGGCAATGAAAG
ACGGTGAGCTGGTGATATGGGATAGTGTTCACCCTTGTTACACCGTTTTCCATGAGCAAACTGAAACGTTTTCATCGCTCTGGAGTGAATACCACGACGAT
TTCCGGCAGTTTCTACACATATATTCGCAAGATGTGGCGTGTTACGGTGAAAACCTGGCCTATTTCCCTAAAGGGTTTATTGAGAATATGTTTTTCGTCTC
AGCCAATCCCTGGGTGAGTTTCACCAGTTTTGATTTAAACGTGGCCAATATGGACAACTTCTTCGCCCCCGTTTTCACCATGGGCAAATATTATACGCAAG
GCGACAAGGTGCTGATGCCGCTGGCGATTCAGGTTCATCATGCCGTTTGTGATGGCTTCCATGTCGGCAGAATGCTTAATGAATTACAACAGTACTGCGAT
GAGTGGCAGGGCGGGGCGTAAGAATATTTAATTACATATGAGTGATTTTTAATCACTCGTATGTAATATTTTTTTAGATTGACTGATAAAAAATATTATG
TCGTACAATGTGTTAGGTCTTACAAATCCTGTAAAAAAACATTAAAAATCTAAAGTCTCCAAGTAAAGTAGCATTTGTATAATTTATATATTCAGATTTT
CTTTGTTAATTTAATATTAATTTAAAAAATTAAACCCACTATTTCATCAAGTAAAGGATGGAATAGTGGGTTTTGTTTGGTTTTAGTTGTTATGTATTAT
AGCTTAAGTCAATCGAGAATATTAACAACAAAATTAACAAAAATAAGTATTTAAGTTAAAATTATATCTTTTCAATTTAAAAATAAATTTTTAAATTGA
AAAGATACAAGCAAATATTGAAAAAAAAAATAATAATTAAATGTGAATTTTCATCAGGAAAATGAATAGCGTCTTTAGTTCAGTTGGTAGAACGTAGGT
CTCCAAAACCTAATGTCGAGGGTTCAAGTCCTTCAAGGCGTGTTTTATGTCTAATATAATATCTACTTATAATAACTGTTTACACTCAAAATATTATTTGA
TAATATCAAGTTAAGAAAAATAGTTTTTTATTCACTAATTCAAAATAAAAAGCTTGAATTTTAGAACAAACCATTAAAACTTGCGTAAAAAATGCCAAAA
AAAATTGTAGCAGTAATTAAGCTTGCGTTAAAAGCTGGTAAAGCAACCCCAGCTCCTCCTGTAGGTCCTGCTTTAGGGCAGCATGGTGTCAATATAGCATT
ATTTTGTAAAGACTATAATGCCAGAACTGCAGATAAAGGTGATTTAGTTATTCCAGTTGAAATATCCGTATATGAGGATAGAAGTTTTTCATTTATTTTA
AAAACTCCGCCTGCATCAGTTTTGTTGAAAGTCAATTTACAAATAAAAAAAGGATCAGCAAAACCTAACAAAGTTAAAGTAGGTTCAATTAGTCGTCAAG
GCATCTTTCTAGAAGATCTCCTACAATATTCTCAGCTGCCATGGAAAATCGATGTTCTTCTTTTATTCTCTCAAGATTTTCAGGCTGTATATTAAAACTTA
TATTAAGAACTATGCTAACCACCTCATCAGGAACCGTTGTAGGTGGCGTGGGTTTTCTTGGCAATCGACTCTCATGAAAACTACGAGCTAAATATTCAATA
TGTTCCTCTTGACCAACTTTATTCTGCATTTTTTTTGAACGAGGTTTAGAGCAAGCTTCAGGAAACTGAGACAGGAATTTTATTAAAAATTTAAATTTTG
AAGAAAGTTCAGGGTTAATAGCATCCATTTTTTGCTTTGCAAGTTCCTCAGCATTCTTAACAAAAGACGTCTCTTTTGACATGTTTAAAGTTTAAACCTCC
TGTGTGAAATTATTATCCGCTCATAATTCCACACATTATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAA
TTGCGTTGCGCTCACTGCCAATTGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATT
GGGCGCTCTTCCGCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACA
GAATCAGGGGATAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCC
GCCCCCCTGACGAGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTC
GTGCGCTCTCCTGTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTC
AGTTCGGTGTAGGTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAAC
CCGGTAAGACACGACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCC
TAACTACGGCTACACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAA
CCACCGCTGGTAGCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGAC
GCTCAGTGGAACGAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAAT
CAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTT
GCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGAT
TTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAG
AGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCG
GTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCA
GTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATT
CTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAA
AACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTT
TCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTT
TCAATATTATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTT
CCCCGAAAAGTGCCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCC 
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B) Mutant version of psbA gene used in plasmid pUH-psbA264A 
I) DNA sequence of psbA gene, AGTGCT codon alternation highlighted in yellow.  
ATGACAGCAACTTTAGAAAGAAGAGAAAGTACTAGCTTATGGGAGCGCTTCTGCTCTTGGATCACTAGCACAGAAAAC
CGTTTATACATCGGTTGGTTCGGTGTTTTAATGATCCCTACATTATTAACAGCTACAAGCTGCTTCATCATCGCTTTCA
TCGCAGCACCTCCAGTAGATATCGATGGTATCCGTGAACCAGTGGCTGGATCACTTTTATACGGAAACAACATTATCA
CAGGTGCGGTTATTCCAAGTTCTAACGCTATTGGTATTCACTTCTACCCAGTTTGGGAAGCTGCGTCTGTAGACGAAT
GGCTTTACAACGGTGGTCCTTACCAACTTGTAGTATTACACTTCTTATTAGGTGTAGCTTGCTACATGGGACGTGAAT
GGGAACTTAGCTACCGTTTAGGGATGCGTCCTTGGATTTTCGTAGCTTTCTCAGCTCCAGTAGCTGCAGCAAGTGCAGT
ATTCTTAATTTACCCAATCGGACAAGGTAGCTTCTCTGATGGTATGCCTTTAGGTATCTCTGGTACTTTCAACTTCATG
TTAGTATTCCAAGCAGAACACAACATTCTTATGCACCCATTCCATATGGCTGGTGTTGCTGGTGTGTTTGGTGGATCT
TTATTCAGTGCAATGCACGGTTCTCTTGTAACATCTAGTTTAATCCGTGAAACTGAAGACGGTGTATCTGCTAACTAC
GGTTACAAATTTGGACAAGAAGAAGAAACTTACAACATCGTAGCTGCACACGGTTACTTTGGACGTTTAATCTTCCAA
TACGCAGCTTTCAACAACTCACGTGCTTTACACTTCTTCTTAGCTGCTTGGCCAGTTGTAGGTATCTGGTTAACTGCTC
TTGGAATTAGCACAATGGCATTCAACTTAAACGGATTCAACTTCAACCAATCAGTTGTTGATAGCCAAGGTCGTGTGA
TCAACACTTGGGCTGACATTATCAACCGTGCTGATTTAGGTATGGAAGTAATGCACGAACGTAACGCGCACAACTTCC
CTCTAGATTTAGCGGTATCTAATGTTCTTCCAGTTGCATTAAACGCTCCAGCTGTTAATGCTTAA 
 
II) Translated sequence of mutated psbA at codon position 264 from serine (S) to alanine (A), which 
is highlighted in yellow.  
MTATLERRESTSLWERFCSWITSTENRLYIGWFGVLMIPTLLTATSCFIIAFIAAPPVDIDGIREPVAGSLLYGNNIITGAVI
PSSNAIGIHFYPVWEAASVDEWLYNGGPYQLVVLHFLLGVACYMGREWELSYRLGMRPWIFVAFSAPVAAASAVFLIYP
IGQGSFSDGMPLGISGTFNFMLVFQAEHNILMHPFHMAGVAGVFGGSLFSAMHGSLVTSSLIRETEDGVSANYGYKFGQE
EETYNIVAAHGYFGRLIFQYAAFNNSRALHFFLAAWPVVGIWLTALGISTMAFNLNGFNFNQSVVDSQGRVINTWADII
NRADLGMEVMHERNAHNFPLDLAVSNVLPVALNAPAVNA- 
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C) Plasmid pUH-psbA264A 
Key: part of rbcS (red), 3’UTR psbA (green), psbA264A on reverse orientation (blue), P/5’UTR psbA 
(purple) and part of chlN (orange). 
GCCCCTGCAGCCGAATTATATTATTTTTGCCAAATAATTTTTAACAAAAGCTCTGAAGTCTTCTTCATTTAAATTCTTAGATGATACTTCATCTGGAAAAT
TGTCCCAATTAGTAGCATCACGCTGTGAGTAAGTTCTAAACCATTTTTTTATTGTTGTATTATCTCTAATCTTACTACTCGATGAGTTTTCGGTATTATCT
CTATTTTTAACTTGGAGCAGGTTCCATTCATTGTTTTTTTCATCATAGTGAATAAAATCAACTGCTTTAACACTTGTGCCTGAACACCATATCCATCCGGC
GTAATACGACTCACTATAGGGAGAGCGGCCGCCAGATCTTCCGGATGGCTCGAGTTTTTCAGCAAGATTCTTTCATTGCTCAACGTCCTTACGAAGAACCA
GGTTTCTACTTAGAACGTCAAGAAACTGAAAGTCGTAACATTCGTTACACTATTCATAGTTATGTTGTTAATAAATATCCTCCAGGAGAACGTTACGTTTT
ATAATCTATAATACATAACAACTAAAACCAAACAAAACCCACTATTCCATCCTTTACTTGATGAAATAGTGGGTTTAATTTTTTAAATTAATATTAAATT
AACAAAGAAAATCTGAATATATAAATTATACAAATGCTACTTTACTTGGAGACTTTAGATTTTTAATGTTTTTTTACAGGATTTGTAAGACCTAACACAT
TGTACGACATAATATTTTTTATCAGTCAATCTAAAAAAATATTACATACGAGTGATTAAAAATCACTCATATGTAATTAAATATTCTTAAGCATTAACAG
CTGGAGCGTTTAATGCAACTGGAAGAACATTAGATACCGCTAAATCTAGAGGGAAGTTGTGCGCGTTACGTTCGTGCATTACTTCCATACCTAAATCAGCA
CGGTTGATAATGTCAGCCCAAGTGTTGATCACACGACCTTGGCTATCAACAACTGATTGGTTGAAGTTGAATCCGTTTAAGTTGAATGCCATTGTGCTAAT
TCCAAGAGCAGTTAACCAGATACCTACAACTGGCCAAGCAGCTAAGAAGAAGTGTAAAGCACGTGAGTTGTTGAAACTTGCGTATTGGAAGATTAAACGT
CCAAAGTAACCGTGTGCAGCTACGATGTTGTAAGTTTCTTCTTCTTGTCCAAATTTGTAACCGTAGTTAGCAGATACACCGTCTTCAGTTTCACGGATTAA
ACTAGATGTTACAAGAGAACCATGCATTGCACTGAATAAAGATCCACCAAACACACCAGCAACACCAGCCATATGGAATGGGTGCATAAGAATGTTGTGT
TCTGCTTGGAATACTAACATGAAGTTGAAAGTACCAGAGATACCTAAAGGCATACCATCAGAGAAGCTACCTTGTCCGATTGGGTAAATTAAGAATACTG
CACTTGCTGCAGCTACTGGAGCTGAGAAAGCTACGAAAATCCAAGGACGCATCCCTAAACGGTAGCTAAGTTCCCATTCACGTCCCATGTAGCAAGCTACA
CCTAATAAGAAGTGTAATACTACAAGTTGGTAAGGACCACCGTTGTAAAGCCATTCGTCTACAGACGCAGCTTCCCAAACTGGGTAGAAGTGAATACCAAT
AGCGTTAGAACTTGGAATAACCGCACCTGTGATAATGTTGTTTCCGTATAAAAGTGATCCAGCCACTGGTTCACGGATACCATCGATATCTACTGGAGGTG
CTGCGATGAAAGCGATGATGAAGCAGCTTGTAGCTGTTAATAATGTAGGGATCATTAAAACACCGAACCAACCGATGTATAAACGGTTTTCTGTGCTAGT
GATCCAAGAGCAGAAGCGCTCCCATAAGCTAGTACTTTCTCTTCTTTCTAAAGTTGCTGTCATAATGAGTACTAGAATAAATAGGGAAATAAACTTCCTAG
GATCATAGGTCTGGCATTAATTGCAAGAGTCTATTTTGCAAAGGATGAATATTTCGTGTATGATGAGGGGGGATAACAGGAATTTCTACAAAGCTGTCTT
ATTTAAATTAATTGTACAATAATTTTATAAATCTTACGGGTTAAATACTTTAGTGTTTTAGTCAACAACAAAAATTTAAACGAGTGTATGGTAGTTTTTC
CAGCCTAGCTCTTTAAAAGTTGTTTGTCTTTGTAATGGTTTAGAAATTAATTCCAAAATATTTTTAGCATTTGTAAAACCATGAATTTGCGATCTTTCTAG
AAGATCTCCTACAATATTCTCAGCTGCCATGGAAAATCGATGTTCTTCTTTTATTCTCTCAAGATTTTCAGGCTGTATATTAAAACTTATATTAAGAACTA
TGCTAACCACCTCATCAGGAACCGTTGTAGGTGGCGTGGGTTTTCTTGGCAATCGACTCTCATGAAAACTACGAGCTAAATATTCAATATGTTCCTCTTGA
CCAACTTTATTCTGCATTTTTTTTGAACGAGGTTTAGAGCAAGCTTCAGGAAACTGAGACAGGAATTTTATTAAAAATTTAAATTTTGAAGAAAGTTCAG
GGTTAATAGCATCCATTTTTTGCTTTGCAAGTTCCTCAGCATTCTTAACAAAAGACGTCTCTTTTGACATGTTTAAAGTTTAAACCTCCTGTGTGAAATTA
TTATCCGCTCATAATTCCACACATTATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCT
CACTGCCAATTGCTTTCCAGTCGGGAAACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCTCTTCC
GCTTCCTCGCTCACTGACTCGCTGCGCTCGGTCGTTCGGCTGCGGCGAGCGGTATCAGCTCACTCAAAGGCGGTAATACGGTTATCCACAGAATCAGGGGA
TAACGCAGGAAAGAACATGTGAGCAAAAGGCCAGCAAAAGGCCAGGAACCGTAAAAAGGCCGCGTTGCTGGCGTTTTTCCATAGGCTCCGCCCCCCTGACG
AGCATCACAAAAATCGACGCTCAAGTCAGAGGTGGCGAAACCCGACAGGACTATAAAGATACCAGGCGTTTCCCCCTGGAAGCTCCCTCGTGCGCTCTCCT
GTTCCGACCCTGCCGCTTACCGGATACCTGTCCGCCTTTCTCCCTTCGGGAAGCGTGGCGCTTTCTCATAGCTCACGCTGTAGGTATCTCAGTTCGGTGTAG
GTCGTTCGCTCCAAGCTGGGCTGTGTGCACGAACCCCCCGTTCAGCCCGACCGCTGCGCCTTATCCGGTAACTATCGTCTTGAGTCCAACCCGGTAAGACAC
GACTTATCGCCACTGGCAGCAGCCACTGGTAACAGGATTAGCAGAGCGAGGTATGTAGGCGGTGCTACAGAGTTCTTGAAGTGGTGGCCTAACTACGGCTA
CACTAGAAGGACAGTATTTGGTATCTGCGCTCTGCTGAAGCCAGTTACCTTCGGAAAAAGAGTTGGTAGCTCTTGATCCGGCAAACAAACCACCGCTGGTA
GCGGTGGTTTTTTTGTTTGCAAGCAGCAGATTACGCGCAGAAAAAAAGGATCTCAAGAAGATCCTTTGATCTTTTCTACGGGGTCTGACGCTCAGTGGAAC
GAAAACTCACGTTAAGGGATTTTGGTCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTTAAATTAAAAATGAAGTTTTAAATCAATCTAAAGTA
TATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATCTGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCC
GTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGCGAGACCCACGCTCACCGGCTCCAGATTTATCAGCAAT
AAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCAGTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTT
CGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCGTCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGAT
CAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTCCGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTC
ATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTCTGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTG
TATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACATAGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGG
GGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTCGTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTT
CTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGACACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATATTATTG
AAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTAGAAAAATAAACAAATAGGGGTTCCGCGCACATTTCCCCGAAAAGTG
CCACCTGACGTCTAAGAAACCATTATTATCATGACATTAACCTATAAAAATAGGCGTATCACGAGGCC 
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D) Plasmid pRY134a 
Sequence of pRY134a plasmid, containing dxs gene amplified from Synechocystis 6803 in pSRSapI 
backbone. Key: P/5’UTR psaA exon 1(red), dxs gene (blue), two stop codons (highlighted in 
turquoise), HA tag (highlighted in red) and 3’UTR rbcL (green). 
AGCTTGGCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGT
AATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGT
ATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGG
GCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGACGA
AAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCC
TATTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGT
ATTCAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTTGCCTTCCTGTTTTTGCTCACCCAGAAACGCTGGTGAAAGTAAAAGATGCTGAAGA
TCAGTTGGGTGCACGAGTGGGTTACATCGAACTGGATCTCAACAGCGGTAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATGATGAGCACTT
TTAAAGTTCTGCTATGTGGCGCGGTATTATCCCGTATTGACGCCGGGCAAGAGCAACTCGGTCGCCGCATACACTATTCTCAGAATGACTTGGTTGAGTAC
TCACCAGTCACAGAAAAGCATCTTACGGATGGCATGACAGTAAGAGAATTATGCAGTGCTGCCATAACCATGAGTGATAACACTGCGGCCAACTTACTTCT
GACAACGATCGGAGGACCGAAGGAGCTAACCGCTTTTTTGCACAACATGGGGGATCATGTAACTCGCCTTGATCGTTGGGAACCGGAGCTGAATGAAGCCA
TACCAAACGACGAGCGTGACACCACGATGCCTGTAGCAATGGCAACAACGTTGCGCAAACTATTAACTGGCGAACTACTTACTCTAGCTTCCCGGCAACAA
TTAATAGACTGGATGGAGGCGGATAAAGTTGCAGGACCACTTCTGCGCTCGGCCCTTCCGGCTGGCTGGTTTATTGCTGATAAATCTGGAGCCGGTGAGCG
TGGGTCTCGCGGTATCATTGCAGCACTGGGGCCAGATGGTAAGCCCTCCCGTATCGTAGTTATCTACACGACGGGGAGTCAGGCAACTATGGATGAACGAA
ATAGACAGATCGCTGAGATAGGTGCCTCACTGATTAAGCATTGGTAACTGTCAGACCAAGTTTACTCATATATACTTTAGATTGATTTAAAACTTCATTTT
TAATTTAAAAGGATCTAGGTGAAGATCCTTTTTGATAATCTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAA
GATCAAAGGATCTTCTTGAGATCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAG
AGCTACCAACTCTTTTTCCGAAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAAC
TCTGTAGCACCGCCTACATACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAG
TTACCGGATAAGGCGCAGCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGA
GCTATGAGAAAGCGCCACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGG
GGAAACGCCTGGTATCTTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAA
CGCCAGCAACGCGGCCTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTAC
CGCCTTTGAGTGAGCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCAATTCGAATCCGCGTTTTCTCCGTGAAAG
GGAGGTGTCCTAGGCCTCTAGACGATGGGGGCTTTTTGTTATATTTTACTAAATATATATTATAATTAAAAAAAATTGAATTGTCAATTTTTAATGTACA
CTTAGTTGAAAGTGCCCCTGTCCCCTTGGCCATATTTAACAGAAGTTATTTATAACGCAGCTGTTTTTTGGAGTCTATAAATTTATAACATCAGTTACTAT
GGATTTCCCTTTAGTTTTATGGCCTAGGACGTCCCCTTCCCCTTCGATGCTGGAGGCATCCTTTTACGGGACAATAAATAAATTTGTTGCCTCGCCTATCGG
CTAACAAGTTCCTTCGGAGTATATAAATATAGGATGTTAATACTGCTATAAACTTTAGTTGCCCAATATTTATATTAGGACGCCAGTGGCAGTGGTACCGC
CACTGCCTGCTTCGCAGTATATAAATATAGGCAGTTGGCAGGCAACTGCCACTGACGTCCTATTTTAATACTCCCAAGTTTACTTGCCTAGGCAGTTGGCA
GGCAACAAATTTATTTATTGTCCACTAAAATTTATTTGCCCGAAGGGGACGTCCACTAAAATTTATTTACCCGAAGGGGACGTCCTAATATAAATATGGG
GATGTCAATGCTCCGTTAGGAAGTAACTAACGTTTTTCAAATAAATTTTATCCCGGAGGGAAGTAGGCAGTAGCCCGCCACTGTCATCCTTTAAGTGGATC
TCTCGTCAGGCAATTTGCTTACACCTTTAAATTAAAAATTAAATTTAAAGAAAAGTGAGCTATTAACGCGTAAGCTTTCTTAATTCAACATTTTTAAGTA
AATACTGTTTAATGTTATACTTTTACGAATACACATATGGTAAAAAATAAAACAATATCTTTAAAATAAGTAAAAATAATTTGTAAACCAATAAAAAAT
ATATTTATGGTATAATATAACATATGATGTAAAAAAAACTATTTGTCTAATTTAATAACCATGCATTTTTTATGAACACATAATAATTAAAAGCGTTGCT
AATGGTGTAAATAATGTATTTATTAAATTAAATAATTGTTATTATAAGGAGAAATCCATGCACATCAGCGAACTGACCCACCCCAATGAGTTAAAGGGTT
TATCTATCCGTGAGCTGGAGGAAGTTTCCCGGCAAATCCGAGAAAAACATCTCCAAACTGTGGCCACCAGCGGCGGTCATCTGGGGCCTGGGTTGGGAGTG
GTGGAACTGACGGTGGCCCTATATTCCACTCTTGATTTAGACAAAGACCGGGTGATTTGGGATGTGGGACACCAAGCCTATCCCCACAAAATGTTGACGGG
ACGTTACCATGATTTCCATACCCTGCGGCAAAAAGATGGGGTGGCTGGTTACCTCAAACGCTCTGAAAGTCGTTTTGACCATTTTGGTGCTGGGCACGCTT
CCACAAGTATTTCCGCTGGTTTGGGCATGGCTTTAGCTCGAGATGCCAAGGGGGAAGATTTTAAAGTAGTTTCCATCATTGGCGATGGTGCTTTAACCGGG
GGCATGGCCTTGGAGGCAATCAACCATGCCGGGCATTTGCCCCATACCAGACTAATGGTGATTCTCAATGACAATGAGATGTCCATTTCCCCCAACGTGGG
AGCCATTTCCCGTTATTTAAATAAAGTCCGCCTCAGCAGTCCGATGCAGTTTTTGACGGACAATCTGGAGGAACAGATCAAACACTTGCCCTTTGTGGGGG
ATTCCCTCACCCCGGAGATGGAAAGGGTCAAGGAGGGAATGAAACGTCTTGTTGTCCCCAAAGTGGGAGCGGTGATTGAAGAACTAGGATTTAAATATTT
TGGTCCCATTGACGGTCATAGTTTACAGGAATTAATCGATACCTTTAAACAAGCGGAAAAAGTGCCTGGTCCGGTGTTTGTCCATGTTTCCACCACCAAGG
GCAAGGGTTATGACTTAGCCGAAAAGGATCAAGTAGGCTACCACGCCCAAAGTCCTTTCAACCTTTCCACCGGTAAGGCCTATCCTTCTAGTAAGCCGAAA
CCCCCCAGCTATTCCAAGGTTTTTGCCCATACGTTGACTACCCTGGCCAAGGAAAATCCCAACATTGTCGGTATCACGGCTGCTATGGCGACGGGGACAGG
GCTAGATAAACTCCAGGCCAAGCTACCCAAGCAGTATGTGGACGTGGGCATTGCGGAACAACACGCAGTTACTTTGGCGGCGGGCATGGCCTGCGAGGGCA
TTCGTCCAGTGGTGGCCATCTATTCCACCTTTTTGCAACGGGGTTACGACCAGATTATCCATGACGTTTGTATTCAAAAATTACCCGTATTTTTCTGCCTA
GACCGGGCGGGCATTGTGGGGGCGGATGGGCCCACCCACCAAGGGATGTATGACATTGCCTATCTCCGTTGCATTCCCAATCTGGTGCTGATGGCTCCCAA
GGATGAAGCAGAGTTACAACAAATGCTGGTTACTGGGGTTAACTACACCGGTGGGGCGATCGCCATGCGTTATCCCCGGGGTAATGGCATCGGGGTGCCCC
TGATGGAGGAAGGTTGGGAACCGCTGGAAATTGGTAAAGCTGAAATTCTCCGGTCGGGGGATGATGTGCTTCTGTTGGGCTACGGCTCCATGGTCTATCCC
GCTCTGCAAACAGCGGAATTACTCCACGAACACGGCATCGAAGCAACGGTGGTTAATGCCCGCTTTGTTAAACCACTAGATACGGAATTAATTTTGCCCTT
GGCCGAGCGCATCGGCAAAGTGGTGACCATGGAAGAAGGTTGCCTCATGGGGGGCTTTGGCTCAGCAGTGGCGGAGGCCCTGATGGATAACAACGTGTTGG
TGCCCTTGAAACGTTTAGGGGTGCCCGACATACTTGTGGACCATGCCACTCCGGAACAATCCACCGTTGACCTTGGTTTAACCCCAGCCCAGATGGCGCAGA
ATATTATGGCTTCACTGTTCAAAACTGAAACTGAATCAGTTGTCGCTCCTGGAGTTAGTTACCCATACGATGTTCCAGATTACGCTTAATAAGCATGCAAG
CTTGTACTCAAGCTCGTAACGAAGGTCGTGACCTTGCTCGTGAAGGTGGCGACGTAATTCGTTCAGCTTGTAAATGGTCTCCAGAACTTGCTGCTGCATGT
GAAGTTTGGAAAGAAATTAAATTCGAATTTGATACTATTGACAAACTTTAATTTTTATTTTTCATGATGTTTATGTGAATAGCATAAACATCGTTTTTAT
TTTTATGGTGTTTAGGTTAAATACCTAAACATCATTTTACATTTTTAAAATTAAGTTCTAAAGTTATCTTTTGTTTAAATTTGCCTGTCTTTATAAATTAC
GATGTGCCAGAAAAATAAAATCTTAGCTTTTTATTATAGAATTTATCTTTATGTATTATATTTTATAAGTTATAATAAAAGAAATAGTAACATACTAAAG
CGGATGTAGCGCGTTTATCTTAACGGAAGGCCAGTGGCACGTCCGCCTGCCACTGCCGAATATAAATATGGTTGAGTTGCTTAGTTTACCTTAGCGAAAAG
AAGACTTAGCAGCTAGCCTTAACAAACAGTTTTATATTTTATGTTTGTGTTAAATAAAATTAAGAAACTTTAGCTAAAGTTTCCCAACTCATAGAAACGT
CATCTAAAATTAAAGAACTGTTGTAAATTTCTAAAATGATTAATAAGAATGCTGCAAATAAAAGGATAAATACAGCCATTAAAACAGTTGTACCCCAGCC
TGGTAATACTTTACCTGCTTCTGAGTTAAGTGGACGTAATAAAGTACCTAATGGTGTAACTAAACCAGGTTCTTGGAAGTCTGAATTTACTTTTGATGGT
TTAGCTTTAGAAGTTCCTGTTGCCATAATTGATTAAATGAATTAAGCGTTATTAGCGCTATTTTATTTACTTTCTGTAAAAAATAAGGAAAATATTCTTC
AGTGCATTCCCTCTCAGGATTATAAATACTCTGAGGATAACGTTCTCTCGTCAAGGGGTTGCTTCTTGTGAGTATAGAAACCTACTAGCACAAGAAATAAA
TTGCATAAAAATGTATTTACCTAGGACCGCAGTAGGCAGTCCCTTTTCCCCTTCAGAACTGCCTGCTTTAAAAGAATGAAAAAACTGCCTTGTCTGGTAAG
TAAAACTCTTTAATTACTCACTAAAGACGATCTTAGAAGTTCTTTGTTCATTTTTTATTTAATATAATATTTGTTATATAAAAATTAAATAATTTTTAAT
TAATGTTTAACTTTGTAAGGACAGTTTCAAAGTGACATGAATGGCTACTGCAAAAACGAAGTAAGTTATTCTTTCTCAGGGCAAAATTTTGAGTAGATTA
ATTTTGTTTAAAAATGTGGGACACAGTCGTCAAGTCTTTTGAACTATCTAAGAGATATGTTGAAAAGAGAATAATTTTATTATTAAATGAGCTATGGAAA
GTCCAGCTTTTTTCTTTACCTTTTTTTTATGGTTTCTTCTGTTAAGTGTAACTGGCTATTCAGTTTATGTTAGTTTTGGTCCACCTTCAAAAAAATTACGT
GATCCTTTTGAAGAACACGAAGATTAAACAAGTTAAAAAGTACTATTTTTACAAGTGACTTCGGTGCCTCTGAGAACCCTAGTTATAGTGATATAAAATA
ACTAGCTAACTACTTTATATTTTTATGAAAGTCATTTTGTCGAGCATATAAACAAAAACAAAATTGCTATACTAGGCAGTCACAGTGCAACTGTCTCCGTC
TCCTTAACCGAGAAAGGGTAAACGTCTTCGGTAAAGTAACAAACTTTAGTTATGTTAACTGCTTGCGAGTTAACCATTTTTTTTCCTCCGAAGGACAACAG
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TTGGCAGTTGCCAAACTTTAGTGGTCTAATATTTATATTAGGCAGTTGGCAGGCAACTGCACTGACGTCCCGAAGGGGAAGGGGTTTACTTACCTCCTAAC
GGAGTATATAAATAGAATAAAATTTATTTCCTGCGCTAGCAGATTTACATACTAGGATTTTAATACTCCGAAGGAGGCAGTGGCGGTACCACTGCCACTG
GCGTCCTCCTTCCCCTTCGGGCAAATGCATTTTAGTGCCACTTAAGTTTACTTGCCTAGGCAGTTGGCAGGACGTCAGTGGCAGTGGTACCGCGACTGCCTA
TATTTATATACTCCTAAGTTTACTTGCCTAGGCAGTTGGCAGGCAACTGCCACTGACGTCCTTCCCCTTCCCCTTCGGGACGTCCCCTTACGGGAATATAAA
TATTAGTGGATATTTATATACTGCGATGTTTACATACTCCGAAGGAGGAGAGCTAGCAGTTGCCTGCCAACTGCCTAATATAAATATTGGGCAAGTAAAC
TTAGAATGTTTACATACTCCGAAGGAGGACGTCCCTTACGGGAATATAAATATTAGTGGCAGTGGTACCGCCACTGCCTCCTTCGGAGTATTAAAATCCTA
GTATATAATATACCGTAAGGGACGTCCTCCGACGGTGGCAGTGGCGGTACCACTGCCACCGGCGTCCTAATATACATATTGAAGTATTTAAACCTGTTAGC
GCACGCTCTAACGAGTCAGTAAACTTCCCTTTTGGGGCTTCTAGGCAGCGCATAAATTTTCTAGGACGAACGTCCACTGGCGTCTCGTAAGGAGCAGTGAC
AGGCCACTAATGTCCCCTTAATGGGTAAATAAATGGCTATCGTCTATCCATGAAGAGACCATATATTCCAGTAGCACCGTTATGATCCTCAAAGGGTAACA
CCATTTGTATAGTATTATGGTGAAATGCATCCCTTTCAGGGTAGATTTATATCTTACAG 
E) Plasmid pRY134aΔdxs  
This plasmid is identical to pRY134a except for the partial deletion of dxs gene. The deleted 141 bp 
from the dxs gene is underlined. Key: NcoI restriction site (highlighted in yellow), HA tag (highlighted 
in red) and two stop codons (highlighted in turquoise). 
ATGCACATCAGCGAACTGACCCACCCCAATGAGTTAAAGGGTTTATCTATCCGTGAGCTGGAGGAAGTTTCCCGGCAAATCCGAGAAAAACATCTCCAAAC
TGTGGCCACCAGCGGCGGTCATCTGGGGCCTGGGTTGGGAGTGGTGGAACTGACGGTGGCCCTATATTCCACTCTTGATTTAGACAAAGACCGGGTGATTT
GGGATGTGGGACACCAAGCCTATCCCCACAAAATGTTGACGGGACGTTACCATGATTTCCATACCCTGCGGCAAAAAGATGGGGTGGCTGGTTACCTCAAA
CGCTCTGAAAGTCGTTTTGACCATTTTGGTGCTGGGCACGCTTCCACAAGTATTTCCGCTGGTTTGGGCATGGCTTTAGCTCGAGATGCCAAGGGGGAAGA
TTTTAAAGTAGTTTCCATCATTGGCGATGGTGCTTTAACCGGGGGCATGGCCTTGGAGGCAATCAACCATGCCGGGCATTTGCCCCATACCAGACTAATGG
TGATTCTCAATGACAATGAGATGTCCATTTCCCCCAACGTGGGAGCCATTTCCCGTTATTTAAATAAAGTCCGCCTCAGCAGTCCGATGCAGTTTTTGACG
GACAATCTGGAGGAACAGATCAAACACTTGCCCTTTGTGGGGGATTCCCTCACCCCGGAGATGGAAAGGGTCAAGGAGGGAATGAAACGTCTTGTTGTCCC
CAAAGTGGGAGCGGTGATTGAAGAACTAGGATTTAAATATTTTGGTCCCATTGACGGTCATAGTTTACAGGAATTAATCGATACCTTTAAACAAGCGGAA
AAAGTGCCTGGTCCGGTGTTTGTCCATGTTTCCACCACCAAGGGCAAGGGTTATGACTTAGCCGAAAAGGATCAAGTAGGCTACCACGCCCAAAGTCCTTT
CAACCTTTCCACCGGTAAGGCCTATCCTTCTAGTAAGCCGAAACCCCCCAGCTATTCCAAGGTTTTTGCCCATACGTTGACTACCCTGGCCAAGGAAAATCC
CAACATTGTCGGTATCACGGCTGCTATGGCGACGGGGACAGGGCTAGATAAACTCCAGGCCAAGCTACCCAAGCAGTATGTGGACGTGGGCATTGCGGAAC
AACACGCAGTTACTTTGGCGGCGGGCATGGCCTGCGAGGGCATTCGTCCAGTGGTGGCCATCTATTCCACCTTTTTGCAACGGGGTTACGACCAGATTATC
CATGACGTTTGTATTCAAAAATTACCCGTATTTTTCTGCCTAGACCGGGCGGGCATTGTGGGGGCGGATGGGCCCACCCACCAAGGGATGTATGACATTGC
CTATCTCCGTTGCATTCCCAATCTGGTGCTGATGGCTCCCAAGGATGAAGCAGAGTTACAACAAATGCTGGTTACTGGGGTTAACTACACCGGTGGGGCGA
TCGCCATGCGTTATCCCCGGGGTAATGGCATCGGGGTGCCCCTGATGGAGGAAGGTTGGGAACCGCTGGAAATTGGTAAAGCTGAAATTCTCCGGTCGGGG
GATGATGTGCTTCTGTTGGGCTACGGCTCCATGGTCTATCCCGCTCTGCAAACAGCGGAATTACTCCACGAACACGGCATCGAAGCAACGGTGGTTAATGC
CCGCTTTGTTAAACCACTAGATACGGAATTAATTTTGCCCTTGGCCGAGCGCATCGGCAAAGTGGTGACCATGGAAGAAGGTTGCCTCATGGGGGGCTTTG
GCTCAGCAGTGGCGGAGGCCCTGATGGATAACAACGTGTTGGTGCCCTTGAAACGTTTAGGGGTGCCCGACATACTTGTGGACCATGCCACTCCGGAACAA
TCCACCGTTGACCTTGGTTTAACCCCAGCCCAGATGGCGCAGAATATTATGGCTTCACTGTTCAAAACTGAAACTGAATCAGTTGTCGCTCCTGGAGTTAG
TTACCCATACGATGTTCCAGATTACGCTTAATAA 
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Appendix. 6 List of conferences 
 Conference – Poster preparation  
Algae Europe 2015 Conference-Lisbon, Portugal 
                Date: 01/12/2015 ‒ 03/12/2015 
 Conference - Poster Preparation 
BioProNET 2nd Annual Scientific Symposium, Manchester Midland Hotel, UK 
Date: 22/10/2015 ‒ 23/10/2015 
 
 Conference – Attendance 
PHYCONET Annual Conference 2015 Bordeax Suite, Novotel London West, UK 
Date: 26/08/2015  
 
 Conference - Poster Presentation 
Algae around the world Symposium, Cambridge University, UK  
                Date: 19/03/2015  
 
 Conference - Poster Preparation 
                Chloroplast Biotechnology, Ventura, California, United States 
                Date: 18/01/2015 ‒ 23/01/2015 
 Conference - Attendance 
Algal Biotechnology Symposium 2014, University of Sheffield, Sheffield, UK 
Date: 26/08/2014    
 
 Conference - Poster Preparation 
PHYCONET symposium, Darwin Building, University College London, Uk  
Date: 14/04/2014   
 
 Conference - Presentation 
Young Algaeneers Symposium 2014, Montpellier-Narbonne, France  
Date: 03/04/2014 ‒ 05/04/2014 
 
 Conference - Poster Preparation 
Alg'n'Chem 2014: Which future for algae in industry, Montpellier, France  
Date: 31/03/2014 ‒ 03/04/2014 
 
 Conference - Poster Preparation 
Sustainable Chemicals from Microalgae: Encompassing Biocrude through to Fine Chemicals 
Burlington House, London, Uk 
Date: 19/11/2013 ‒ 19/11/2013 
 
 Conference - Attendance 
High-Value Chemicals from Biomass, RSC, Burlington House, London, UK 
Date: 17/09/2013 ‒ 17/09/2013 
 
 Conference - Presentation 
Plastid Preview 2013, University of Greenwich, London, UK 
Date: 09/09/2013 ‒ 10/09/2013 
 
 Conference - Poster Preparation 
The 2013 Algal Biotechnology Symposium, Cambridge University, UK 
Date: 02/09/2013 ‒ 02/09/2013 
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Appendix. 7 Publication 
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